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ABSTRACT

A protein’s sequence of amino acids determines how it folds. That folded structure
is linked to protein function, and misfolding to dysfunction. Protein misfolding and
aggregation into β-sheet rich fibrillar aggregates is connected with over 20
neurodegenerative diseases, including Alzheimer’s disease (AD). AD is characterized in
part by misfolding, aggregation and deposition of the microtubule associated tau protein
into neurofibrillary tangles (NFTs). However, two questions remain:
fibrillization mechanism, and what is tau’s cytotoxicity mechanism?
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What is tau’s

Tau is prone to heterogeneous interactions, including with lipid membranes. Lipids
have been found in NFTs, anionic lipid vesicles induced aggregation of the microtubule
binding domain of tau, and other protein aggregates induced ion permeability in cells. This
evidence prompted our investigation of tau's interaction with model lipid membranes to
elucidate the structural perturbations those interactions induced in tau protein and in the
membrane.
We show that although tau is highly charged and soluble, it is highly surface active
and preferentially interacts with anionic membranes. To resolve molecular-scale structural
details of tau and model membranes, we utilized X-ray and neutron scattering techniques.
X-ray reflectivity indicated tau aggregated at air/water and anionic lipid membrane
interfaces and penetrated into membranes. More significantly, membrane interfaces
induced tau protein to partially adopt a more compact conformation with density similar to
folded protein and ordered structure characteristic of β-sheet formation. This suggests
possible membrane-based mechanisms of tau aggregation.
Membrane morphological changes were seen using fluorescence microscopy, and
X-ray scattering techniques showed tau completely disrupts anionic membranes,
suggesting an aggregate-based cytotoxicity mechanism. Further investigation of protein
constructs and a “hyperphosphorylation” disease mimic helped clarify the role of the
microtubule binding domain in anionic lipid affinity and demonstrated even
“hyperphosphorylation” did not prevent interaction with anionic membranes. Additional
studies investigated more complex membrane models to increase physiological relevance.
These insights revealed structural changes in tau protein and lipid membranes after
interaction. We observed tau’s affinity for interfaces, and aggregation and compaction once
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tau partitions to interfaces. We observed the beginnings of β-sheet formation in tau at
anionic lipid membranes. We also examined disruption to the membrane on a molecular
scale.
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CHAPTER 1 INTRODUCTION

1.1 Intrinsically disordered proteins
1.1.1 Protein structure-function paradigm
It has long been noted that a folded protein’s 3-dimensional structure determined
its function. A protein consists of a sequence of amino acids; this sequence would then
define how the protein will fold, and the folded structure would determine the protein’s
function (Daughdrill et al., 2008; Dunker et al., 2001; Dyson & Wright, 2005; Fischer,
1894; Uversky et al., 2008).
Intrinsically disordered proteins (IDPs) are a class of proteins abundant in nature
which, under physiological conditions, lack stable secondary and tertiary structure (Dunker
et al., 2001; Dyson & Wright, 2005; Uversky et al., 2008). IDPs challenge the long-held
structure-function paradigm, as they are biologically active though intrinsically disordered.
Instead, their disorder allows structural plasticity. IDPs fulfill critical functions when they
transition from ordered to disordered formations upon binding to physiological partners
(Daughdrill et al., 2008; Dunker et al., 2001; Dyson & Wright, 2005; Uversky & Dunker,
2010). IDPs are also found to be excessively connected to protein-associated diseases,
including neurodegenerative diseases, cancers, amyloidosis, diabetes mellitus and
cardiovascular diseases (Arispe et al., 1994; Demuro et al., 2005; Goedert et al., 2010;
Iakoucheva et al., 2002; Khemtemourian et al., 2008; Selkoe, 2000; Soto, 2003; Uversky
et al., 2008).
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1.1.2 Protein misfolding
Misfolding or completely denaturing a protein can prevent it from performing its
normal physiological function (Chi et al., 2008; Meredith, 2005; Soto, 2003). In addition
to this loss of function, it is possible that accumulated misfolded proteins form toxic
aggregates. Research has found that many neurological and systemic diseases are likely
caused by such dysfunction of proteins (Clavaguera et al., 2013; Goedert et al., 2010;
Meredith, 2005; Soto, 2003; Uversky et al., 2008; Walker et al., 2013). These protein
conformational disorders cover a wide range, from the more common neurodegenerative
diseases such as Alzheimer’s disease to rare inherited diseases such as Pick’s disease.
The largest group of these protein conformational disorders is related to a class of
proteins known to form amyloid fibrils - highly ordered, insoluble, filamentous protein
aggregates (Uversky et al., 2008). Once the proteins are converted from their functional
state to the diseased fibril state, they accumulate and deposit into various organs and
tissues. Protein fibrils are observed in a range of neurodegenerative disorders including
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS),
Huntington’s disease, and prion diseases (Figure 1.1). Although the specific protein
involved differs, misfolding and aggregation of protein is present in all cases (Soto, 2003).

2

Figure 1.1 Aggregates in neurodegenerative diseases.

Protein aggregates are found in many diseases. Extracellular amyloid plaques and
intracytoplasmic neurofibrillary tangles are pathological hallmarks of Alzheimer’s disease.
In spite of the different protein compositions across the range of diseases, the ultrastructure
of these deposits seems to be similar and composed mainly of a network of fibrillar
polymers (center) (Soto, 2003).
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1.2 Alzheimer’s disease as a representative protein misfolding disorder
1.2.1 Alzheimer’s disease
The most common protein misfolding neurodegenerative disease, Alzheimer’s
disease (AD), affects over 5 million people in the U.S. alone: 3-8% of those over the age
of 65 and 50% of those over 85. The estimated cost of AD care in 2014 is over
$200 billion, and is expected to reach $1.1 trillion by the year 2050 ("Treatments and
Research," 2014). There is currently no known cure, prevention or treatment to slow the
progression of AD. Currently available prescription medications such as anti-depressants
for mood or anxiolytics for anxiety treat symptoms only, without modification of the
underlying neurodegenerative process ("Treatments and Research," 2014). In AD, two
IDPs, amyloid beta (Aβ) and tau, aggregate to form plaques (Figure 1.1) and neurofibrillary
tangles (NFTs) (Figure 1.1), respectively. β sheet-rich insoluble fibrils are known to be
associated with neurodegeneration in AD (Ghanta et al., 1996; Kim et al., 2003; Kim,
Muresan, Lee, & Murphy, 2004; Kim & Murphy, 2004; Kremer & Murphy, 2003;
Mandelkow et al., 2007; Marx, 2007; Meredith, 2005; Soto, 2003).

1.2.2 Amyloid beta and tau proteins
Amyloid beta (Aβ) is a protein produced by the amyloid precursor protein (APP),
whose main physiologic function is not well understood (Hiltunen et al., 2009). After
cleavage from APP by the β- and γ-secretases, Aβ becomes an extracellular protein. Aβ
denotes peptides of 36–43 amino acids. In a diseased state, Aβ proteins aggregate into
amyloid plaques. These extracellular plaques have long been observed in AD (Ghanta et
4

al., 1996; Selkoe, 2000). The most common isoform of Aβ contains 40 residues (Figure
1.2, top) and was used exclusively in our studies. The Aβ42 isoform is more hydrophobic
and the most amyloidogenic, but the central sequence KLVFFAE which most likely forms
the core of the amyloid fibril also occurs in Aβ40 (De Groot, 2006).
However, the role of tau protein and its aggregates, NFTs, in AD has not been as
clear as the role of Aβ. Different, and sometimes even contradictory, conclusions have been
drawn (Ballatore et al., 2007). In tauopathies like AD, the equilibrium of tau is upset and
unbound proteins begin to accumulate in the cytosolic environment. A number of
pathogenic events may contribute to the subsequent hyperphosphorylation, misfolding and
aggregation of tau. Several tau mutations, including those that can cause frontotemporal
dementia with parkinsonism linked to chromosome 17 (Goedert et al., 1996), may lead to
mutants which are: prone to rapid tau fibrillization (Goedert, 2005; Goedert & Jakes, 2005),
more readily phosphorylated or less prone to dephosphorylation (Alonso Adel et al., 2004),
or which exhibit impaired MT binding (Hong et al., 1998; Nacharaju et al., 1999). A study
which found that decreasing tau levels can block Aβ-induced cognitive impairments in AD
mouse models (Berger et al., 2007) exhibited that tau abnormalities alone may cause
neurodegeneration, strengthening the hypothesis that tau plays a critical role in AD
pathogenesis.
The tau protein (Figure 1.2, bottom) is an IDP normally involved in the stabilization
of microtubules to facilitate intracellular transport. It naturally undergoes a cycle of
phosphorylation and dephosphorylation as it detaches from and attaches to microtubules.
Its misfolding and aggregation have been linked to over 20 diseases such as hereditary
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frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17),
collectively termed tauopathies, including AD (Lee et al., 2001).

Figure 1.2 Schematics of amyloid beta (Aβ) 40 (top) and wild type tau protein (bottom).

1.2.3 Tau structural compaction and membrane disruption
The physiological factors and conditions that trigger tau misfolding and
aggregation into fibrils, called paired helical filaments (PHFs), are currently unknown. The
tau protein is soluble and rich in charged and hydrophilic residues which results in less
likelihood of aggregate formation. In order for tau to form β-sheet rich fibrils in vitro,
polyanionic cofactors such as heparin or anionic micelles must be introduced. This suggests
that tau aggregation proceeds through a nucleation-controlled polymerization pathway.
Whether the cofactors also induce conformational changes to the tau is unknown.
Physiological factors which trigger tau fibrils to form in vivo are also unclear. We wish to
address this knowledge gap.
Several lines of investigation suggest that interaction of tau with plasma
membranes may be involved in tau aggregation. Research has shown tau interacts at least
6

indirectly with the plasma membrane through its aminoterminal projection domain (Figure
1.2, bottom) and that it is present in detergent-resistant membrane microdomains
(Kawarabayashi et al., 2004; Williamson et al., 2008). Membrane glycolipids have been
found to be associated with PHFs isolated from AD brains (Gray et al., 1987). More
recently, membrane-associated chimeric tau has been shown to seed the formation of PHFs
from full length tau protein (Campos-Pena et al, 2009), and anionic lipid vesicles have been
shown to promote the aggregation of the MT binding domain of tau (K18) at submicromolar concentrations (Elbaum-Garfinkle et al., 2010). Thus, plasma membranemediated tau misfolding and aggregation may serve as an in vivo mechanism by which the
protein nucleates and grows into PHFs. As such, even if the membrane-bound tau is only
a small fraction of the protein population, it may be capable of seeding the growth of mature
fibrils.

1.3 Lipid membranes
1.3.1 Structure of biological membranes
Physiological cell membranes form a continuous protective barrier which is
selectively impermeable to the entrance of substances into and out of the cell. These
membranes are complex structures composed of a phospholipid bilayer with globular
proteins, receptors, transmembrane channels, and glycoproteins floating in the lipid
structure (Butterfield & Lashuel, 2010) (Figure 1.3A). The membrane interacts with
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structures inside and outside of the cell including the cytoskeleton, a dynamic network of
protein fibers including microtubules, involved in cellular functions such as transport and
structure. Because of the hypothesized link between membrane lipids and the microtubuleassociated protein tau’s misfolding and aggregation, we wish to investigate the
membrane’s interaction with tau.
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(A)

(B)

Figure 1.3 (A) Illustration of a biological cell membrane including many of its
complexities (Skou, 1965) and (B) basic schematic of a phospholipid bilayer (Team,
2008) with inset of individual phospholipid.
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Due to the inherent complexity of cell membranes, researchers commonly employ
simplified model lipid membranes (Figure 1.3B) in their experiments wherein components
of the system can be individually modified and tested. A simplified membrane consisting
of either a lipid monolayer or bilayer, as we utilized in our experiments, is formed from
pure phospholipids. Phospholipids are amphiphilic and consist of two main regions, the
hydrophilic phosphate group “head” and the hydrophobic fatty acid “tails” (Figure 1.4A).
The head contains a choline, phosphate and glycerol group while the tail is composed of
two hydrocarbon chains. Because of their amphiphilic nature, in an aqueous environment
phospholipids spontaneously form structures which limit the contact of the hydrophobic
tails with water, either micelles (single layer spheres) or bilayers (two layer spheres and
films) (Skou, 1965). Formation of these structures shields the hydrophobic tails from
contacting the aqueous environment and exposes the hydrophilic heads to the polar water
molecules. Bilayers function to separate an internal aqueous environment from the
surrounding outer environment.
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(A)

(B)

Figure 1.4 A detailed schematic of a phospholipid’s basic structure and structures formed
in aqueous solutions.

As illustrated in Figure 1.4, the phospholipid is composed of a hydrophilic “head”
group and two hydrophobic “tails” (Team, 2008); and (B) structures formed by
phospholipids in aqueous solutions (Skou, 1965).

1.3.2 Properties of cell membranes
A phospholipid bilayer cell membrane forms a semipermeable protective
membrane which is permeable to lipid-soluble materials but impermeable to all but the
smallest water-soluble materials. Transport of polar or ionic materials across a cell
11

membrane is highly regulated by specialized transport proteins located in the membrane.
In general, there are three ways that material can cross a membrane. First is by diffusion,
with molecules dispersing from an area of lower concentration to an area of higher
concentration. Small lipid-soluble materials like CO2 or O2 can rapidly cross the lipid
membrane in this manner. Second is by facilitated diffusion, whereby large polar molecules
cross via specialized protein channels in response to a concentration gradient. Third is
active transport, in which the cell uses energy to pump a molecule against the concentration
gradient (low to high) (Skou, 1965). Disruption of cell membranes deregulates transport,
ultimately leading to imbalances that cause cell death.

1.3.3 Modeling cell membranes
1.3.3.1 Fluid mosaic and lipid raft models
In 1972, Singer proposed the fluid-mosaic model of cell membrane structure. In
this model, the phospholipid membrane can be considered a two-dimensional fluid (Singer,
1972; Singer & Nicolson, 1972) through which lipid and protein molecules diffuse easily.
Lipids are constantly moving laterally along the surface, while a large number of proteins
lend more structure to the membrane. The class of integral membrane proteins pass through
the bilayer to facilitate ionic transport across the membrane. Disruption of the membrane
can destroy the gradient and lead to cell death. More recent membrane models extend this
understanding (Korade & Kenworthy, 2008; Pike, 2008; Simon & Ehehalt, 2002). The lipid
membrane is no longer seen to be a homogeneous fluid, but instead to contain lipid
assemblies, or rafts, rich in cholesterol and sphingomyelin which complex with internal
structures and proteins in the cell. The phospholipids within a bilayer or monolayer may
12

also form microdomains with varying packing density depending on lipid composition and
surface pressure (Rajendran & Simons, 2005; Goodsaid-Zalduondo et al., 1982).

1.3.3.2 Phospholipid phase behavior
Phase behavior of a bilayer references the relative fluidity of the bilayer’s
constituent lipid molecules and how this is influenced by changes in temperature and/or
pressure (Silvius, 1982; Berg, 1993). This behavior of phospholipids may be modeled
similarly to phase behavior when transitioning from gas to liquid to solid state by using
monolayers in Langmuir troughs (Feigenson, 2006; Kaganer et al., 1999). In the gas phase,
lipids in a monolayer are very dilute, with an area per molecule in the range of hundreds of
Å2/molecule. As pressure is increased, the area per molecule decreases and the monolayer
enters what is termed the liquid-expanded (LE or L1) state. Further pressure increase leads
to the liquid-compressed (LC or L2) state, where the area per molecule has decreased to
about 25 Å2/molecule. As this LC lipid packing density is reported to be comparable to a
lipid bilayer under physiological conditions (Seelig, 1987), lipid monolayers in the LC state
are frequently used as membrane models. Our studies employed both lipid monolayers and
bilayers to model the interaction of proteins and lipid membranes. In this way we could
test for changes in the structure of both the protein and membrane, which we hypothesize
may lead to either protein misfolding or membrane disruption.
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1.3.4 IDPs such as tau and interaction with lipid membranes
Several IDPs, including tau, have been shown to interact with lipid membranes
(Arispe et al., 1993; Arispe et al., 1994; Simakova & Arispe, 2007; Uversky et al., 2008).
Because of the presence of charged groups, tau in particular is prone to heterogeneous
interactions, including with the lipid membrane. Such interaction of tau with the lipid
membrane could induce structural changes in the protein itself and also affect membrane
integrity. We propose that interactions between tau and interfaces such as the cell
membrane can induce disordered-to-ordered transitions in the protein, lowering the
activation free energy of aggregation. We hypothesize that IDPs like tau are highly
susceptible to abnormal binding to interfaces due to their unique combination of high
specificity and low affinity for coupled binding-and-folding events. Such interaction can
induce transitions from a disordered but non-aggregate-forming conformation to a
conformation that is aggregation-competent, which can then template the assembly of tau
into highly ordered fibrils.
We also propose that tau-induced membrane disruption may serve as a pathway by
which the protein exerts toxicity. We hypothesize that tau will cause changes to both the
order and integrity of anionic lipid membranes, which will result in death of the cell. Lipid
membrane damage will lead to ion dysregulation, which can serve as a method of
cytotoxicity in vivo.
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1.4 Neutron and X-ray scattering studies give structural information about
membrane and tau upon their interaction
Several scattering techniques in recent years, including neutron and X-ray
reflectivity (NR or XR) and grazing incidence X-ray diffraction (GIXD) have been used
to study the surface properties of thin films ( Als-Nielsen et al., 1994; Als-Nielsen & Kjaer,
1989; Eisenberger & Feldman, 1981; Feidenhans'l, 1989; Russell, 1990). These techniques,
which can provide information about molecular scale composition and ordering of
molecules at interfaces, utilize the wave characteristics of the probe (neutron or X-ray in
this case) near the condition of perfect reflection. After being incident upon the atoms,
X-rays are scattered from the electrons while neutrons are scattered from nuclei (Dubey et
al., 2011; Majewski et al., 2000; Russell, 1990). These X-rays or neutrons are then incident
upon a detector. The resulting signals from the detector give valuable and detailed
information about the molecular composition and ordering of the films. X-ray reflectivity
provides the electron density composition of the film and GIXD provides information
about the in-plane ordering of the film. NR provides information about the chemical
composition of the film (Als-Nielsen & Kjaer, 1989; Pedersen & Hamley, 1994). This data
cannot be gathered from other experimental assays such as Langmuir trough pressure/area
assays or fluorescence imaging of a model membrane.

1.4.1 Neutron scattering
Neutron reflectivity (NR) studies result in information about membrane
perturbation of model lipid bilayers, including from tau’s interaction with the lipid
15

membrane (Figure 1.5). Analysis of NR data provides knowledge of coherent scattering
length density (SLD) distribution in a model lipid bilayer sample. SLD is a value unique
to a particular chemical composition and is the sum of coherent scattering lengths of
constituent elements divided by the volume they occupy. Structural changes of a bilayer
upon interaction with tau protein can be easily observed using neutron scattering (AlsNielsen et al., 1984; Pedersen & Hamley, 1994).
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Figure 1.5 A typical scattering geometry for neutron reflectometry.

In Figure 1.5, ki and kf are the incident and reflected neutron wave vectors,
respectively, and qz is the z component of the momentum transfer vector.
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1.4.2 X-ray scattering
1.4.2.1 Grazing incidence X-ray diffraction
Grazing incidence X-ray diffraction (GIXD) provides information about the
disruption of lipid ordering on a molecular scale. In GIXD, the angle GIXD data give
structural information on the in-plane (i.e., in the plane of the monolayer) ordered (hence
diffracting) portion of the film (Figure 1.6). Presence of Bragg peaks in GIXD data
indicates 2D ordered structures.

Figure 1.6 Schematic of grazing incidence X-ray diffraction and top down simplified
view of a lipid monolayer.

In Figure 1.6, ki and kf are the incident and final X-ray wave vectors, respectively,
with αi and αf as the incident and final angles. q is the momentum transfer vector, which in
the diagram is broken into its z and xy components. The 2θxy angle refers to the angular
distance which is traversed by the detector as it translates in the xy plane.
17

1.4.2.2 X-ray reflectivity
X-ray reflectivity gives information about the compaction and aggregation of protein.
XR data give information about the out-of-plane (perpendicular to the lipid film) electron
density profile of the film averaged over the LE and LC phases (Figure 1.7). In general, at
every interface a portion of X-rays is reflected. Interference of these partially reflected
beams creates a reflectometry pattern.

Figure 1.7 Schematic of X-ray reflectivity.
Figure 1.7 illustrates a schematic of X-ray reflectivity and a sample graph showing how
chemically distinct molecular layers (e.g., proteins, lipid headgroups and tails) have
different electron densities and can be modeled as boxes. ki and kf are the incident and final
X-ray wave vectors, respectively, with α as the incident and final angle. qz is the z
component of the momentum transfer vector, equal to 2ksin α.
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1.5 Effects of osmolytes
In order to better understand the interaction of proteins with lipid membranes, the
simple model of a lipid monolayer or bilayer on a water subphase must be extended to a
more physiological model. Factors which are ignored in the simpler models include
molecular crowding and preferential exclusion. In a human cell, the cytoplasm has a high
concentration of macromolecules (50-400 mg/mL) (Chebotareva et al., 2004). This
molecular crowding may significantly change the stability, conformation and functional
property of protein molecules (Batra et al., 2009; Harries & Rosgen, 2008; Johansen et al.,
2011). A major contributor to this crowding is the presence of osmolytes. Osmolytes are
small co-solutes that influence and counterbalance the osmotic pressure of the cell and the
cellular environment (Yancey, 1982). The most common naturally occurring osmolytes
include polyols (glucose and sucrose), urea and methylamines (Lee, 1981). Osmolytes are
also preferentially excluded over water from the protein surface, exerting non-specific
interfacial effects on proteins. The result is an increase in the surface tension of the
protein/solvent interface, driving the stabilization of protein structure as the protein
conformation equilibrium is shifted to a more folded state (Harries & Rosgen, 2008;
Arakawa & Timasheff, 1985).
Examining the effects of sucrose, a model osmolyte, on the surface activity of Aβ
and its interaction with a lipid membrane moves the model to a more physiological
representation. Sucrose shifts the protein conformation equilibrium toward a minimal
exposed surface area. In the presence of a membrane interface, the protein will insert into
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a leaflet of a lipid (membrane interface) to further minimize solvent exposed surface area
(Anaya, 2013).

1.6 Structural and molecular insights gained from study of additional polyampholytes
with lipid membranes
1.6.1 Polyampholytes and amphiphiles
Polymers are large molecules formed from many repeating subunits. These can be
produced by living organisms (biopolymers) or synthetically created. Both natural and
artificial polymers are created by the polymerization of many small molecules, or
monomers, into a long, covalently bonded chain (Painter & Coleman, 1997; McCrum et
al., 1997). Polymeric biomolecules include three main classes: polynucleotides (DNA and
RNA), polysaccharides (e.g., starches or glycogen), and polypeptides (polymers of amino
acids) (Mohanty et al., 2005; Meyers et al., 2008; Chandra, 1998). An amphoteric molecule
is defined as one which can react either as an acid or as a base. Polyampholytes, polymers
which contain both acidic and basic groups, are one type of this molecule. These molecules
are prone to heterogeneous interactions because of their charged nature (Kudaibergenov,
2002, 2008). Ampholytes can also be classified as amphiphilic when they possess both
hydrophilic and hydrophobic characteristics.
A range of chemical compounds, such as soaps, detergents and lipoproteins, are
amphiphiles. One example group is hydrocarbon based surfactants, which may have an
ionic or non-ionic polar region. Many components of physiological cell membranes are
amphiphilic, including phospholipids, cholesterol and glycolipids. The amphiphilic
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properties of phospholipids are the driving force behind their self-assembly into structures
such as micelles and bilayers (Furse, 2011; Royal Society of Chemistry, 2014). Peptides
also possess amphiphilic properties, driving their self-assembly into folded structures with
hydrophobic residues at the center of their structure protected from interaction with
aqueous surroundings (Yu et al, 1996).
The tau protein is both a polyampholyte and amphiphile. To learn more about how
tau interacts with amphiphilic lipid membranes, and the subsequent effects on both the lipid
and the tau molecule, we performed studies of the analogous interactions of lipid
membranes with other polyampholyte molecules, including biocidal polymers and the
galectin GM-1.

1.6.2 OPEs, CPEs, and membrane destabilization
Cationic phenylene ethynylene oligomers and polymers (OPEs and CPEs) can
exhibit biocidal activity against bacteria via membrane destabilization (Y. Wang et al.,
2010). Membrane destabilization is dependent on the lipid composition of bacterial cell
membranes as opposed to mammalian cell membranes (Ji et al., 2011). This is similar to
the charge-dependent interaction of tau protein with lipid monolayers or bilayers.
Examination of the changes to the photophysical characteristics of lipid membranes after
interaction with OPEs provides insight into possible mechanisms of cellular toxicity
resulting from tau protein and lipid membrane interaction.
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1.6.3 Galectin
Studying the interaction between galectin and a ganglioside GM1-containing lipid
membrane provides insight into how insertion of galectin into a model lipid monolayer
affects membrane properties such as fluidity, as well as the structure of the protein itself.
H-Gal1, the protein discussed here, is a member of the galectin family. Galectins are
proteins which are defined by their binding specificity for β-galactoside sugars (Barondes,
1994). They have a broad range of functions from mediation of cell-cell interactions to
transmembrane signaling (Taylor, 2011). H-Gal1, whose structure has been shown to
change upon entering a hydrophobic environment (Gupta et al., 2006), exerts growth
control via GM1 binding on human neuroblastoma (SK-N-MC) cells in vitro and on
activated T effector cells (Kopitz et al., 2010; Ledeen et al., 2012; J. Wang et al., 2009; Wu
et al., 2011). Investigation of H-Gal1and its insertion into lipid membranes via X-ray
scattering techniques provides further insight into the structural changes that take place in
both the protein and the membrane when protein insertion occurs.

1.7 Structural explication of tau protein and lipid membrane interaction
With these models in mind, we began our study of the tau protein and its interaction
with lipid membranes in order to learn more about the structural changes which occur in
both the protein itself and the lipid membranes. Studies of model lipid membranes
interacting with the full length tau protein, as described in Chapter 2, helped elucidate the
structural changes which take place in the tau protein and in the membrane upon such
interaction. Further experiments described in Chapter 3 using tau constructs and a
hyperphosphorylation mimic investigated the effects of domain composition and
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hyperphosphorylation on the structural effect of this interaction between tau and lipid
membranes. To further the complexity of the model, additional studies described in
Chapter 4 explored the role of osmolytes in protein folding at lipid interfaces. Investigation
into photophysical characteristics of ampholytic membrane destabilization, described in
Chapter 5, supplied insight into the ways that ampholytes such as tau may induce cellular
toxicity. Structural changes that occur in a protein and lipid after protein insertion into a
lipid interface were also examined using X-ray reflectivity techniques as described in
Chapter 6. Together, these studies provide insight into the structural changes that take place
in both the tau protein itself and in the lipid membranes it interacts with. This work helps
elucidate the causes of tau protein misfolding leading to aggregation and lipid membrane
disruption.
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CHAPTER 2 INTERACTION OF TAU PROTEIN WITH MODEL LIPID
MEMBRANES INDUCES TAU STRUCTURAL COMPACTION AND
MEMBRANE DISRUPTION

(This chapter has been published in Biochemistry and appears as Emmalee M. Jones,
Manish Dubey, Phillip J. Camp, Briana C. Givler, Jacek Biernat, Eckhard Mandelkow,
Jaroslaw Majewski, Eva Y. Chi. 2012. Interaction of tau protein with model lipid
membranes induces tau structural compaction and membrane disruption, Biochemistry, 51:
2539-2250)

Abstract
Neurofibrillary tangles composed of the tau protein are major hallmarks of
Alzheimer's disease. The mechanism of tau’s aggregation is unknown, but likely involves
polyanionic cofactors. Tau is mainly a cytosolic microtubule-associated protein, but has
also been proposed to interact with the plasma membrane and membranous organelles.
This prompted our detailed investigation of tau's interactions with model lipid membranes.
We show that the intrinsically disordered full-length tau is highly surface active,
preferentially associates with anionic DMPG lipid membranes, undergoes structural
compaction, and induces membrane morphological changes observed with fluorescence
microscopy. To resolve molecular-scale structural details of tau at the air/water and
membrane interfaces, X-ray scattering techniques are used. X-ray reflectivity modeling
indicates tau’s presence under a DMPG monolayer and partial insertion into the lipid
headgroup region, while grazing incidence X-ray diffraction shows that tau insertion
disrupts lipid packing. Moreover, both interfaces induce tau to partially adopt a more
compact conformation similar to that of a folded protein. Neutron reflectivity assays show
that tau completely disrupts DMPG bilayers while leaving the neutral DPPC bilayer intact.
Our results indicate that tau’s strong interaction with anionic lipid membranes induces tau
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structural compaction and membrane disruption, suggesting possible membrane-based
mechanisms of tau aggregation and toxicity.

2.1 Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by
neurofibrillary tangles (NFTs) and amyloid plaques found in the brains of affected patients
(Buée et al., 2000; Soto, 2003). The extracellular amyloid plaques consist of deposits of
the amyloid-β peptide (Aβ) (Selkoe, 2000) and the intracellular NFTs are composed of
aggregates of the hyperphosphorylated tau protein (Kosik et al., 1986). In addition to AD,
NFTs have also been linked to the pathogenesis of more than 20 other neurodegenerative
disorders collectively termed tauopathies (Lee et al., 2001). Tau’s role in the development
of neurodegenerative diseases is still unclear, but a link between pathological tau
aggregation and cognitive impairments has been shown (Berger et al., 2007). Moreover,
the identification of multiple tau gene point mutations that result in hereditary tauopathies
is evidence that tau malfunction alone is sufficient to cause neurodegeneration (Poorkaj et
al., 1998; Spillantini & Goedert, 1998). However, two key features of tau pathology are
still unclear. First, the molecular basis of the early aggregation events, such as the structural
fluctuations that trigger the aberrant accumulation of tau into NFTs rich in β-sheets in vivo,
remain unknown. Second, the mechanism(s) by which tau aggregation causes neuronal
dysfunction is unclear.
Tau proteins are expressed primarily in the central nervous system, and their critical
function of promoting microtubule (MT) assembly and stability is mediated by six isoforms
and phosphorylation, which decreases tau’s affinity to MT resulting in the disassociation
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of tau from MTs (Buée et al., 2000; Cleveland et al., 1977; Weingarten et al., 1975) (Figure
2.1A). Tau is rich in charged and hydrophilic residues, and thus is highly soluble. In
solution, tau is intrinsically disordered. In vitro, tau aggregation can be induced by
polyanionic cofactors, which compensate for tau’s positive charges (Barghorn &
Mandelkow, 2002; Chirita et al., 2003; Goedert et al., 1996; King et al., 2000; Wilson &
Binder, 1997). Physiological factors and conditions that trigger tau aggregation in vivo are
still poorly understood.

Figure 2.1 Schematics of hTau40, Langmuir trough containing a lipid monolayer, and
solid-liquid interface cell.
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Figure 2.1 illustrates through schematics (A) hTau40, indicating projection and
microtubule binding domains and their overall charge states, (B) the Langmuir trough
containing a lipid monolayer, and (C) the solid-liquid interface cell used in bilayer
experiments.
Several lines of evidence suggest that plasma membranes may modulate tau
dynamics. Tau has been shown to interact at least indirectly with the plasma membrane
through its amino-terminal projection domain (Brandt et al., 1995) and is present in
detergent resistant membrane microdomains (Kawarabayashi et al., 2004; Williamson et
al., 2008). Membrane glycolipids have been found to be associated with paired helical
filaments (PHFs) isolated from AD brains (Gray et al., 1987). Recently, membrane
associated chimeric tau has been shown to seed the formation of PHFs from full length tau
proteins (Campos-Peña et al., 2009), and anionic lipid vesicles have been shown to promote
the aggregation of the microtubule binding domain of tau (K18) at sub-μM concentrations
(Elbaum-Garfinkle et al., 2010). Thus, plasma membrane mediated tau misfolding and
aggregation may serve as an in vivo mechanism by which the protein nucleates and grows
into PHFs. As such, even if the membrane bound tau is only a small fraction of the protein
population, it may be capable of seeding the growth of mature fibrils.
Tau-mediated neurodegeneration can arise from the loss of physiological function
and/or the gain-of-toxicity (Gendron & Petrucelli, 2009; Lovestone & McLoughlin, 2002).
Tau aggregation abolishes its MT-stabilizing function and can impair axonal transport
(Deshpande et al., 2008). However, the absence of significant neuronal abnormalities in
tau knock-out mice suggests that tau’s MT-stabilizing function may not be critical and that
gain-of-toxicity is more likely. There is a debate on whether mature tau fibrils are toxic or
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mere inert waste, but a high β-propensity of "pro-aggregant" tau clearly leads both to tau
aggregation and toxicity, whereas "anti-aggregant" tau with no -propensity is not toxic
(Sydow et al., 2011). The mechanism by which tau aggregates cause neuronal cell death is
unknown. The roles of several other oligomeric protein aggregates have recently received
considerable attention in numerous neurodegenerative diseases, including Aβ, α-synuclein,
huntingtin, and prion oligomers (Conway et al., 2000; Lashuel et al., 2002; Novitskaya et
al., 2006; Sharon et al., 2003; Walsh et al., 2002). A leading hypothesis for the mechanism
of protein aggregate-induced toxicity is cell membrane disruption, resulting in the
alteration of ion homeostasis and dysregulation of neuronal signal transduction (Chi et al.,
2008; Chi et al., 2007; Kayed et al., 2004; Quist et al., 2005). Increases in ion permeability
have been found in cells exposed to various aggregates (Demuro et al., 2005; Deshpande
et al., 2006; Simakova & Arispe, 2007; Sun et al., 2003). Studies using model lipid
membranes showed that Aβ induces either the formation of discrete ion channels (Arispe
et al., 1993, 1994) or increases of bilayer conductance (Kayed et al., 2004; Sokolov et al.,
2006; Valincius et al., 2008). Additionally, these types of membrane disruptions have been
shown to be the molecular basis of toxicity and selectivity of antimicrobial compounds,
including antimicrobial peptides (Gidalevitz et al., 2003) and biocidal conjugated
polyelectrolytes (Wang et al., 2010).
We propose that interactions between tau and interfaces such as the cell membrane
can induce disordered-to-ordered transitions in the protein, lowering the activation free
energy of aggregation. We hypothesize that IDPs like tau are highly susceptible to
abnormal binding to interfaces due to their unique combination of high specificity and low
affinity for coupled binding-and-folding events. Such interaction can induce transitions
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from a disordered but non-aggregate forming conformation to a conformation that is
aggregation-competent, which can then template the assembly of tau into highly ordered
fibrils. Furthermore, we propose that tau induced membrane disruption may serve as a
pathway by which the protein exerts toxicity.
The focus of the current investigation is on characterizing tau-lipid membrane
interactions and their effects on protein conformation and membrane stability. The fulllength isoform of recombinant human tau protein (hTau40) (Figure 2.1A) is used in this
study. Two model membrane systems, (i) lipid monolayer at the air-water interface, which
models one leaflet of the plasma membrane, and (ii) supported lipid bilayers, are used to
probe tau-membrane interactions. A combination of biophysical techniques, including
pressure-area isotherms, fluorescence microscopy (FM), and X-ray and neutron scattering
techniques, are used to characterize tau-membrane interactions and their effects on
membrane properties. We found that although highly charged and soluble, tau is highly
surface active, strongly interacts with anionic membranes, and readily disrupts membrane
morphology, lipid packing, and integrity.

2.2 Materials and methods
2.2.1 Materials
Full-length human tau (hTau40 isoform, 441 residues) was provided by Drs. J.
Biernat and E. Mandelkow (Max Planck Institute for Structural Biology, Hamburg,
Germany) and used without further purification. Three lipids were used to evaluate the
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effect of lipid head group charge on tau-membrane interactions – zwitterionic
1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC),
anionic 1,2-Dimyristoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (DMPG),
and cationic 1,2- Dimyristoyl-3-Trimethylammonium-Propane (DMTAP).
Zwitterionic Dipalmitoylphosphatidylcholine (DPPC) was used for neutron reflectivity
experiments. All lipids were purchased from Avanti Polar Lipids.
DMPC, DMTAP and DPPC were dissolved in chloroform (HPLC grade, Fisher Scientific)
while DMPG was dissolved in 10 vol% methanol in chloroform. For FM, the headgrouplabeled fluorescent dye Texas Red 1,2-dihexadecanoyl 3-phosphoethanolamine (TRDHPE) (Molecular Probes) was dissolved in chloroform and included in lipid spreading
solutions at 0.5 mol%. Lipid stock solutions ranged from 2 to 10 mg/ml and diluted to 0.2
or 0.5 mg/mL for spreading solutions. All lipid solutions were stored at -20°C in glass
vials.

2.2.2 Adsorption of hTau40 to air/water interface
To evaluate the surface activity of hTau40, the surface pressure (π) measured by
the adsorption of hTau40 from a water subphase was measured. The experiment was
carried out at 25°C and on a 45 mL water subphase (Milli-Q system, Millipore, Bedford,
MA) using a MiniMicro Langmuir trough (KSV Instruments Ltd., Finland). A Wilhelmy
plate sensor at the center of the trough measured π of the lipid monolayer where π = γ0 – γ
and γ0 is the air-water surface tension and γ is the lipid film surface tension. The trough had
a working surface area of 86.39 cm2. Before injecting hTau40 into the subphase, barriers
were partially closed to give a total surface area of 45 cm2, roughly the same as the surface
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area of the lipid monolayers compressed to 25 mN/m for the subsequent insertion
experiments. For a final tau concentration of 1 μM, 1 mL of 45 μM tau was injected into
the subphase using a microsyringe (Hamilton, Reno, NV).

2.2.3 Constant pressure insertion assay and fluorescence microscopy
To evaluate the interactions between hTau40 and lipid membranes, insertion of
hTau40 into lipid monolayers at the air/water interface at constant π was measured. Figure
2.1B is a schematic of the insertion assay. All experiments were carried out on water
subphase and at room temperature. Lipids were first spread at the air/water interface. The
barriers then symmetrically compressed the monolayer at 0.3 mm/s to a target π of 25
mN/m, and π was kept constant via a feedback loop. This π was chosen for its relevance to
physiological conditions as the lipid-packing density of a bilayer is reported to roughly
correspond to that of a monolayer at ~30 mN/m (Ege & Lee, 2004; Seelig, 1987). Protein
was then injected into the subphase to achieve a final 1 μM concentration. Since the
monolayer was kept at a constant π, the barriers expanded as a result of protein insertion.
Monolayer surface area was recorded and the % area expansion was taken as a measure of
favorable tau-lipid interactions. Surface area expansion is defined as ΔA/A = (A-Ai)/Ai,
where A is the surface area at time t and Ai is the initial surface area of the monolayer when
it first reached 25 mN/m.
To monitor monolayer morphology, the trough was positioned on top of the
motorized stage of an inverted optical microscope (Olympus IX 71) with a 50× objective
centered on a quartz window in the bottom of the trough. A 100 Watt mercury lamp was
used for fluorescence excitation. Fluorescence images were collected by a QImaging
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camera (EXi Blue, QImaging Photometrics) and analyzed using the software QCapture
Pro. 0.5 mol% TR-DHPE was included in the spreading solution. Due to steric hindrance,
the dye partitions into the liquid-expanded (LE) phase rather than the liquid-condensed
(LC) phase, giving rise to contrast (Knobler, 1990).

2.2.4 X-ray scattering measurements
Grazing-incidence X-ray diffraction (GIXD) and X-ray reflectivity (XR) data were
collected at the BW1 beamline (HASYLAB, DESY, Hamburg, Germany) for both hTau40
adsorbed to the air/water interface and hTau40 inserted into a DMPG monolayer at the
air/water interface. GIXD data give structural information on the in-plane (i.e., in the plane
of the monolayer) ordered (hence diffracting) portion of the film. Presence of Bragg peaks
in GIXD data indicates 2D ordered structures. XR data give information about the out-ofplane (perpendicular to the lipid film) electron density profile of the film averaged over the
LE and LC phases. The theory of XR and GIXD has been presented in detail elsewhere
(Alsnielsen & Kjaer, 1989 ; Kjaer, 1994).

2.2.5 Neutron reflectivity measurements
Neutron reflectometry (NR) experiments were performed on hTau40 associated
with supported lipid bilayers using the Surface ProfilE Analysis Reflectometer (SPEAR,
Los Alamos National Lab). Methods and measurement of NR using SPEAR has been
previously described (Dubey et al., 2010). In general, lipid bilayers were created using a
Langmuir-Blodgett/Langmuir-Schaefer deposition method. Figure 2.1C is a schematic of
the assembled flow cell. Neutrons entered the lateral face of the substrate and were
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scattered from the substrate-subphase interface. D2O provided scattering contrast between
the substrate, hydrogen-rich bilayer, and subphase. During the experiments, the ratio of
elastically scattered to incident neutrons, or reflectivity (R), was measured as a function of
the momentum-transfer vector Qz. Analysis of the NR data provided information about
coherent scattering-length density (SLD) distribution normal to the sample.

2.3 Results
2.3.1 Surface activity of hTau40
To evaluate the surface activity of hTau40, pressure (π) reached by the adsorption
of hTau40 from a water subphase was measured (Figure 2.2). As shown, hTau40 rapidly
adsorbed to the air/water interface after its injection into the subphase, with no lag time,
and reached an equilibrium π of ~ 16 mN/m. This value is comparable to those reached by
the amphiphilic Aβ peptide (Chi et al., 2010; Ege & Lee, 2004). Moreover, the adsorption
isotherm showed a reproducible, two-stage adsorption behavior. π initially increased
sharply to about 9 mN/m, followed by a plateau and subsequent slowed increase to achieve
a final π of 16 mN/m.
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Figure 2.2 Adsorption of hTau40 to air/water interface at 25°C and 1 μM.

The XR data obtained for the adsorbed hTau40 at the air/water interface and the
corresponding electron density profile (normalized to water, ρ/ρH2O) are shown in
Figure 2.3. ρ/ρH2O profile shows that hTau40 assembles in a ~10 Å thick layer at the
air/protein interface with an additional 10-12 Å diffused protein layer that extends into the
subphase. Fitting parameters are summarized in Table 2.1. GIXD data of the film did not
reveal any diffraction peaks (data not shown) indicating a lack of long-range in-plane order
for hTau40 adsorbed at the air/water interface.
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Figure 2.3 (A) Fresnel normalized X-ray reflectivity and (B) water normalized electron
density of hTau40 adsorption to the air/water interface at 23 °C and 1 μM. The dashed
line indicates a model independent fit and the solid line indicates a box-model fit.

Table 2.1 X-ray Reflectivity Parameters for hTau40 Adsorption to Air/water Interface
Thickness (Å) ρ / ρH20

Sample

Box
Composition

hTau40

air/protein
7.99 ± 2.4 E-2 1.27 ± 3.4 E-3 2.66 ± 7.4 E-4
interface
protein/subphase 7.93 ± 8.6 E-2 1.02 ± 4.2 E-3 2.37 ± 6.4 E-4
interface
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Roughness (Å)

2.3.2 hTau40 insertion into lipid monolayers
Isotherms and the accompanying % area expansion of hTau40 insertion into
DMPC, DMPG, and DMTAP monolayers are shown in Figure 2.4. The protein did not
insert into the neutral DMPC monolayer held at 25 mN/m and only inserted when the
surface pressure was lowered to 16 mN/m (black curve in Figure 2.4A). Since this π
coincided with hTau40’s equilibrium π (Figure 2.2), our data show that hTau40 did not
exhibit favorable interactions with the DMPC membrane. In contrast, when injected
underneath the negative DMPG monolayer held at 25 mN/m, hTau40 spontaneously
inserted into the monolayer and caused an area expansion of 91%. When injected
underneath the positive DMTAP monolayer at 25 mN/m, hTau40 inserted into the
monolayer after a short delay, but only resulted in an 8.5% area expansion (Figure 2.4).

Figure 2.4 Isotherms and corresponding area expansion profiles.

Figure 2.4 illustrates isotherms (A) and corresponding area expansion profiles (B)
for hTau40 insertion into DMPC, DMPG, and DMTAP monolayers at 25°C on water
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subphase. The lipid monolayers were first compressed to 25 mN/m, after which tau was
injected into the subphase. No insertion was observed at 25 mN/m for DMPC. Pressure
was reduced until insertion was observed at 16 mN/m. Tau spontaneously inserted into
DMPG and DMPTAP monolayers at 25 mN/m.

Disruption of the DMPG monolayer induced by hTau40 insertion was assessed by
monitoring the morphology of the lipid film before and after hTau40 injection.
Representative FM images are shown in Figure 2.5. At 25 °C, the DMPG monolayer on
water undergoes a liquid-expanded (LE) to liquid-condensed (LC) phase transition at
~17 mN/m (Figure 2.4A). Because the bulky lipid headgroup dye molecules, TR-DHPE,
are preferentially excluded from the LC phase, it appears as dark domains whereas the LE
phase containing the dyes is bright. Figure 2.5A shows that at 25 mN/m, the DMPG
monolayer contains predominantly the LC phase. Ten minutes after the injection of hTau40
(~5% area expansion), the ratio of dark to light regions is reduced and the general
appearance of the LC domains changed from a well-defined circular shape to one that is
less well-defined, indicative of decreased line tension around the LC domains (Figure
2.5B). These changes in the monolayer morphology became more pronounced with
continued insertion of hTau40, where, in addition to decreased dark to light regions, the
dark LC domains are also smaller in general, pointing to the disruption of LC domains.
Note, however, the LC domain boundaries remained distinct.
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Figure 2.5 FM images of a DMPG lipid monolayer during hTau40 insertion.

The FM images in Figure 2.5 were collected (A) before tau injection, and (B) 10,
(C) 30, and (D) 120 minutes after injection, corresponding to ~ 5%, 14%, and 45% area
expansion, respectively.

2.3.3 X-ray scattering measurements of hTau40 associated with lipid monolayers
GIXD data of hTau40 associated with a DMPG monolayer showed that the
insertion of tau disrupted lipid packing (Figure 2.6). The DMPG monolayer at 25 mN/m
showed a single Bragg peak. The Qxy position of the peak maximum (1.483 Å-1)
corresponds to a d-spacing of 4.237 Å and the 2D hexagonal unit cell dimension, ah, is
4.893 Å. The area per DMPG molecule is 41.47 Å2 and the average size of the ordered
domains is ~270 Å. No diffraction peaks were observed after tau inserted into the
monolayer (Figure 2.6). Tau associated with the DMPG monolayer did not show any
scattering peaks (data not shown), indicating that the protein did not fold and order into
domains detectable by GIXD. Qualitatively, reflectivity profiles of tau-associated DMPG
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monolayer exhibited significant differences compared to that of lipids alone (Figure 2.7).
XR data of the DMPG monolayer before and at two different time points (t1 and t2) after
the injection of hTau40 are shown for comparison. Qualitatively, reflectivity of the DMPG
film alone showed the characteristic “two humps” of the lipid monolayer, one
corresponding to the lipid headgroups and the second to the alkyl tails. After the addition
of tau, significant differences in the reflectivity were observed in a time-dependent manner.
Minima in the reflectivity curves became shallower and the overall intensity of the signals
decreased. Fitting parameters are summarized in Table 2.2.

Figure 2.6 Background subtracted GIXD data of DMPG and DMPG/tau monolayers at 23
°C.

Figure 2.6 illustrates that the DMPG monolayer at 25 mN/m showed a single Bragg
peak whereas no peaks were observed from the DMPG/tau film. Data are offset for clarity.
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Figure 2.7 Fresnel normalized X-ray reflectivity (R/RF) of DMPG and DMPG/hTau40
monolayers at 23 °C.

As illustrated in Figure 2.7, pure DMPG and the DMPG/hTau40 (time t1) data were
collected at 25 mN/m. t2 data was collected at a slightly higher pressure since tau insertion
caused an area expansion beyond maximum trough area. Panel A of the figure shows the
model independent fits (solid lines) of the XR data obtained from StochFit, which
correspond to water normalized electron density distributions shown in panel B. Box model
fit of the electron density profiles are also shown. Data are offset for clarity.
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Table 2.2 X-ray Parameters for hTau40 Insertion into DMPG Monolayera
Sample

Box
Thickness (Å) ρ / ρH20
Composition

DMPG

Lipid tails

14.9 ± 5.1 E-2 0.94 ± 1.2 E-2 3.11 ± 1.5 E-3

Lipid
headgroups

9.78 ± 9.7 E-2 1.37 ± 1.5 E-2 2.91 ± 4.6 E-3

+ hTau40 t1 Lipid tails

Roughness
(Å)

13.4 ± 5.4 E-2 0.93 ± 1.4 E-2 2.96 ± 1.2 E-2

Lipid tails + 10.3 ± 1.0 E-1 1.32 ± 1.6 E-3 3.19 ± 1.8 E-2
headgroups +
hTau40
hTau40
+ hTau40 t2 Lipid tails

10.1 ± 1.6 E-2 1.01 ± 2.9 E-3 3.33 ± 1.6 E-2
12.3 ± 2.7 E-1 0.91 ± 1.5 E-2 3.25 ± 1.1 E-2

Lipid tails + 11.2 ± 3.4 E-1 1.25 ± 2.9 E-2 3.25 ± 2.3 E-2
headgroups +
hTau40
hTau40

9.1 ± 1.4 E0

1.04 ± 3.3 E-1 2.33 ± 4.3 E-2

a

Errors reported are standard deviations obtained from the nonlinear least-squares fitting
of the reflectivity data with box models using the Levenberg-Marquadt algorithm
(Danauskas et al., 2011).

Analysis of the XR data using the StochFit model (Danauskas et al., 2008) yielded
ρ/ρH2O distribution perpendicular to the air/water interface (Figure 2.7B). As shown, upon
injection of hTau40, ρ/ρH2O in the headgroup region of DMPG decreased and the length of
this region increased. Additionally a region of slightly higher ρ/ρH2O adjacent to the DMPG
headgroup on the subphase side was required to fit the data. The size of this region
corresponds to hTau40 inserted into the DMPG monolayer, thus confirming the strong
association of tau with the negatively charged membrane.
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2.3.4 Neutron reflectivity measurements of hTau40 and supported lipid bilayers
Figures 2.8 and 2.9 summarize the NR data obtained before and after the injection
of hTau40 into DPPC and DMPG lipid bilayers, respectively. DPPC was chosen instead of
the more fluid DMPC to obtain a more stable bilayer vis-à-vis the solid support. Similar to
the XR data, the NR results are normalized by Fresnel to highlight important features.
Intact bilayers are indicated by a distinctive “two-hump” pattern, with each peak
representing an intact monolayer, whereas bilayers that have been disrupted lack these two
peaks (Figure 2.9C). Figure 2.8 shows the NR and corresponding SLD profile for a DPPC
bilayer, deposited at 25 mN/m before (Figure 2.8A and 2.8B) and after (Figure 2.8C and
2.8D) the injection of hTau40 in the subphase. A cartoon depiction for these two cases is
also shown. The parameters are summarized in Table 2.3. Our data show that the addition
of hTau40 did not have any effect on the DPPC membrane structure. In contrast, the
addition of hTau40 completely disrupted a DMPG bilayer deposited at 40 mN/m (Figure
2.9C and 2.9D). A similar effect was observed for a DMPG bilayer deposited at 25 mN/m
(data not shown). Note that, unlike DPPC, DMPG deposited at 25 and 40 mN/m showed a
lower surface occupancy as seen from the SLD of the bilayer.
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Figure 2.8 Fresnel normalized X-ray reflectivity and corresponding SLD profiles for a
DPPC bilayer.

In Figure 2.8, Fresnel normalized X-ray reflectivity (R/RF) (A and C) and
corresponding SLD profiles (B and D) for a DPPC bilayer deposited onto a quartz substrate
at 25 mN/m before (A and B) and after (C and D) tau addition. The lines are the fitted NR
and SLD profiles. Schematics depicting lipids and proteins in the system are also included.
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Figure 2.9 Fresnel normalized X-ray reflectivity and corresponding SLD profiles for a
DMPG lipid bilayer.

In Figure 2.9, the Fresnel normalized X-ray reflectivity (R/RF) (A and B) and
corresponding SLD profiles (B and D) for a DMPG lipid bilayer deposited onto a quartz
substrate at 40 mN/m before (A and B) and after (C and D) tau addition are illustrated. The
lines are the fitted NR and SLD profiles. Schematics depicting lipids and proteins in the
system are also included.
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Table 2.3 Neutron Reflectivity Least-Squares Fit Parameters
Flow
Contents

Cell Layer
Composition

SLD
(10-6 Å-2)

Roughness
(Å)

D2O + DPPC 15.9
heads
DPPC tails
41.0

6.00

8.00

-0.300

6.15

DPPC 25 mN/m + D2O + DPPC 10.8
heads
hTau40
DPPC tails
41.0

5.20

7.97

-0.300

2.48

D2O + DMPG 10.9
heads
DMPG tails
39.7

5.64

6.82

1.15

3.82

DPPC 25 mN/m

DMPG 40 mN/m

Thickness (Å)

2.4 Discussion
2.4.1 hTau40 is highly surface active
Although highly charged and soluble, the full-length human recombinant hTau40
exhibited significant surface activity, adsorbing readily to the air/water interface to give a
final π comparable to that reached by the adsorption of the amphipathic Aβ40 peptide to
an air/water interface (Ege & Lee, 2004). The intrinsically disordered, or “soft” nature, of
the tau protein thus renders it highly surface active, prone to partition or bind to different
interfaces. The initial sharp increase in π (Figure 2.2) is indicative of hTau40’s high affinity
to the hydrophobic interface and the reproducible two-stage adsorption behavior suggests
that the protein undergoes structural rearrangements once adsorbed to the interface.
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2.4.2 hTau40 selectively interacts with anionic membranes
To understand the role lipid membranes play in mediating the dynamics of hTau40,
we investigated the interactions between model lipid membranes and hTau40. The
Langmuir monolayer is used to model one leaflet of the plasma membrane, while the
supported lipid bilayers provide a better model of the plasma membrane. As demonstrated
by the monolayer insertion assays, hTau40 strongly associated and inserted into the anionic
DMPG monolayer, presumably in part mediated by the attractive electrostatic interactions
between the positively charged MT binding domain of hTau40 (Figure 2.1A) and the lipids.
The strong affinity of the MT binding domain with anionic membranes is also in agreement
with previous reports on the tau repeat domain construct (K18), which forms the core of
the paired-helical filaments, aggregating in the presence of anionic lipid vesicles (ElbaumGarfinkle et al., 2010). Tau also favorably interacted with positively charged DMTAP,
presumably through its negatively charged projection N-terminus, but inserted to a much
lesser extent compared to DMPG. hTau40 did not exhibit any favorable interactions with
the neutral DMPC lipids. The selective affinity of hTau40 towards anionic membranes is
further evidenced by the complete disruption of a supported DMPG bilayer while leaving
DPPC bilayer intact (Figure 2.8 and 2.9). Our findings suggest that electrostatic
interactions play an important role in modulating tau-membrane interactions, with hTau40
displaying a strong affinity toward the anionic DMPG membrane. However, the extent of
tau interaction with membranes could be mediated by additional factors, as evidenced by
the disparate extents of insertion into anionic and cationic membranes. Further
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investigations utilizing different tau mutants will help to clarify the importance of these
factors.
2.4.3 Air/water and lipid membrane interfaces induce tau structural compaction
The tau film adsorbed to the air/water interface is about 20 Å thick and is not
homogeneous in its electron density distribution perpendicular to the film surface (Figure
2.3). A more dense ~10 Å layer with a ρ/ρH2O of 1.3 is formed at the hydrophobic air phase,
followed by a more diffuse layer with a ρ/ρH2O close to 1 that extends another 10 Å into the
water phase. The radius of gyration (Rg) of the intrinsically disordered hTau40 in solution
(determined by small-angle X-ray scattering) has been reported to be 65 Å (Bernadó et al.,
2007), much larger than a globular, folded protein of ~400 amino acids with Rg typically
ranging from 20-25 Å. In addition, a ρ/ρH2O of 1.3 of the more dense hTau40 layer at the
air phase is comparable to the density of folded proteins that have an average specific
volume of 0.73, which corresponds to a density of 1.37 g/ml (Lee & Timasheff, 1974).
XR data modeling of tau inserted into a DMPG monolayer show that the membrane
association and partial insertion of tau into the lipid headgroup region gave rise to a
10-20 Å layer of protein at the lipid interface with a ρ/ρH2O of about 1.3 (Figure 2.7B).
Our structural measurements of air/water interface-adsorbed and membrane
interface-associated tau layers of smaller dimension and higher density compared to tau in
solution thus suggest that as the intrinsically disordered tau adsorbs to the air/water
interface, at least a portion of the protein undergoes structural compaction to resemble the
density of a folded protein. Structurally compacted conformations of the full-length tau
protein that exhibit enhanced aggregation propensity have been shown in several cases,
including phosphorylation at several sites diagnostic of AD (Jeganathan et al., 2008;
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Jeganathan et al., 2006), binding to exogenous aggregation inducers ( Chirita et al., 2005),
and fast heating/cooling (Shkumatov et al., 2011). We show here that the partition and
binding of tau to two different interfaces, including a physiological membrane interface,
can also induce structural compaction. Our data, along with previous reports, clearly
demonstrate that structural plasticity of the tau protein and that multiple mechanisms can
induce structural compaction that accompanies disordered-to-order transitions in the
protein to render it aggregation-competent. However, the exact nature of the air/water and
membrane interface-induced folding of tau is not clear. The interfacial tau films appear to
be amorphous in long-range order, as no ordered crystalline domains were detectable by
GIXD. But the lack of long-range order does not preclude the formation of local, whether
intramolecular or intermolecular, secondary structures, which can render the otherwise
soluble and stable tau “pro-aggregant” or aggregation-competent.

2.4.4 hTau40 association with membranes disrupts lipid packing and membrane
integrity
Morphological changes to the DMPG lipid monolayer caused by the insertion of
tau were observed by FM. As previously shown in Aβ-membrane studies (Bokvist et al.,
2004; Ege & Lee, 2004), changes in monolayer morphology can be indicative of disruption
to lipid packing. An overall increase in the ratio of light to dark regions indicates
preferential insertion of the protein into the LE phase and also a change from a LC to a LE
phase. For hTau40 insertion into negatively charged DMPG, this ratio grew with an
increase in the % area expansion until ~45% expansion, at which point the % area
expansion continued to increase without any appreciable differences in monolayer images.
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One possible explanation for this finding is that beyond 45% expansion the DMPG
monolayer was no longer compressed enough to provide steric inhibition of dye movement.
On the molecular level, GIXD data of hTau40 associated with DMPG monolayers showed
that the insertion of the protein completely disrupted lipid packing and eliminated the
ordered LC phase.
NR assays used to assess lipid bilayer structure before and after insertion of hTau40
showed that tau selectively disrupted anionic DMPG lipid bilayers even at lipid packing
densities higher than those of a cell membrane. Tau disrupted DMPG bilayers deposited at
both 25 and 40 mN/m. In contrast, the neutrally charged DPPC bilayer was not affected by
the addition of tau. These results confirm that hTau40 preferentially interacts with anionic
membranes, not only with a DMPG monolayer at the air-water interface, but also with a
more physiologically relevant bilayer system. Moreover, these interactions disrupt lipid
membrane structure, both on a molecular scale of disrupting lipid packing and on a
morphological scale of completely disrupting the integrity of lipid bilayers.

2.5 Conclusions
Our results provide some insights into the driving forces of the folding and
aggregation of the AD-associated protein hTau40. We hypothesize that the aggregation of
the highly charged, soluble, and intrinsically disordered tau is catalyzed by the formation
of a structurally compact, pro-aggregant conformation, followed by energetically favorable
assembly reactions to form larger aggregates. Normally, tau aggregation requires
exogenous polyanionic cofactors. We examine here the interaction of tau with the more
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physiological lipid membranes and the effect of these interactions on tau conformation and
membrane integrity. The “soft nature” of the protein gives rise to a high surface activity as
evidenced by tau’s high affinity to partition to the hydrophobic air/water interface. Tau
also has a strong tendency to associate with negatively charged lipid monolayer and bilayer
surfaces. Both interfaces induce the intrinsically disordered hTau40 to partially adopt a
more compact conformation similar to that of a folded protein. This interface-induced
compaction may serve to seed the aggregation of tau. Tau’s interaction with anionic lipid
monolayers disrupted lipid packing and compromised integrity of the lipid bilayer,
suggesting a mechanism of protein aggregate-induced toxicity in diseased cells. Further
study of lipid membrane interaction with hyperphosphorylated forms of tau will provide
more understanding of tau-mediated neurodegenerative processes.
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CHAPTER 3 EFFECTS OF HYPERPHOSPHORYLATION AND DOMAIN
COMPOSITION ON THE INTERACTION OF TAU PROTEIN WITH MODEL
LIPID MEMBRANES
(This chapter was prepared for possible publication collaboratively by Emmalee Jones,
Ann Junghans, Jacek Biernat, Eckhard Mandelkow, Jaroslaw Majewski, and Eva Y. Chi)

Abstract
Tau protein is known to misfold and aggregate in the course of several
neurodegenerative diseases, including Alzheimer’s disease. Previous studies have
demonstrated that the full length hTau40 interacts with negatively charged lipid
membranes, initiating both structural compaction of the protein itself and disruption of
lipid membrane structure. To better understand both the behavior of the tau in its diseased
state and which domains of the protein are involved in its interaction with membranes, we
investigated both a mutant tau protein which mimicked a diseased hyperphosphorylated
state and tau constructs containing only certain domains of the protein. We found that both
the mimic and the constructs interacted strongly with negative membranes.

3.1 Introduction
Alzheimer’s disease (AD) is a progressive, and ultimately fatal, neurodegenerative
disease currently affecting more than five million Americans (“Treatments and Research,”
2014). One of the major pathological hallmarks of AD is the misfolding and aggregation
of two proteins, amyloid beta (Aβ) and tau. The Aβ protein misfolds and aggregates into
extracellular amyloid neuritic plaques, while the microtubule associated protein tau forms
intracellular neurofibrillary tangles (NFTs) (Soto, 2003). In addition to AD, NFTs have
also been linked to the pathogenesis of over 20 other neurodegenerative disorders,
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collectively termed tauopathies (Buée et al., 2000). Tau’s role in the development and
progression of neurodegenerative diseases is still unclear, but a link between pathological
tau aggregation and cognitive impairments has been demonstrated (Gendron & Petrucelli,
2009). Moreover, the identification of multiple tau gene point mutations that result in
hereditary tauopathies is evidence that tau malfunction alone is sufficient to cause
neurodegeneration (Poorkaj et al., 1998; Spillantini & Goedert, 1998). Investigation of the
conditions and triggers for tau’s aggregation and toxicity in neurodegenerative diseases is
vital.
Tau is primarily expressed in the central nervous system. Its vital function,
promoting microtubule (MT) assembly and stability, is mediated by six isoforms. These
tau proteins are further regulated by phosphorylation, which decreases tau’s binding
affinity to MT resulting in the disassociation of tau from MTs (Buée et al., 2000; Cleveland
et al., 1977; Weingarten et al., 1975). All of the isoforms have multiple charged and
hydrophilic residues, and thus they are highly soluble. Because of its high solubility, tau is
also resistant to aggregation. However, tau protein does form aggregates of insoluble paired
helical filaments (PHFs) when it is hyperphosphorylated (Ihara et al., 1986; Kosik et
al.,1986). Although, as mentioned, tau is highly soluble, in vitro aggregation can be
induced by polyanionic cofactors such as heparin, which compensate for tau’s positive
charges (Goedert et al., 1996). Aggregation is largely determined by ionic interactions,
with anionic micelles and vesicles demonstrated to promote the aggregation of tau
(Chirita et al., 2003; Elbaum-Garfinkle et al., 2010), suggesting that tau aggregation
proceeds through a nucleation controlled polymerization pathway. The interactions
between tau and the anionic inducers increase the protein’s local concentration and
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compensate for its positive charges (Barghorn & Mandelkow, 2002; Chirita et al., 2003;
Goedert et al., 1996; King et al., 2000; Wilson & Binder, 1997), both of which favor second
or higher order reactions such as fibril formation. Several prior lines of research suggest
that tau’s interaction with the plasma membrane may modulate tau aggregation (ElbaumGarfinkle et al., 2010; Jones et al., 2012). One hypothesis of the toxic function of amyloid
proteins like tau is the misfolded proteins’ ability to disrupt the lipid membrane (Demuro
et al., 2005; Kayed et al., 2004). This compromises the membrane’s biological function as
an impermeable barrier.
To understand the molecular basis of early aggregation events and the mechanism
by which tau aggregation causes neuronal dysfunction, we have previously examined the
interaction of the wild type full-length human tau isoform hTau40 (Figure 3.1) and lipid
membranes. Our results provided some structural insights into the dual roles that the lipid
membrane plays in catalyzing tau misfolding and aggregation and in serving as a target for
tau aggregates to exert toxicity via membrane destabilization. The wildtype tau protein was
highly surface active, and selectively associated with and intercalated into anionic lipid
membranes. The hydrophobic air/water interface and an anionic lipid membrane interface
induced the intrinsically disordered hTau40 protein to partially adopt a more compact
conformation similar to that of a folded protein. Furthermore, association of hTau40 with
anionic membranes disrupted lipid packing and compromised membrane integrity.
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Figure 3.1 Wildtype full length hTau40, tau-derived constructs K18 and K32, and the
mutant hTau40/3Epi.

The isoform hTau40, illustrated in Figure 3.1, is the largest one in the human central
nervous system (441 residues). In each of the isoforms, the C-terminal half contains three
or four pseudorepeats (∼31 residues each, R1–R4, blue shade), which are involved in MT
binding and form the core of PHFs. The construct K18 represents only the repeat domains
of hTau40, comprising four repeats. The construct K32 represents the repeat domains of
hTau40 and both of the flanking domains to either side. The “hyperphosphorylated” mutant
hTau40/3Epi has nine extra anionic residues, indicated by the red arrows in Figure 3.1.
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We now examine the effects of domain composition and hyperphosphorylation on
tau-lipid membrane interactions and subsequent membrane-induced tau conformational
change and tau-induced membrane disruption. The tau construct K18 consists only of the
"repeat domain" in the C-terminal half of tau which contains all four microtubule binding
repeats, while the K32 construct contains the repeat domains as well as the two flanking
domains to either side (Figure 3.1). Binding to MTs requires both the repeat domains and
the flanking domains. When bound to microtubules for its biological function, the
C-terminal half of tau adopts α-helical structures, and when assembled into PHFs, the
C-terminal half adopts the characteristic β-sheet structure (Chirita et al., 2003; Mandelkow
et al., 2007; Mylonas et al., 2008; von Bergen et al., 2005). Anionic lipid vesicles have also
been shown to promote the aggregation of the MT binding domain of tau (K18) at submicromolar concentrations (Elbaum-Garfinkle et al., 2010). Examination of the K18 and
K32 constructs will help to further elucidate which domains of the protein are involved in
its misfolding, aggregation and ultimate toxicity.
Tau in PHF is also known to be highly phosphorylated (Wille et al., 1992). In
PHF-tau, 19 phosphorylation sites have been identified, and all but Ser-262 are localized
to the amino- and carboxyl-terminal flanking regions of the microtubule-binding domain
(Morishima-Kawashima

et

al,

1995).

The

mutant

hTau40/3Epi

mimics

hyperphosphorylation with 9 extra anionic residues (Figure 3.1) focused in the flanking
regions of the microtubule-binding domain. We examine this mutant of the tau protein,
hTau40/3Epi, to learn more about the interaction of tau in its diseased state with lipid
membranes.
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3.2 Results
3.2.1 Surface activity of K18, K32 and hTau40/3Epi
To better understand the effects of domain composition and phosphorylation on tau
interaction with hydrophobic interfaces, we compared the surface activity of the wildtype
hTau40 protein with that of the K18 and K32 constructs as well as the hTau40/3Epi
hyperphosphorylation mimic. Measurement of surface activity assessed the protein’s
inherent propensity to exhibit exogenous interactions. We measured the surface pressure
(π) reached by the adsorption of the tau proteins to the air/water interface from a water
subphase. As shown by the adsorption isotherms in Figure 3.2, all of the proteins adsorbed
readily to the air/water interface. The mutant hTau40/3Epi visibly exhibited two-stage
adsorption behavior similar to hTau40, possibly reflecting structural rearrangements of the
protein layer following rapid adsorption of the protein to the air/water interface. The K32
construct had a lag time of about 15 minutes before adsorbing to the interface, while the
K18 construct immediately adsorbed.
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Figure 3.2 Adsorption isotherms for hTau40 (black), K18 construct (blue), K32 construct
(green) and mutant hTau40/3Epi (red). Time zero corresponds to the time of protein
injection into the subphase.

The XR data obtained for the tau proteins at the air/water interface and the
corresponding model independent electron density profiles (ρ, normalized to water, ρ/ρH2O)
are shown in Figure 3.3 and fitting parameters are found in Table 3.1. In general, a denser
portion is formed at the hydrophobic air phase, followed by a more diffuse layer with lower
ρ close to that of water (ρ/ρH2O ≈ 1). This disparity in electron densities indicates
inhomogeneity of the surface adsorbed tau film in the direction perpendicular to the
air/water interface. GIXD data of the films did not show any diffraction peaks (data not
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shown), indicating a lack of long-range ordering, in the plane of the film, for any of the tau
proteins adsorbed at the air/water interface.

hTau40
K18
K32
hTau40/3Epi

Figure 3.3 X-ray reflectivity (A) and p/pH20 (B) of four tau proteins – hTau40 (black),
K18 construct (blue), K32 construct (green), and mutant hTau40/3Epi (red) – adsorbed to
air/water interface. Data are offset for clarity.
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Table 3.1 X-ray Reflectivity Parameters for Adsorption of Tau to Air/water Interface
Box
Composition

hTau40

7.99 ± 2.4 E-2
air/protein
interface
protein/subphase 7.93 ± 8.6 E-2
interface

1.27 ± 3.4 E-3 2.66 ± 7.4 E-4

air/protein
interface
protein/subphase
interface
air/protein
interface
protein/subphase
interface
air/protein
interface
protein/subphase
interface

9.38 ± 8.3 E-2

1.33 ± 1.7 E-2 2.57 ± 7.1 E-3

8.58 ± 9.9 E-1

1.12 ± 2.0 E-2 3.38 ± 1.6 E-2

8.65 ± 7.3 E-2

1.29 ± 1.0 E-2 2.51 ± 3.0 E-3

K18

K32

hTau40/3Epi

Thickness (Å)

ρ / ρH20

Sample

Roughness (Å)

1.02 ± 4.2 E-3 2.37 ± 6.4 E-4

17.21 ± 4.7 E-1 1.07 ± 1.1 E-2 2.12 ± 1.1 E-2
6.61 ± 1.4 E-1

1.22 ± 1.4 E-2 2.57 ± 1.7 E-2

9.63 ± 1.6 E-1

1.09 ± 2.9 E-3 2.57 ± 1.7 E-2

3.2.2 Tau construct and hyperphosphorylation mimic insertion into anionic lipid
monolayers
We next examined the effects of domain composition and phosphorylation on tau’s
interaction with lipid membranes. The % trough area expansions of the tau proteins into a
DMPG monolayer held at constant pressure are shown in Figure 3.4A. Time zero of the
area expansion corresponds to the time of protein injection into the water subphase via an
injection port on the side of the trough below the level of the subphase. As previously
described, a feedback loop is utilized to maintain constant surface pressure. When the film
is perturbed, the barriers move to compensate for the fluctuations in monolayer pressure.
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Just as with hTau40, both K18 and hTau40/3Epi inserted readily into the anionic DMPG
monolayer held at 25 mN/m. The construct K18 caused an area expansion of over 140%
and hTau40/3Epi an expansion of 52%, compared to hTau40’s 91% expansion. The K32
construct did insert, but caused an expansion of only 22%.

Figure 3.4 % area or pressure change versus time during insertion of hTau40, K18, K32
and hTau40/3Epi mutant proteins into DMPG lipid monolayers.

Figure 3.4 illustrates the % area or pressure change versus time during insertion of
hTau40, K18 construct, K32 construct, and hTau40/3Epi mutant proteins into DMPG lipid
monolayers held at either constant pressure (A) or constant area (B). Constant pressure
assays for hTau40, K18 and hTau40/3Epi were performed at UNM and accompanied by
FM imaging to monitor morphology. The constant pressure assay with K32 was performed
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at HASYLAB and accompanied by X-ray scattering measurements. All four of the constant
area assays also took place at HASYLAB and were accompanied by X-ray scattering.
The pressure increase of the tau construct or mimic into a DMPG monolayer held
at constant area is shown in Figure 3.4B. Time zero of the pressure increase corresponds
to the time of protein injection into the ~ 25 mL water subphase. In these experiments, a
needle was inserted directly into the lipid monolayer from above to inject into the water
subphase. The feedback loop in this circumstance was used to maintain constant trough
area, and the barriers did not move. All four tau proteins exhibited an immediate increase
in surface pressure after injection. The wildtype had a final percent pressure increase of
56%, the mimic hTau40/3Epi an increase of 68%, K18 an increase of 90% and K32 an
increase of 88%.
To assess changes in lipid packing and disruption of the constant pressure DMPG
monolayers induced by tau protein insertion, we monitored the morphology of the lipid
films before and after protein injection. Representative FM images for hTau40, K18, and
hTau40/3Epi are shown in Figure 3.5. % area expansion is indicated for each image. At 25
°C, the DMPG monolayer on water undergoes a liquid-expanded (LE) to liquid-condensed
(LC) phase transition at ∼17 mN/m (Jones et al., 2012). Because the bulky lipid dye
molecules, TR-DHPE, are preferentially excluded from the ordered LC phase, it appears
as dark domains in FM whereas the fluid LE phase containing the dyes is bright.
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Figure 3.5 FM images of the DMPG monolayer for the hTau40 (A), K18 (B) and
hTau40/3Epi (C).

FM images in Figure 3.5 of the DMPG monolayer for the hTau40 (A), K18 (B)
and hTau40/3Epi (C) constant pressure insertion experiments were collected at UNM. K32
were not obtained due to limited protein sample. The images were collected right before
injection of the protein (0), 10 minutes after injection (1), 30 minutes after injection (2),
and 60 minutes after injection (3). The scale bar is equal to 25 µm and the percentages
overlaid on each image correspond to the % area expansion at the time each image was
collected.

Figures 3.5A0, 3.5B0 and 3.5C0 show that at 25 mN/m the DMPG monolayer
contains predominantly the LC phase. Ten minutes after injection (Figure 3.5A1, 3.5B1,
3.5C1), the appearance in general of the LC domains changed from a well-defined circular
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shape to one that is less well-defined, indicative of decreased line tension around the LC
domains due to the association of the tau proteins to the lipid monolayer (Figure 3.5A2,
3.5B2, 3.5C2). Thirty minutes after injection, the ratio of dark to light regions is reduced.
The dark LC domains also became smaller, pointing to the disruption of these ordered
domains. One hour after injection (Figure. 3.5A3, 3.5B3, 3.5C3), these changes are even
further pronounced.

3.2.3 X-ray scattering measurements of tau constructs and mutant associated with lipid
monolayers
XR profiles of DMPG monolayers held at constant area with tau proteins injected
underneath showed significant differences compared to that of lipids alone (Figure 3.6A,
3.7A, 3.8A, 3.9A). XR data before and at two different timepoints (t1=4 hours and t2= 7
hours) after the tau protein injections are shown for comparison. Qualitatively, reflectivity
of the DMPG film alone showed the characteristic “two humps” of the lipid monolayer:
one corresponding to the lipid headgroups and the second to the alkyl tails. After the
injection of the tau proteins, significant differences in the reflectivity were observed in a
time-dependent manner. Overall, minima in the reflectivity curves became shallower and
the overall intensity of the signals decreased.
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Figure 3.6 (A) Fresnel normalized X-ray reflectivity (R/RF) and (B) water normalized
electron density (ρ/ρH2O) curves of DMPG monolayer with hTau40.

As seen in Figure 3.6, (A) Fresnel normalized X-ray reflectivity (R/RF) and (B)
water normalized electron density (ρ/ρH2O) curves of DMPG monolayer before and at two
time points (t1=4 hours and t2=7 hours) after injection of hTau40 protein into subphase are
illustrated. Figure 3.6 (A) Model dependent fits (lines) to R/RF data (filled symbols) are
from Stochfit. (B) ρ/ρH2O profiles from model dependent (curved lines) and box model fits
(straight line profiles). Data for both reflectivity and electron density has been offset for
clarity. The reflectivity value for bare DMPG is offset by 1000 and t1 is offset by 10. The
electron density for DMPG is offset by 2 and for t1 by 1. Schematics depicting location of
tau protein and lipids are also shown. Thickness value 0 corresponds to the air/lipid tail
interface.
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Table 3.2 X-ray Reflectivity Box Fit Parameters for hTau40 Insertion
Sample

Box
Composition

Thickness (Å)

ρ / ρH20

Roughness (Å)

DMPG

Lipid Tails

15.30 ± 8.4 E-2

0.95 ± 3.7 E-2

3.22 ± 3.0 E-2

Lipid Heads

9.31 ± 1.5 E-1

1.45 ± 5.0 E-3

3.22 ± 3.0 E-2

13.45 ± 2.8 E-2
DMPG
+ Lipid Tails
hTau40
Lipid Tails + 10.67 ± 8.0 E-1
t1= 4 hours
Heads + hTau40

0.97 ± 4.7 E-3

4.19 ± 5.61 E-3

1.36 ± 6.5 E-4

2.13 ± 5.61 E-3

Lipid Heads + 11.53 ± 1.6 E-2
hTau40

1.03 ± 1.7 E-3

3.14 ± 5.61 E-3

hTau40

1.01 ± 1.8 E-3

2.10 ± 5.6 E-3

7.82 ± 2.2 E-1
0.55 ± 3.4 E-2
DMPG
+ Lipid Tails
hTau40
t2 = 7 hours Lipid Tails + 20.84 ± 2.6 E-1 1.34± 6.5 E-2
Heads + hTau40

3.09 ± 3.2 E-2

10.67 ± 1.4 E-2

5.15 ± 5.6 E-3

hTau40

15.63 ± 3.4 E-1

1.11 ± 1.9 E-1

6.77 ± 9.7 E-3

hTau40

25.53 ± 1.2 E-2 1.05 ± 3.8 E-1

3.03 ± 1.0 E-1
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Figure 3.7 Fresnel normalized X-ray reflectivity and water normalized electron density
curves of DMPG monolayer with K18.

Figure 3.7 illustrates (A) Fresnel normalized X-ray reflectivity (R/RF) and (B)
water normalized electron density (ρ/ρH2O) curves of DMPG monolayer before and at two
time points (t1=4 hours and t2=7 hours) after injection of K18 protein into subphase. (A)
Model dependent fits (lines) to R/RF data (filled symbols) from Stochfit. (B) ρ/ρH2O profiles
from model dependent (curved lines) and box model fits (straight line profiles). Data for
both reflectivity and electron density has been offset for clarity. The reflectivity value for
bare DMPG is offset by 10000 and t1 is offset by 100. The electron density for DMPG is
offset by 2 and for t1 it is offset by 1. Schematics depicting location of tau protein and
lipids are also shown. Thickness value 0 corresponds to the air/lipid tail interface.
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Table 3.3 X-ray Reflectivity Box Fit Parameters for K18 Insertion
Sample

Box
Composition

Thickness (Å) ρ / ρH20

Roughness (Å)

DMPG

Lipid Tails

15.30 ± 8.4 E-2 0.95 ± 3.1 E-2

3.22 ± 3.0 E-2

Lipid Heads

9.31 ± 1.5 E-1

1.45 ± 5.0 E-3

3.22 ± 3.0 E-2

Lipid Tails

14.52 ± 4.7 E-2 0.85 ± 1.2 E-2

3.75 ± 1.4 E-2

Lipid Tails + 9.83 ± 1.443 E-1 1.36 ± 1.3 E-3
Heads + K18

3.75 ± 1.4 E-2

Lipid Heads + 11.11 ± 3.3 E-3 1.09± 3.6 E-3
K18

3.75 ± 1.4 E-2

K18

10.89 ± 3.6 E-3 1.04 ± 3.7 E-3

3.75 ± 1.4 E-2

Lipid Tails

7.77 ± 4.6 E-2

0.46 ± 2.5 E-2

2.86 ± 2.1 E-2

Lipid Tails + 15.06 ± 1.8 E-1 1.26 ± 3.7 E-3
Heads +K18

6.11 ± 5.4 E-2

Lipid Heads + 11.66 ± 1.1 E-1 1.21 ± 1.6 E-3
K18

2.25 ± 2.4 E-2

K18

12.88 ± 1.5 E-1 1.09 ± 3.6 E-3

4.89 ± 6.1 E-2

K18

13.61 ± 1.9 E-1 1.05 ± 2.2 E-3

3.55 ± 3.1 E-2

DMPG + K18
t1= 4 hours

DMPG + K18
t2= 7 hours
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Figure 3.8 Fresnel normalized X-ray reflectivity and water normalized electron density
curves of DMPG monolayer with K32.

Figure 3.8 illustrates (A) Fresnel normalized X-ray reflectivity (R/RF) and (B)
water normalized electron density (ρ/ρH2O) curves of DMPG monolayer before and at two
time points (t1=4 hours and t2=7 hours) after injection of K32 protein into subphase. (A)
Model dependent fits (lines) to R/RF data (filled symbols) from Stochfit. (B) ρ/ρH2O profiles
from model dependent (curved lines) and box model fits (straight line profiles). Data for
both reflectivity and electron density has been offset for clarity. The reflectivity value for
bare DMPG is offset by 10000 and t1 is offset by 100. The electron density for DMPG is
offset by 2 and for t1 it is offset by 1. Schematics depicting location of tau protein and
lipids are also shown. Thickness value 0 corresponds to the air/lipid tail interface.
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Table 3.4 X-ray Reflectivity Box Fit Parameters for K32 Insertion

ρ / ρH20

Sample

Box
Composition

Thickness (Å)

DMPG

Lipid Tails

15.30 ±8.4 E-2 0.95 ± 3.7 E-2 3.22 ± 3.0 E-2

Lipid Heads

9.31 ± 1.5 E-1

16.36 ± 8.9 E-2
DMPG
+ Lipid Tails
K32
t1= 4 hours
Lipid Heads + 8.28 ± 8.2 E-2
K32
K32
4.77 ± 2.4 E-1
DMPG
+ Lipid Tails + 13.11 ± 1.1 E-1
K32
K32
t2 = 7 hours
Lipid Tails + 12.76 ± 4.8 E-1
Heads + K32

Roughness (Å)

1.45 ± 5.0 E-3 3.22 ± 3.0 E-2
0.94 ± 2.4 E-2 3.96 ± 3.2 E-3
1.5 ± 2.8 E-2

3.56 ± 6.7 E-3

1.11 ± 1.1 E-1 4.01 ± 3.7 E-2
1.07 ± 3.3 E-2 4.94 ± 3.1 E-2
1.28 ± 4.6 E-3

2.31± 3.1 E-2

K32

10.12 ± 1.8 E-1 1.18 ± 2.9 E-3

2.13± 3.1 E-2

K32

12.27 ± 3.6 E-1 1.09 ± 1.2 E-2

3.09± 3.1 E-2
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Figure 3.9 Fresnel normalized X-ray reflectivity and water normalized electron density
curves of DMPG monolayer with hTau40/3Epi.

Figure 3.9 illustrates (A) Fresnel normalized X-ray reflectivity (R/RF) and (B)
water normalized electron density (ρ/ρH2O) curves of DMPG monolayer before and at two
time points (t1=4 hours and t2=7 hours) after injection of hTau40/3Epi protein into
subphase. (A) Model dependent fits (lines) to R/RF data (filled symbols) from Stochfit. (B)
ρ/ρH2O profiles from model dependent (curved lines) and box model fits (straight line
profiles). Data for both reflectivity and electron density has been offset for clarity. The
reflectivity value for bare DMPG is offset by 10000 and t1 is offset by 100. The electron
density for DMPG is offset by 2 and for t1 it is offset by 1. Schematics depicting location
of tau protein and lipids are also shown. Thickness value 0 corresponds to the air/lipid tail
interface.
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Table 3.5 X-ray Reflectivity Box Fit Parameters for hTau40/3Epi Insertion
Sample

Box
Composition

Thickness (Å)

ρ / ρH20

DMPG

Lipid Tails

15.30 ± 8.4 E-2

0.95 ± 3.7 E-2 3.22 ± 3.04 E-2

DMPG
hTau40/3Epi
t1= 4 hours

Lipid Heads
+ Lipid Tails
Lipid Tails
Heads
hTau40/3Epi

9.31 ± 1.5 E-1
1.45 ± 5.0 E-3 3.22 ± 3.04 E-2
11.35 ± 1.071 E-1 0.66 ± 3.271 E-2 3.15 ± 3.8 E-2
+ 11.57 ± 6.9 E-1
+

Lipid Heads + 6.90 ± 1.2 E-2
hTau40/3Epi
hTau40/3Epi
6.68 ± 2.4 E-2
hTau40/3Epi
14.25 ± 2.6 E-2
8.02 ± 1.1 E-1
DMPG
+ Lipid Tails
hTau40/3Epi Lipid Tails + 16.31 ± 1.7 E-1
t2 = 7 hours
Heads
+
hTau40/3Epi
Lipid Heads + 9.89 ± 6.9 E-1
hTau40/3Epi
hTau40/3Epi
hTau40/3Epi

Roughness (Å)

10.42 ± 2.4 E-1
28.61 ± 1.0 E-1
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1.43 ± 4.3 E-3

7.55 ± 3.2 E-2

1.30 ± 4.8 E-3

1.47 ± 2.8 E-2

1.23 ± 2.4 E-2
1.08 ± 2.6 E-2
0.57 ± 1.9 E-2
1.23 ± 3.1 E-2

3.69 ± 3.8 E-2
7.44 ± 3.2 E-2
3.35 ± 1.3 E-2
6.53 ± 7.8 E-4

1.18 ± 5.9 E-2

1.78 ± 1.9 E-2

1.10 ± 1.3 E-1
1.03 ± 1.1 E-1

2.52 ± 2.7 E-2
7.28 ± 5.1 E-2

Analysis of the XR data using the StochFit program (Danauskas et al., 2008)
yielded ρ/ρH2O distributions perpendicular to the protein/lipid film (Figure 3.6B, 3.7B,
3.8B, 3.9B). Box model fitting parameters are summarized in Tables 3.2-3.5. A two box
model fit of the DMPG lipids alone shows a region of high density corresponding to lipid
headgroups and a region of lower density corresponding to lipid acyl tails (see top
schematics in Figure 3.6B, 3.7B, 3.8B, 3.9B). With the insertion of protein, three or more
boxes were required to provide good fits to the two XR data sets, t1 and t2. The box at the
air interface corresponds to DMPG tail groups alone and this box decreased in thickness
with protein insertion. The box corresponding to the headgroup region of DMPG increased
in thickness and slightly decreased in ρ/ρH2O with tau protein insertion.
These physical changes to the DMPG film taken together indicate the presence of
protein both in the headgroup and tail regions of the lipid monolayer as well as a diffuse
layer of protein underneath the headgroups (see middle and bottom schematics in Figure
3.6B, 3.7B, 3.8B). The middle layers thus encompass a portion of lipid tails, lipid
headgroups, and protein, all of which contribute to the overall ρ/ρH2O fitted for this layer.
Lipid tails, which have significantly lower electron density, most likely caused the
decreases in the electron density of this middle layer as more of the tail region became
incorporated into this layer.
Thus, XR measurements revealed that all four tau proteins inserted into the DMPG
monolayer were located (1) underneath the lipid headgroups, (2) in the charged headgroup
region, and (3) partially in the hydrophobic tail region. With time, all tau proteins
penetrated further into the hydrophobic tail region. The three modes of interaction gave
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rise to a protein layer at the membrane surface with the portion of the protein that had
intercalated into the lipid membrane exhibiting a density of ~1.3.
GIXD data of K18 and hTau40/3Epi associated with a DMPG monolayer held at
constant area showed that the insertion of the tau proteins disrupted the ordered packing of
lipid tails (Figure 3.10), in agreement with observed disruption to monolayer morphology
observed by FM (Figure 3.5). The DMPG monolayer at 25 mN/m showed a single Bragg
peak, consistent with the LC domains observed from FM. After injection of K18 and
incubation for ~13 hours, no diffraction peaks were observed in the monolayer (Figure
3.10A), indicating that the ordered lipid phase had been disrupted by the insertion of tau
protein. After injection of hTau40/3Epi and incubation for ~13 hours, the Bragg peak
associated with the DMPG monolayer had significantly decreased in intensity, indicating
partial disruption of the ordered lipid phase. Moreover, K18 or hTau40/3Epi adsorbed to
the bare air/water interface did not give rise to any scattering peaks (data not shown),
indicating that they did not fold and assemble into in-plane crystalline structures detectable
by GIXD.
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Figure 3.10 GID of DMPG overlaid with DMPG + K18 (A) or DMPG + mutant
hTau40/3Epi (B) after 2.5 hours and 13 hours.

During the insertion experiments GIXD measurements were also taken before
injection of protein, after two and half hours of incubation with the protein (t1) and at
twelve hours after incubation (t2). The diffraction patterns obtained for the DMPG
monolayer at 25 mN/m and 25 °C before and after protein injection are shown in Figure
3.11, 3.12, 3.13, and 3.14.
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Figure 3.11 Bragg peaks (top) and rods (bottom) of pure DMPG monolayer and hTau40.
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Figure 3.11 illustrates Bragg peaks (top row) and rods (bottom row) of pure DMPG
monolayer (A, A’) at the air water interface at the surface pressure of 25 mN/m and the
temperature of 25°C and with hTau40 after t1=2.5 hours (B, B’) and t2=12 hours (C, C’,
C’’) of incubation, respectively. Due to the measurements at the constant area of the trough
the protein injection caused the surface pressure increase for the consecutive time periods:
at t1, 34 and at t2, 39 mN/m, respectively. The Bragg peaks were fitted using the sum of
two Voigt profiles (solid line) and de-convoluted into separate peaks (dashed lines)
corresponding to each of {1,0}+{0,1} and {1,-1} Bragg peaks. Bragg peaks were obtained
by integrating over the (-0.05 Å-1 ≤ Qz ≤ 0.75 Å-1). A’, B’ and C’’ show the sum of the
two {1,0}+{0,1} and {1,-1} Bragg rods corresponding to DMPG, t1 and t2 after injection
of hTau40. The Bragg rods were obtained by integrating over the (1.35 Å-1 ≤ Qxy ≤ 1.55
Å-1) region and fitted (solid line) by approximating the coherently scattering part of the
alkyl tail by a cylinder of constant electron density. Each of the separate Bragg rods are
shown as dashed lines in the bottom row. The {0,1} and {1,0} Bragg rods are
superimposable. The Bragg peak and rod associated with the hTau40 protein are indicated
by *. The Bragg rod (C’) was obtained by integrating over the (1.25 Å-1 ≤ Qxy ≤ 1.35 Å-1)
region.
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Table 3.6 Structural Parameters from GIXD of hTau40 Insertion into DMPG Monolayer

DMPG
(25 mN/m)

DMPG:
hTau40
t1=2.5hrs
(34 mN/m)

DMPG:
hTau40
t=12hrs
(39 mN/m)

Distorted a (Å)
Hexagonal
b (Å)
Unit Cell
γ
(degrees)
Area per
molecule
(Å2)

4.93  0.01

4.92  0.01

4.96  0.01

4.93  0.01

4.92  0.01

4.96  0.01

118.8  0.4

119.0  0.4

118.0  0.4

42.6  0.1

42.4  0.2

43.4  0.1

Integrated
Intensity
(%)

100

90

13

Coherence
Length, Lc
(Å)

14.0  0.5

11.5  0.5

11.7  0.5

tilt angle,
t (°)

18.1  1.0

15.5  1.0

16.7  1.0

Tilt dir.
from NN,
non-symmetry
(°)

0

0

0


(Å)

0.5  0.2

0.6  0.2

0.6  0.2

25ºC
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Extracted from the GIXD measurements structural parameters of the DMPG before
and after injection of the hTau40 protein measured at constant trough area at t1=2.5 and
t2=12 hours, respectively. The GIXD measurements are shown in Figure 3.11. Due to the
constant area of the trough the protein injection caused the surface pressure increase for
the consecutive time periods. Lc is the length of the coherently scattering part of the alkyl
tail measured along its backbone. Tilt angle is measured from the surface normal. The tilt
angle is measured between direction of nearest neighbor and the projection of the alkyl tail
on the subphase surface. Nearest neighbor (NN) is along a + b, where a and b are the 2D
unit cell vectors. Debye-Waller factor is the root mean-square molecular displacement.

Table 3.7 In-Plane Bragg Peaks Coherence Length for hTau40 Insertion into DMPG

25ºC

DMPG
DMPG+hTau40, t1=2.5hrs
DMPG+hTau40, t2=12hrs

In-Plane Bragg
Peaks
Coherence
Length, Lxy
(Å)  10 Å
L10+01
L1-1
170
310
90
500
100
240

Length, Lxy, is the in-plane coherence length; an average size of the 2D “crystalline”
islands.
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Table 3.8 Structural Parameters Extracted from hTau40 Protein Peak at Qxy=1.325Å-1

25ºC

hTau40
t1=2.5hrs
(34 mN/m)
hTau40
t=12hrs
(39 mN/m)


(Å)

InPlane
Bragg
Peaks
Coherence
Length,
Lxy
(Å)
 10 Å

-

-

-

0

0.83 0.2

200

d-spacing
(Å)

Integrated
Intensity
(%)

Coherence
Length, Lc
(Å)

tilt
angle,
t (°)

-

-

-

4.74  .02

100

7.2  1

Lc is the length of the coherently scattering part of the protein.
Length, Lxy, is the in-plane coherence length; an average length over which the scattering
units are in registry.
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Figure 3.12 Braggs peaks (top) and rods (bottom) of pure DMPG monolayer with K18.
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Figure 3.12 illustrates Bragg peaks (top row) and rods (bottom row) of pure DMPG
monolayer (A, A’) at the air water interface at the surface pressure of 25 mN/m and the
temperature of 25°C and with K18 after t1=2.5 hours (B, B’, B’’) and t2=12 hours (C, C’,
C’’) of incubation, respectively. Due to the measurements at the constant area of the trough
the protein injection caused the surface pressure increase for the consecutive time periods:
at t1, 45 and at t2, 45 mN/m, respectively. The Bragg peaks were fitted using the sum of
two Voigt profiles (solid line) and de-convoluted into separate peaks (dashed lines)
corresponding to each of {1,0}+{0,1} and {1,-1} Bragg peaks. Bragg peaks were obtained
by integrating over the (0.05 Å-1 ≤ Qz ≤ 0.75 Å-1). (A’, B’’, and C’’) show the sum of the
two {1,0}+{0,1} and {1,-1} Bragg rods corresponding to DMPG, t1 and t2 after injection
of K18. The Bragg rods were obtained by integrating over the (1.35 Å-1 ≤ Qxy ≤ 1.55 Å-1)
region and fitted (solid line) by approximating the coherently scattering part of the alkyl
tail by a cylinder of constant electron density. Each of the separate {0,1}, {1,0} and {-1,1}
Bragg rods are shown as dashed lines in bottom row. The {0,1} and {1,0} Bragg rods are
superimposable. The Bragg peaks and rods associated with the K18 protein is indicated by
*. The protein peak Bragg rods (B’, C’) were obtained by integrating over the (1.25 Å-1 ≤
Qxy ≤ 1.35 Å-1) region.
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Table 3.9 Structural Parameters from GIXD of K18 Insertion into DMPG Monolayer
DMPG
(25 mN/m)

DMPG:
K18
t1=2.5hrs
(45 mN/m)

DMPG:
K18
t=12hrs
(45 mN/m)

Distorted a (Å)
Hexagonal
b (Å)
Unit Cell
γ (degrees)

4.93  0.01

4.96  0.01

5.00  0.01

4.93  0.01

4.96  0.01

5.00  0.01

118.8  0.4

118.1  0.4

120

Area per
molecule
(Å2)

42.6  0.1

43.4  0.2

43.2  0.2

Integrated
Intensity
(%)

100

70

30

Coherence
Length, Lc
(Å)

14.0  0.5

11.6  0.5

10.5  0.5

tilt angle,
t (°)

18.1  1.0

19.5  1.0

13.6  1.0

0

0

0

.5  0.2

.5  0.2

0.6  0.2

25ºC

tilt dir.
from
NN,
non-symmetry
(°)

(Å)
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Extracted from the GIXD measurements structural parameters of the DMPG before
and after injection of the K18 protein measured at constant trough area at t1=2.5 and t2=12
hours, respectively. The GIXD measurements are shown in Figure 3.12. Due to the constant
area of the trough the protein injection caused the surface pressure increase for the
consecutive time periods. Lc is the length of the coherently scattering part of the alkyl tail
measured along its backbone. Tilt angle is measured from the surface normal. The tilt angle
is measured between direction of nearest neighbor and the projection of the alkyl tail on
the subphase surface. Nearest neighbor (NN) is along a + b, where a and b are the 2D unit
cell vectors.  is the Debye-Waller factor or root mean-square molecular displacement.

Table 3.10 In-Plane Bragg Peaks Coherence Length for K18 Insertion into DMPG
In-Plane Bragg
Peaks
Coherence
Length, Lxy

25ºC

(Å)  10 Å
L10+01

L1-1

DMPG

170

310

DMPG+K18, t1=2.5hrs

100

200

DMPG+K18, t2=12hrs

40

40

Length, Lxy, is the in-plane coherence length; an average size of the 2-D “crystalline”
islands.
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Table 3.11 Structural Parameters Extracted from K18 Protein Peak at Qxy=1.325Å-1

25ºC

K18
t1=2.5hrs
(45 mN/m)
K18
t=12hrs
(45 mN/m)


(Å)

In-Plane
Bragg
Peaks
Coherence
Length,
Lxy
(Å)

d-spacing
(Å)

Integrated
Intensity
(%)

Coherence
Length,
Lc
(Å)

tilt
angle
t (°)

4.74  0.03

56

4.5*

0

0.6 0.2

150  20 Å

4.77  0.02

100

6.5 1

0

0.7 0.2

120  10 Å

Structural parameters extracted from the K18 protein peak at Qxy=1.325Å-1.
Lc is the length of the coherently scattering part of the protein. Length, Lxy, is the in-plane
coherence length; an average length over which the protein scattering units are in registry.
* Due to weak scattering and high background the extraction of the Bragg rod and resulting
structural data was with high degree of uncertainty.
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Figure 3.13 Bragg peaks (top) and rods (bottom) of pure DMPG monolayer with
hTau40/3Epi.
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0.8

Figure 3.13 illustrates Bragg peaks (top row) and rods (bottom row) of pure DMPG
monolayer (A, A’) at the air water interface at the surface pressure of 25 mN/m and the
temperature of 25°C and with hTau40/3Epi after t1=2.5 hours (B, B’, B’’) and t2=12 hours
(C, C’, C’’) of incubation, respectively. Due to the measurements at the constant area of
the trough the protein injection caused the surface pressure increase for the consecutive
time periods: at t1, 47 and at t2, 44 mN/m, respectively. The Bragg peaks were fitted using
the sum of two Voigt profiles (solid line) and de-convoluted into separate peaks (dashed
lines) corresponding to each of {1,0}+{0,1} and {1,-1} Bragg peaks. Bragg peaks were
obtained by integrating over the (0.05 Å-1 ≤ Qz ≤ 0.75 Å-1). (A’, B’’, and C’’) show the
sum of the two {1,0}+{0,1} and {1,-1} Bragg rods corresponding to DMPG, t1 and t2 after
injection of hTau40/3Epi. The Bragg rods were obtained by integrating over the (1.35 Å-1
≤ Qxy ≤ 1.55 Å-1) region and fitted (solid line) by approximating the coherently scattering
part of the alkyl tail by a cylinder of constant electron density. Each of the separate {0,1},
{1,0} and {-1,1} Bragg rods are shown as dashed lines in bottom row. The {0,1} and {1,0}
Bragg rods are superimposable. The Bragg peaks and rods associated with the
hTau40/3Epi protein is indicated by *. The protein peak Bragg rods (B’, C’) were obtained
by integrating over the (1.25 Å-1 ≤ Qxy ≤ 1.35 Å-1) region.
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Table 3.12 Structural Parameters from GIXD of hTau40/3Epi Insertion into DMPG
Monolayer
DMPG
(25 mN/m)

DMPG:
hTau40/3Epi
t1=2.5hrs
(47 mN/m)

DMPG:
hTau40/3Epi
t=12hrs
(44 mN/m)

Distorted a (Å)
Hexagonal
b (Å)
Unit Cell
γ (degrees)

4.93  0.01

4.95  0.01

4.98  0.01

4.93  0.01

4.95  0.01

4.98  0.01

118.8  0.4

118.2  0.4

117.6  0.4

Area per
molecule
(Å2)

42.6  0.1

43.2  0.1

43.9  0.1

Integrated
Intensity
(%)

100

80

58

Coherence
Length, Lc
(Å)

14.0  0.5

10.9  0.5

10.9  0.5

tilt angle,
t (°)

18.1  1.0

18.1  1.0

19.2  1.0

tilt dir.
from NN,
non-symmetry
(°)
Tilt dir.
from NN,
non-symmetry
(°)

0

0

0


(Å)

0.5  0.2

0.6  0.2

0.6  0.2

25ºC
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Extracted from the GIXD measurements structural parameters of the DMPG before
and after injection of the hTau40/3Epi protein measured at constant trough area at t1=2.5
and t2=12 hours, respectively. The GIXD measurements are shown in Figure 3.13. Due to
the constant area of the trough the protein injection caused the surface pressure increase
for the consecutive time periods. Lc is the length of the coherently scattering part of the
alkyl tail measured along its backbone. Tilt angle is measured from the surface normal.
The tilt angle is measured between direction of nearest neighbor and the projection of the
alkyl tail on the subphase surface. Nearest neighbor (NN) is along a + b, where a and b are
the 2D unit cell vectors.  is the Debye-Waller factor or root mean-square molecular
displacement.

Table 3.13 In-plane Bragg Peaks Coherence Length for hTau40/3Epi Insertion into
DMPG

25ºC

DMPG
DMPG+hTau40/3Epi, t1=2.5hrs
DMPG+hTau40/3Epi, t2=12hrs

In-Plane
Bragg
Peaks
Coherence Length,
Lxy
(Å)  10 Å
L10+01
L1-1
170
310
80
170
70
110

Length, Lxy, is the in-plane coherence length; an average size of the 2-D “crystalline”
islands.
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Table 3.14 Structural Parameters Extracted from hTau40/3Epi Protein Peak at
Qxy=1.325Å-1

25ºC

dspacing
(Å)

hTau40/3Epi 4.72  .02 37
t1=2.5hrs
(47 mN/m)
hTau40/3Epi 4.72  .02 100
t=12hrs
(44 mN/m)


tilt
(Å)
angle,
t (°)

5.5  1

0

0.63 0.2

In-Plane
Bragg
Peaks
Coherence
Length,
Lxy
(Å)  10
Å
110

5.5  1

0

0.67 0.2

130

InteCo-herence
grated
Length, Lc
Intensity (Å)
(%)

Structural parameters extracted from the hTau40/3Epi protein peak at Qxy=1.33Å-1.
Lc is the length of the coherently scattering part of the protein. Length, Lxy, is the in-plane
coherence length; an average length over which the scattering units are in registry.
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Figure 3.14 Bragg peaks (top) and rods (bottom) of pure DMPG monolayer with K32.
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Figure 3.14 illustrates Bragg peaks (top row) and rods (bottom row) of pure DMPG
monolayer (A, A’) at the air/water interface at the surface pressure of 25 mN/m and the
temperature of 25°C and with K32 protein after t1=2.5 hours (B, B’) and t2=12 hours (C,
C’, C’’) of incubation, respectively. Due to the measurements at the constant area of the
trough the protein injection caused the surface pressure increase for the consecutive time
periods: at t1, 40 and at t2, 48 mN/m, respectively. The Bragg peaks were fitted using the
sum of two Voigt profiles (solid line) and de-convoluted into separate peaks (dashed lines)
corresponding to each of {1,0}+{0,1} and {1,-1} Bragg peaks. Bragg peaks were obtained
by integrating over the (0.05 Å-1 ≤ Qz ≤ 0.75 Å-1). (A’, B’, and C’’) show the sum of the
two {1,0}+{0,1} and {1,-1} Bragg rods corresponding to DMPG, t1 and t2 after injection
of K32. The Bragg rods were obtained by integrating over the (1.35 Å-1 ≤ Qxy ≤ 1.55 Å-1)
region and fitted (solid line) by approximating the coherently scattering part of the alkyl
tail by a cylinder of constant electron density. Each of the separate {0,1}, {1,0} and {-1,1}
Bragg rods are shown as dashed lines in bottom row. The {0,1} and {1,0} Bragg rods are
superimposable. The Bragg peaks and rods associated with the K32 protein is indicated by
*. The protein peak Bragg rods (C’) were obtained by integrating over the (1.25 Å-1 ≤ Qxy
≤ 1.35 Å-1) region.

For all four of the insertion experiments we obtained a strong initial signal for the
Bragg peaks representing the DMPG monolayer (Figure 3.11A, 3.12A, 3.13A, and 3.14A).
The DMPG monolayer at 25 mN/m showed two Bragg peaks, consistent with the LC
domains observed from FM. For each of the systems measured, two Bragg peaks were
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observed at Qxy ~ 1.45 Å–1 and Qxy ~ 1.48 Å–1. The presence of two Bragg peaks indicates
a distorted hexagonal 2D unit cell. For each of the systems the ratio of the integrated
intensities of the two Bragg peaks (-0.05 Å-1 ≤ Qz ≤ 0.75 Å-1) were approximately 2:1, in
agreement with the multiplicity rule. The two peaks can be indexed as {1, 0}+{0, 1} and
{1,-1}. The observed two d-spacings (= 2π/Qxy): d10+01, and d1-1 give rise to a primitive 2D
unit cell with dimensions and of the unit vectors |a| = |b| and the angle between them γ, as
well as the area per two alkyl chains listed in the Tables. The diffraction patterns were
fitted using the sum of two Voigt profiles (solid lines) and de-convoluted into separate
peaks (dashed lines) corresponding to {1,0}+{0,1} and {1,-1} Bragg peaks. The structural
parameters extracted from the analysis of the GIXD diffraction data are listed in the Tables.
Assuming the monolayer consists of perfect 2D crystallites of finite average dimension Lxy
(the lateral coherence length) in the crystallographic direction {h, k} with no preferred
azimuthal orientation, the Scherrer formula can be used to calculate the coherence length
in the three crystallographic directions.
In principle, the diffraction from the DMPG monolayer after injection of the
proteins is similar and shows the same final result of reduction of the amount of ordered
monolayer phase at the interface. This is indicated by the decreased integrated intensities
of the Bragg peaks, the increased area per lipid molecule, and reduction in the average
coherence lengths Lxy (the peaks becoming broader). The coherently scattering parts of the
alkyl tails (Lc) are also becoming shorter and the Debye-Waller factors (σ) are increasing.
The initial distorted hexagonal packing (|a| = |b|, γ<120°) is becoming hexatic-like, with
little or no distinction between lipid tail packing along {0,1}+{1,0} and {-1,1}
crystallographic directions.
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In the cases of the hTau40, K18 and hTau40/3Epi insertions (Figure 3.11B, 3.12B,
and 3.13B) we also saw a small peak emerging at 1.325 Å-1. After twelve hours of
incubation we observed both a greater decrease in the DMPG signal and an increased
intensity at the location of the small peak of ~ 1.325 Å-1for all proteins (Figure 3.11C,
3.12C, 3.13C, and 3.14C). Bragg rods which were derived from this data (Figure 3.11A’,
3.12A’, 3.13A’, and 3.14A’; 3.11B”, 3.12B”, 3.13B”, and 3.14B’; and 3.11C”, 3.12C”,
3.13C”, and 3.14C”) corresponded to the DMPG monolayer {1,0}+{0,1} and {1,-1} Bragg
peaks and the Bragg rods in Figure 3.11B’, 3.12B’, and 3.13B’; and 3.11C’, 3.12C’ 3.13C’,
and 3.14C’ corresponded to the small peak at around 1.4 Å-1. The combined Bragg rod
profiles of the {0,1}+{1,0} and {1,-1} reflections, were obtained by integrating the
scattering data through the 1.35 Å-1 ≤ Qxy ≤ 1.55 Å-1 region of the two peaks. Analysis of
the Bragg rod profiles were done by approximating the lipid alkyl tails as tilted cylinders
with constant electron density and length Lc. See the tables for the numerical results of this
analysis.
The d-spacings associated with these peaks are ~ 4.75 (± 0.03) Å and the length
coherently scattering units obtained from the Bragg rod fits are from 4.5 to 7.2 Å. Due to
small intensity of these ‘protein peaks’ and the proximity of the strong scattering peaks
from the DMPG monolayer, extraction of the their Bragg rods was difficult. The in-plane
coherence lengths calculated from the FWHMs of these peaks vary from 110 to 200 Å and
correspond to 23 - 42 d-spacings. The integrated intensities of the peaks increased
significantly with the incubation time indicating increased amount of material
accumulating at the surface.
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No diffraction signals were observed in the low Qxy region (0.05 - 1.2 Å-1)
corresponding with d-spacings of from 120 Å 5.5 Å (data not shown). Therefore we can
conclude that no regular molecular arrays with such characteristic distances are formed or
detectable by GIXD.

3.2.4 Neutron reflectivity measurements of K18, htau40/3Epi and K32 associated with
supported lipid bilayers
To study the effect of the K18 tau protein construct on a charge neutral DPPC lipid
bilayer, NR measurements have been performed using a custom made solid-liquid interface
cell as previously described (Dubey, 2010.) Reflectivity and corresponding SLD profile
are shown in Figure 3.15A. The simplest physically meaningful model was used to fit the
data. The system was described using two slabs. The first slab accounts for a thin D2O layer
between the quartz substrate and the lipid bilayer and the second for the alkyl tails of the
bilayer. Fit parameters resulting in best χ2 values are included in Table 3.15. The lipid
bilayer was fabricated by LB/LS transfer at 25 mN/m, which leads to a moderate densely
packed bilayer with the lipids in LC phase. The water buffer layer between quartz and the
bilayer has an initial thickness of 26 Å. The initial thickness of the alkyl tails of DPPC is
approximately 41.1 Å. The obtained SLDDPPC of -0.12 ×106 Å-2 indicates that the surface
coverage is approximately 95%. After the characterization of the DPPC bilayer, K18
protein was added into the system. The ~7 hour incubation of the bilayer with 5 µM protein
had no significant effect on the thickness or the SLD of the DPPC bilayer. This indicates
that K18 has small or no effect on the neutrally charged model membrane. Only a slight
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change was recorded in the thickness of water layer between quartz and the bilayer. The
thickness of this layer changed from 26 to 23 Å.

(A)

(B)
Figure 3.15 Reflectivity (RQz4 vs. Qz) and corresponding SLD profiles (inset) of a DPPC
(A) and DMPG (B) bilayer measured in D2O with (black) and without (gray) K18.
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The error bars in Figure 3.5 denote the standard deviation for each measurement.
The bilayers were deposited utilizing the Langmuir-Blodgett/Langmuir-Schaefer
technique at the surface pressures of 25 mN/m (A) and 40 mN/m (B).

Table 3.15 Fit Parameters for DPPC Bilayer Measured in D2O with and without K18.
DPPC before K18

DPPC after K18

Background

2.3e-9 ± 1e-5

3.0e-8 ± 6.1e-6

RoughnessSubstrate

1.8 ± 0.1

5.8 ± 0.2

ThicknessWater [Å]

25.5 ± 0.3

22.5 ± 3

SLDWater ×106 [Å-2]

5.8 ± 0.4

5.9 ± 0.4

RoughnessWater [Å]

3.7 ± 0.3

6.8± 0.2

ThicknessDPPC [Å]

41.1 ± 0.1

42.3 ± 0.4

SLDDPPC ×106 [Å-2]

-0.12 ± 0.2

0.22 ± 0.3

RoughnessDPPC [Å]

4.5 ± 0.1

2.7 ± .2
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Table 3.16 Fit Parameters for DMPG Bilayer Measured in D2O with and without K18.
DMPG before k18

DMPG after k18

Background

9.0e-7±2.5e-8

6.4e-8±2e-8

RoughnessSubstrate

16.5±0.1

5.3±0.3±3e-8

ThicknessWater [Å]

31.6±0.2

--

SLDWater ×106 [Å-2]

5.8±0.1

--

RoughnessWater [Å]

9.7±0.25

--

ThicknessDMPG [Å]

38.2±0.1

40.9±1.5

SLDDMPG ×106 [Å-2]

1.5±0.1

3.9±0.1

RoughnessDMPG [Å]

8.9±0.1

2.0±0.1

The interaction of the tau construct K18 and a negatively charged DMPG bilayer
was investigated by NR in a similar solid-liquid interface cell. Reflectivity and
corresponding SLD profile are shown in Figure 3.15B. Fit parameters resulting in best fits
are shown in Table 3.16. Differences between neutrally charged DPPC membranes and
negatively charged DMPG are immediately visible. Although LB/LS transfer was
conducted at a much higher surface pressure of 40 mN/m, the surface occupancy of the
resulting bilayer is much smaller than in the case of DPPC. The obtained SLDDMPG of
1.5 ×106 Å-2 indicates that the surface coverage is approximately 75%. The much higher
roughness parameters obtained from the fit indicate much less organized structures. The
thickness of the aqueous layer (32 Å) between the quartz wafer and the DMPG bilayer is
larger as compared to similar layer studied in the DPPC case. This can be attributed to the
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repulsive interaction between negatively charged DMPG headgroups and quartz surface,
respectively.
The fitted thickness of the DMPG bilayer before K18 was added is 38 Å. After the
addition of K18 pronounced changes in the NR can be observed. The intensity of the first
interference fringe drops substantially indicating that most of the material is removed from
the interface. The NR can be fitted using one layer only. The thickness of this layer is
approximately 41 Å with the SLD of 3.9 × 106 Å-2. The structure and composition of this
layer is unknown but its direct contact with the quartz surface might indicate membrane
patches which are attached to the interface after the DMPG bilayer is disrupted by K18
protein. Proximity of this layer to the negatively charged quartz surface can indicate some
saturation of the negatively charged DMPG headgoups by the positively charged K18 tau
construct.
Further tests with the K18 construct injected into bilayers of varying ratios of
anionic DMPG to zwitterionic DPPC revealed that a membrane composed of even as high
a ratio as 60% DMPG to 40% DPPC was not completely disrupted (Figure 3.16A-C). These
results, summarized in Tables 3.17-3.19, demonstrate that K18 did not completely disrupt
the mixed bilayers. The only disruption evidenced at the highest proportion of PG to PC
lipids (60:40) was an increase in thickness of the water layer between the membrane and
quartz, indicating a less stable membrane.
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(A)

(B)

(C)
Figure 3.16 Reflectivity and corresponding SLD profiles (inset).
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In Figure 3.16, reflectivity (RQz4 vs. Qz) and corresponding SLD profiles (inset)
of 80:20 ratio (A), 60:40 ratio (B), and 40:60 ratio (C) of DPPC:DMPG bilayers show
measurements in D2O with (black) and without (gray) K18. The error bars in Figure 3.16
denote the standard deviation for each measurement.

Table 3.17 Fit Parameters for 80:20 DPPC:DMPG Bilayer Measured in D2O with and
without K18
80:20 before K18

80:20 after K18

Background

1e-7

1e-7

RoughnessSubstrate

4 (fixed)

4 (fixed)

ThicknessWater [Å]

25.53

10.42

SLDWater ×106 [Å-2]

5.68

6.25

RoughnessWater [Å]

4 (fixed)

4 (fixed)

ThicknessDMPG [Å]

42.99

43.49

SLDDMPG ×106 [Å-2]

-0.3

-0.3

RoughnessDMPG [Å]

4 (fixed)

4 (fixed)
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Table 3.18 Fit Parameters for 60:40 DPPC:DMPG Bilayer Measured in D2O with and
without K18
60:40 before K18

60:40 after K18

Background

4.6e-6

1.99e-7

RoughnessSubstrate

4 (fixed)

4 (fixed)

ThicknessWater [Å]

34.99

28.85

SLDWater ×106 [Å-2]

6.29

5.27

RoughnessWater [Å]

4 (fixed)

4 (fixed)

ThicknessDMPG [Å]

43.78

42.28

SLDDMPG ×106 [Å-2]

-0.3 (fixed)

-0.3

RoughnessDMPG [Å]

4 (fixed)

4 (fixed)
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Table 3.19 Fit Parameters for 40:60 DPPC:DMPG Bilayer Measured in D2O with and
without K18

40:60DPPC:DMPG

40:60DPPC:DMPG

before K18

after K18

Background

5.2e-9 ± 1.5e-8

2.1e-6 ± 3e-6

RoughnessSubstrate

3.6 ± 0.4

2 (fixed)

ThicknessWater [Å]

25.0 ± 0.8

35.2 ± 0.25

SLDWater ×106 [Å-2]

5.9 ± 0.6

5.6 ± 0.2

RoughnessWater [Å]

7.9 ± 0.8

8.4 ± 1.4

ThicknessDMPG [Å]

42.4 ± 0.9

39.8 ± 0.3

-0.3 ± 0.2

-0.3 (fixed)

2 (fixed)

2 (fixed)

SLDDMPG ×106 [Å-2]
RoughnessDMPG [Å]

To study the effect of hTau40/3Epi protein on a charge neutral DPPC lipid bilayer,
NR measurements have been performed using a similar solid-liquid interface cell.
Reflectivity and corresponding SLD profile are shown in Figure 3.17A. The system was
again described using two slabs, with the simplest physically meaningful model used to fit
the data. The first slab accounts for a thin water layer between the quartz substrate and the
lipid bilayer and the second for the alkyl tails of the bilayer. Fit parameters resulting in best
χ2 values are included in Table 3.20. The lipid bilayer was fabricated by LB/LS transfer at
25 mN/m. The scattering length density (SLD) of the lipid tails
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(SLDDPPC = 0.67 × 106 Å-2) indicates 87% coverage of the surface. The water buffer layer
between quartz and the bilayer has an initial thickness of 11.3 Å. The initial thickness of
the alkyl tails of DPPC is approximately 42 Å. After the characterization of the DPPC
bilayer, hTau40/3Epi protein was added into the system. The 7 hour incubation of the
bilayer with 5 µM of the hTau40/3Epi protein had no significant effect on the thickness or
the SLD of the DPPC bilayer. This indicates that hTau40/3Epi has small or no effect on
the neutrally charged model membrane. Only a slight change was recorded in the thickness
of water layer between quartz and the bilayer. The thickness of this layer increased from
11.3 to 13.7 Å. Although the cause of this increase is unknown, it might be due to
perturbation of the DPPC bilayer during the addition of hTau40/3Epi which required a slow
exchange of the subphase during the protein injection.
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(A)

(B)
Figure 3.17 Reflectivity (RQz4 vs. Qz) and corresponding SLD profiles (inset) of a DPPC
(A) and DMPG (B) bilayer measured in D2O with (black) and without (gray)
hTau40/3Epi.

The Figure 3.17 error bars denote the standard deviation for each measurement.
The bilayers were deposited utilizing the Langmuir-Blodgett/Langmuir-Schaefer
technique at the surface pressures of 25 mN/m (A) and 40 mN/m (B).
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Table 3.20 Fit Parameters for DPPC Bilayer Measured in D2O with and without
hTau40/3Epi
DPPC before 3Epi

DPPC after 3Epi

Background

0 (fixed)

0 (fixed)

RoughnessSubstrate

6.6 ± 0.1

6.5 ± 0.1

ThicknessWater [Å]

11.3 ± 0.2

13.7 ± 0.3

SLDWater ×106 [Å-2]

5.6 ± 0.1

5.6 ± 0.1

RoughnessWater [Å]

4.1 ± 0.6

4.9 ± 0.4

ThicknessDPPC [Å]

41.6 ± 0.1

42.3 ± 0.1

SLDDPPC ×106 [Å-2]

0.67 ± 0.04

0.66 ± 0.04

RoughnessDPPC [Å]

5.6 ± 0.1

5.2 ± 0.1

The interaction of the hyperphosphorylation mimic hTau40/3Epi and a negatively
charged DMPG bilayer was investigated by NR in a similar solid-liquid interface cell.
Reflectivity and corresponding SLD profile are shown in Figure 3.17B. Fit parameters
resulting in best fits are shown in Table 3.21. LB/LS transfer was conducted at a much
higher surface pressure of 40 mN/m, and the obtained SLDDMPG of 0.23 ×106 Å-2 indicates
that the surface coverage is approximately 90%. The thickness of the aqueous layer
(13 Å) between the quartz wafer and the DMPG bilayer is slightly larger as compared to
the similar layer studied in the DPPC case. This again can be attributed to the repulsive
interaction between negatively charged DMPG headgroups and the quartz surface,
respectively. The fitted thickness of the DMPG bilayer before hTau40/3Epi was added is
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40 Å. After the addition of hTau40/3Epi pronounced changes in the NR can be observed.
The NR can no longer be fitted, indicating that no patches of lipids in a bilayer or even
micellar structure remain close to the interface once the DMPG bilayer is disrupted.

Table 3.21 Fit Parameters for DMPG Bilayer Measured in D2O with and without
hTau40/3Epi
DMPG before 3Epi

DMPG after3Epi

Background

0 (fixed)

0 (fixed)

RoughnessSubstrate

4 (fixed)

4 (fixed)

ThicknessWater [Å]

12.7 ± 0.5

--

SLDWater ×106 [Å-2]

5.3 ± 0.9

--

RoughnessWater [Å]

4 (fixed)

--

ThicknessDMPG [Å]

40.4 ± 0.1

--

SLDDMPG ×106 [Å-2]

0.23 ± 0.06

--

RoughnessDMPG [Å]

4 (fixed)

--

Examinations of the tau construct K32 and its interaction with similar DPPC and
DMPG bilayers were also conducted. While the results of these assays (Figure 3.18 and
Tables 3.22-3.23) are not as reliable due to problems with constructing the solid-liquid
interface cells, they do suggest further areas of investigation.
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(A)

(B)
Figure 3.18 Reflectivity (RQz4 vs. Qz) and corresponding SLD profiles (inset) of a DPPC
(A) and DMPG (B) bilayer measured in D2O with (black) and without (gray) K32

The Figure 3.18 error bars denote the standard deviation for each measurement.
The bilayers were deposited utilizing the Langmuir-Blodgett/Langmuir-Schaefer
technique at the surface pressures of 25 mN/m (A) and 40 mN/m (B).

116

Injection of the K32 construct into the DPPC bilayer (Figure 3.18A) caused partial
disruption of the membrane, shown by the larger water thickness and the higher SLD of
the DPPC layer, both of which indicate D2O has penetrated further into the membrane. The
effects of injection of K32 into the DMPG bilayer (Figure 3.18B) are quite different from
the effects of the other three tau proteins. Here, injection of K32 actually does not
completely disrupt the bilayer. The reflectivity data retains the distinctive “two-hump”
pattern indicative of a bilayer, and modeling the data affirms that while the thicknesses of
the layers and the SLD of the water layer have increased, the SLD of the DMPG layer has
decreased which indicates that less D2O is inside of the lipid layer.

Table 3.22 Fit Parameters for DPPC Bilayer Measured in D2O with and without K32
DPPC before K32

DPPC after K32

Background

5.51e-8

1.81e-9

RoughnessSubstrate

4 (fixed)

4 (fixed)

ThicknessWater [Å]

5.98

33.49

SLDWater ×106 [Å-2]

2.74

3.98

RoughnessWater [Å]

4 (fixed)

4 (fixed)

ThicknessDPPC [Å]

41.38

45.12

SLDDPPC ×106 [Å-2]

0.59

1.58

RoughnessDPPC [Å]

4 (fixed)

4 (fixed)
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Table 3.23 Fit Parameters for DMPG Bilayer Measured in D2O with and without K32
DMPG before K32

DMPG after K32

Background

5.51e-8

8.25e-7

RoughnessSubstrate

4 (fixed)

4 (fixed)

ThicknessWater [Å]

5.99

49.31

SLDWater ×106 [Å-2]

2.74

4.58

RoughnessWater [Å]

4 (fixed)

4 (fixed)

ThicknessDMPG [Å]

41.38

40.03

SLDDMPG ×106 [Å-2]

0.56

-0.28

RoughnessDMPG [Å]

4 (fixed)

4 (fixed)

3.3 Discussion
3.3.1 Tau constructs, K18 and K32, and mimic, hTau40/3Epi, are highly surface active
The constructs K18 and K32, along with the hyperphosphorylation mimic
hTau40/3Epi, are highly charged and soluble, but like the full-length hTau40 they adsorb
readily to the air/water interface. They all exhibit significant surface activity, reaching
pressures comparable to that reached by the full-length hTau40 (Figure 3.2) and to the
pressure of the amphipathic Aβ40 peptide to an air/water interface (Ege & Lee, 2004). As
with hTau40, the other tau proteins are intrinsically disordered which renders them prone
to partition or to bind to different interfaces. All four tau proteins have a sharp initial
increase in pressure indicating a high affinity to the hydrophobic interface. GIXD
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measurements of the adsorbed tau protein films reveal no diffraction peaks, indicating no
long-range repeat structures in the plane of the films are formed at the air/water interface.
As our previous work with hTau40 describes, however, this does not rule out the possible
formation of local, nonproprogating, secondary structures or amorphous aggregates of the
proteins at the air/water interface.

3.3.2 K18, K32 and hTau40/3Epi strongly interact with negative membranes
In order to more fully understand the role interaction with negative membranes
plays in mediating the dynamics of K18, K32 and hTau40/3Epi, we investigated the
interactions between two types of model lipid membranes and the tau constructs and
mutant. The Langmuir monolayer modeled one leaflet of the plasma membrane, while the
supported lipid bilayers provided a model of both leaflets of the membrane. Both constant
pressure and constant area insertion assays demonstrated that like the wildtype hTau40,
K18, K32 and hTau40/3Epi strongly associated and inserted into the anionic DMPG
monolayer (Figure 3.4). The K18 MTB domain construct is very membrane-active even
without the projection domain, presumably mediated in part by the attractive electrostatic
interactions between the overall positively charged K18 (Figure 3.1) and the lipids. This
strong affinity of the MT binding domain for anionic membranes is also in agreement with
previous reports of K18 aggregating in the presence of anionic lipid vesicles (ElbaumGarfinkle et al., 2010). The addition of the two flanking, proline-rich domains to either side
of the MTB domain in the K32 construct lowered the rate at which the protein adsorbed
but did not prevent it from the interaction. Even with the addition of further negative charge
through the mutation of select amino acids (Figure 3.1), the hyperphosphorylation mimic
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hTau40/3Epi interacted strongly with anionic membranes. Both K18 and hTau40/3Epi also
demonstrated a selective affinity toward anionic membranes by disrupting only supported
DMPG bilayers while leaving the zwitterionic DPPC bilayer intact (Figure 3.15 and 3.17).
Our findings give further evidence toward the MTB domain’s role in the affinity of the tau
protein for anionic membranes. They also suggest that even in a diseased,
hyperphosphorylated state, the tau protein retains this affinity.

3.3.3 Air/Water and lipid membrane interfaces induce K18, K32 and hTau40/3Epi
structural compaction
The films of the four tau proteins – hTau40, K18, K32 and hTau40/3Epi – adsorbed
to the air/water interface are approximately 20-25 Å thick and are not homogenous in
electron density perpendicular to the film surface (Figure 3.3). At the hydrophobic air
phase, a layer ~10 Å thick, with a ρ/ρH2O approaching 1.3, forms. A more diffuse layer of
ρ/ρH2O ~1 then extends out into the water phase.
Modeling of hTau40, K18, K32 and hTau40/3Epi inserted into a DMPG monolayer
(Figure 3.6-3.9) shows that all four associated with and partially inserted into the lipid
membrane. The wildype hTau40, the MT binding domain K18, the MTB plus flanking
regions K32 and the hyperphosphorylation mimic Tau40/3Epi all gave rise to a ~15 Å layer
of protein inserted in the membrane with a density of about 1.3, followed by a more diffuse
layer of ~9 Å underneath the DMPG headgroups with a density close to 1 extending into
the water phase. As previously described, the radius of gyration (Rg) of the intrinsically
disordered hTau40 in solution (determined by small-angle X-ray scattering) has been
reported to be 65 Å, (Mylonas et al., 2008) much larger than a globular, folded protein
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of ~400 amino acids with Rg typically ranging from 20 to 25 Å. Furthermore, a ρ/ρH2O of
1.3 of the more dense portion of the layers at the air/water and membrane interfaces is
comparable to the density of folded proteins that have an average specific volume of 0.73,
which corresponds to a density of 1.37 g/mL (Lee & Timasheff, 1974). GIXD
measurements of this data showed that all the tau proteins built up at the interface over
time, indicating that the tau proteins partitioned to the interface and began to form
amorphous aggregates.
For the GIXD studies of hTau40, K18, K32 and hTau40/3Epi proteins incubated
with DMPG monolayers at constant area for 12 hours, the presence of a new diffraction
peak at Qxy ~ 1.325 Å-1 was detected. That peak (with smaller intensity) was also present
for shorter (~2 hour) incubation times but only for K18 and hTau40/3Epi proteins. The dspacings associated with these peaks are ~ 4.75 (± 0.03) Å and the out-of-plane length of
the coherently scattering units associated with these peaks and obtained from the Bragg
rod fits are from 4.5 to 7.2 Å. The in-plane coherence lengths calculated from the FWHMs
of the Bragg peaks vary from 110 to 200 Å and correspond to 23 - 42 d-spacings. For the
K18 and hTau40/3Epi cases, the integrated intensities of the peaks increased significantly
with the incubation time indicating increased amount of material accumulating at the
surface. The d-spacing of 4.75 Å closely matches the distance between β-sheets units in
Aβ fibrils (Chi et al., 2008).
Taken together, our structural measurements of air/water interface-adsorbed and
membrane interface-associated tau layers of a smaller dimension and higher density
compared to tau in solution suggest that along with our previous findings on the wildtype
hTau40 (Jones et al., 2012), as the tau constructs and mimic partition to interfaces, at least
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a portion undergoes structural compaction to resemble the density of a folded protein. This
conformational change may also be accompanied by protein-protein interactions that lead
to amorphous aggregation of tau protein at the interfaces. Our GIXD measurements of the
tau proteins forming structures at anionic membrane interfaces which indicate the
formation of β-sheet fibrils also strongly points to the formation of misfolded aggregates
at the surface.
In addition to previous reports on the ability of anionic membranes to induce tau
fibrillization ( Chirita et al., 2003; Elbaum-Garfinkle et al., 2010) and the ability of anionic
membrane to induce structural compaction of the full length hTau40 (Jones et al., 2012),
the ability of anionic membrane to also strongly induce structural compaction of K18
described here suggests that the MT binding domain of tau plays a vital role in the early
structural changes that can then lead to fibrillization. Anionic membrane also induced
structural compaction of the mutant hyperphosphorylation mimic. Structurally compacted
conformations of the full-length tau protein that exhibit enhanced aggregation propensity
have been shown in several cases, including phosphorylation at several sites diagnostic of
AD (Jeganathan et al., 2006; Jeganathan et al., 2008) binding to exogenous aggregation
inducers (Chirita et al., 2005) and fast heating/cooling (Shkumatov et al., 2011). We show
here that the binding of the tau constructs K18 and K32 and the mimic hTau40/3Epi to a
hydrophobic interface (the air/water interface), and the binding of K18, K32 and
hTau40/3Epi to a physiological membrane interface, can also induce structural compaction
and lead to fibril formation.
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3.3.4 K18, K32 and hTau40/3Epi association with lipid membranes disrupts lipid
packing and membrane integrity
We observed morphological changes to the DMPG lipid monolayer caused by the
insertion of the tau construct K18 and mimic hTau40/3Epi. As we previously showed in
our hTau40-membrane study (Jones et al., 2012), disruption to monolayer morphology can
be indicative of disruption to lipid packing. An overall increase in the ratio of light LE
phase to dark LC phase can be caused by preferential insertion of the proteins into the more
fluid LE region and/or disruption of the ordered LC domains. The decrease in size of LC
domains indicates that the insertion disrupts lipid packing in the LC domains, which is
corroborated by GIXD data. On the molecular level, K18 or hTau40/3Epi insertion into
DMPG monolayers disrupted the ordered packing of lipid tails.
We used NR experiments to assess lipid bilayer structural integrity before and after
the addition of K18, K32 or hTau40/3Epi. Both K18 and hTau40/3Epi selectively disrupted
anionic DMPG lipid bilayers even at lipid packing densities higher than those of a cell
membrane. The neutrally charged DPPC bilayer, however, was unaffected by addition of
either K18 or hTau40/3Epi.
Our results confirm that the MT binding domain of tau, K18, the MTB domain plus
the flanking regions, K32, and the hyperphosphorylation mimic, hTau40/3Epi, interact
with an anionic monolayer at the air/water interface, but also with more physiologically
relevant lipid bilayers. They also disrupted lipid membrane structure on a molecular scale
by disrupting lipid packing and on a morphological scale by completely disrupting lipid
bilayer integrity. However, a lipid bilayer of even only 40% PC lipids to 60% anionic lipids,
was not completely disrupted by the addition of the MTB domain, K18.
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3.4 Conclusions
Our results provide some understanding of the effects of domain composition and
phosphorylation on the interaction of tau protein with lipid membranes. Although the
projection domain is absent in the K18 and K32 constructs, both were highly surface active.
K18 strongly associated with anionic membranes which disrupted lipid packing and
membrane integrity. The mutant hyperphosphorylation mimic hTau40/3Epi, despite
containing additional negative charge from the mutations in the regions flanking the MT
binding domain, was also highly surface active and strongly interacted with negative
membranes, disrupting lipid packing and membrane integrity.
For K18 and hTau40/3Epi, the hydrophobic air/water interface and the anionic lipid
membrane interface induced the intrinsically disordered proteins to partially adopt a more
compact conformation similar to a folded protein. The behavior of the K18 MT binding
domain construct suggests that this domain plays an essential role in both tau misfolding
and aggregation and in exerting toxicity via membrane destabilization. Despite the addition
of extra negative charges mimicking a diseased hyperphosphorylated state, the
hTau40/3Epi mutant also exhibited a strong affinity to both adsorb to the air/water interface
and associate with and intercalate into negatively charged lipid monolayers and bilayers.
These results indicate that hyperphosphorylation of the tau protein, as seen in a
diseased state, did not prevent interaction of tau protein with negatively charged lipid
membranes that lead to misfolding and structural compaction of the tau protein and may
seed the assembly of tau into fibrils. Furthermore, just as in the case of the wild type
hTau40 protein, the interaction of hTau40/3Epi with anionic lipid membranes disrupted
lipid packing and destabilized the membrane. Hyperphosphorylation of the tau protein,
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which occurs early during the pathogenesis of Alzheimer’s disease, causes detachment of
tau from microtubules.
We demonstrate that hTau40/3Epi, mimicking this free tau, is then capable of
interacting with anionic lipids in the plasma membrane. This interaction could then both
seed formation of PHFs and disrupt the lipid membrane, a proposed mechanism of protein
aggregate-induced toxicity in diseased cells. We propose that hTau40/3Epi’s ability to still
interact with negatively charged membranes and overcome any repulsive force because of
its additional negative charge is likely due to the fact that it still contains the positively
charged repeat domains which make up the K18 construct which strongly interacts with
anionic membranes.

3.5 Materials and Methods
Full-length

human

tau

isoform

(hTau40,

441

residues),

a

mutant

hyperphosphorylation mimic (hTau40/3Epi, 441 residues), and the MT binding repeat
domain (K18, 130 residues) and the MT binding domain plus the flanking regions (K32,
196 residues) were synthesized and purified as previously described (Figure 3.1) (Gustke
et al., 1994; Trinczek et al., 1995). Two lipids were used to evaluate the effect of lipid
headgroup charge on tau–membrane interactions:
anionic

1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]

(DMPG)

and

zwitterionic 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Figure 3.19C).
Lipids were purchased from Avanti Polar Lipids and used as received. DPPC was dissolved
in chloroform (CHCl3) (HPLC grade, Fisher Scientific) while DMPG was dissolved in 10
vol % methanol (MeOH) in chloroform. For FM, the headgroup-labeled fluorescent dye
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Texas Red 1,2-dihexadecanoyl 3-phosphoethanolamine (TR-DHPE) (Molecular Probes)
was first dissolved in chloroform and subsequently added to lipid spreading solutions at
0.5 mol %. Lipid stock solutions ranged from 2 to 10 mg/mL were prepared and then
diluted to 0.2 or 0.5 mg/mL for spreading solutions. All lipid solutions were stored at −20
°C in glass vials.

3.5.1 Adsorption of tau proteins to air/water interface
To evaluate the surface activity of the wildtype, mutant and K18 construct, the
surface pressure (π) measured by the adsorption of the proteins from a water subphase was
measured. The experiment was carried out at 25 °C and on a 45 mL water subphase (MilliQ system, Millipore, Bedford, MA) using a MiniMicro Langmuir trough (KSV Instruments
Ltd., Finland). A Wilhelmy plate sensor at the center of the trough measured π of the lipid
monolayer where π = γ0 – γ and γ0 is the air/water surface tension and γ is the lipid film
surface tension. The trough had a working surface area of 86.39 cm2. Before injecting
protein into the subphase, barriers were partially closed to give a total surface area of 45
cm2, roughly the same as the surface area of the lipid monolayers compressed to 25 mN/m
for the subsequent insertion experiments. For a final tau concentration of 1μM, 1 mL of
45μM tau was injected into the subphase using a gastight glass microsyringe (Hamilton,
Reno, NV).
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3.5.2 Constant pressure insertion assay and fluorescence microscopy
To evaluate the interactions between the tau proteins and lipid membranes,
insertion of tau into lipid monolayers at the air/water interface held at a constant π was
measured (Figure 3.19A). All experiments were carried out on water subphase and at room
temperature. Lipids were first spread at the air/water interface. The barriers then
symmetrically compressed the monolayer at 0.3 mm/s to a target π of 25 mN/m, and this π
was kept constant via a feedback loop. A π of 25 mN/m was chosen for its relevance to
physiological conditions as the lipid-packing density of a bilayer is reported to roughly
correspond to that of a monolayer at 30 mN/m (Ege & Lee, 2004; Seelig, 1987).
The speed at which the barriers moved to maintain this target pressure was
controlled by the feedback loop and depended upon how fast the barriers needed to expand
or contract in response to a perturbation, for example, rate of tau insertion. A maximum
barrier speed of 3 mm/min was set during the constant pressure duration of the experiment.
Protein was then injected into the subphase underneath the monolayer into the water
subphase via an injection port on the side of the trough below the level of the subphase to
achieve a final 1 μM concentration. Since the monolayer was kept at a constant π, the
barriers expanded as a result of protein insertion. Monolayer surface area was recorded,
and the % area expansion was taken as a measure of favorable tau–lipid interactions.
Surface area expansion is defined as ΔA/A = (A – Ai)/Ai, where A is the surface area at time
t and Ai is the initial surface area of the monolayer when it reached 25 mN/m.
To monitor lipid monolayer morphological change during tau insertion, the trough
was positioned on top of a motorized stage of an inverted optical microscope
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(Olympus IX 71) with a 50× objective centered on a quartz window in the bottom of the
trough. A 100 W mercury lamp was used for fluorescence excitation. Fluorescence images
were collected by a QImaging camera (EXi Blue, QImaging Photometrics) and analyzed
using the software QCapture Pro. 0.5 mol % TR-DHPE was included in the spreading
solution. Because of steric hindrance, the dye partitions into the liquid-expanded (LE)
phase rather than the liquid-condensed (LC) phase, giving rise to fluorescence contrast
(Knobler, 1990).

3.5.3 Constant area insertion assay
To evaluate the interactions between the tau proteins and lipid membranes,
insertion of tau into lipid monolayers at the air/water interface held at a constant area was
measured. In these experiments, a needle was inserted directly into the lipid monolayer
from above to inject into the water subphase. All experiments were carried out on water
subphase and at room temperature. Lipids were first spread at the air/water interface.
Protein was then injected into the subphase underneath the monolayer to achieve a final
1 μM concentration. Since the monolayer was kept at a constant area via a feedback loop,
the pressure increased as a result of protein insertion. The amount of pressure increase was
taken as a measure of favorable tau–lipid interactions.

3.5.4 X-ray scattering measurements
Grazing-incidence X-ray diffraction (GIXD) and X-ray reflectivity (XR) data were
collected at the BW1 beamline (HASYLAB, DESY, Hamburg, Germany) for both hTau40
adsorbed to the air/water interface and hTau40 inserted into a DMPG monolayer at the
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air/water interface. XR data give information about the out-of-plane (perpendicular to the
lipid film) electron density profile of the film averaged over the LE and LC phases. GIXD
measurements give structural information on the in-plane (i.e., in the plane of the
monolayer) ordered (hence diffracting) portion of the film. Presence of Bragg peaks in
GIXD data indicates 2D ordered structures. The theory of XR and GIXD has been
presented in detail elsewhere (Als-Nielsen et al., 1994; Als-Nielsen & Kjær, 1990).
The synchrotron X-ray beam was monochromated to a wavelength (λ) of around
1.304 Å by Bragg reflection from a beryllium (200) monochromator crystal in Laue
geometry. By tilting the reflecting crystal planes out of the vertical plane the
monochromatic beam was deflected down to impinge on the horizontal liquid surface at a
shallow glancing angle. All experiments were carried out in an ultrasmall volume
Langmuir trough liquid diffractometer (20 mL subphase volume) at 23 °C and an hTau40
concentration of 1 μM in pure water. The trough was temperature controlled and equipped
with a Wilhelmy balance for surface pressure measurements and a motorized barrier for
surface area variation was mounted on the diffractometer. During the XR experiments at
low incident angles, due to the small dimensions of the trough, the footprint of the beam
was larger than the size of the trough. Therefore, the normalized XR data were truncated
to only include data at which the footprint of the incoming beam is smaller than the size of
the trough.
For the XR experiments, reflectivity, R, is defined as the ratio of the intensity of Xrays specularly reflected from a surface relative to that of the incident X-ray beam
measured as a function of wave-vector transfer (Qz = |kout – kin| = 4π sin θ/λ, where θ is
the grazing angle and λ is the wavelength of the X-ray beam). The R profile contains
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information on the sample-normal profile of in-plane average of the electron density.
Chemically distinct molecular layers (e.g., proteins, lipid headgroups and tails) have
different electron densities. Electron density profile of a film, therefore, gives us
information on the location and thickness of the protein layer associated with the lipids
(Als-Nielsen et al., 1994; Jensen & Kjaer, 2001). The absolute R was derived by subtracting
background followed by normalization to the incident beam flux. The data was reduced
and plotted as R/RF versus Qz (the division by Fresnel reflectivity, RF, increases the
visibility of the reflectivity profile by removing a sharp Qz–4 decrease of the reflectivity due
to Fresnel’s law). The error bars on the data represent the statistical errors in the
measurements (standard deviation, σR).
Analysis of the measured reflectivity profiles was performed using a free form
StochFit fitting routine (Danauskas et al., 2008; Pedersen & Hamley, 1994). StochFit
utilizes a stochastic procedure for analyzing XR data of thin films at an interface. StochFit
first provides a model-independent electron density profile (ρ) of the XR data, after which
ρ is fit with a box model with smeared interfaces to extract physically meaningful results
(Chi et al., 2010). Each box represents a layer of distinct chemical composition, thus ρ.
From the box model fitting, lengths, ρ normalized to that of water ρH2O, (ρ/ρH2O), and
interfacial roughness values are reported for each box.
For the GIXD experiments, the X-ray beam was adjusted to strike the surface at an
incident angle of 0.11°, which corresponds to a qz = 0.85Qc, where Qc = 0.02176 Å–1 is the
critical scattering vector for total external reflection from the liquid subphase. At this angle
the incident wave is totally reflected, while the refracted wave becomes evanescent,
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traveling along the liquid surface. Such a configuration maximizes surface sensitivity. The
dimension of the X-ray beam footprint on the liquid surface was approximately
2 × 50 mm2 and was bigger than the width of the ultrasmall volume Langmuir trough we
used. This caused over illumination of the sample and small increases in the scattering
background. The scattered intensity was measured by scanning over a range of horizontal
scattering vectors, Qxy, the combination of horizontal components Qx and Qy
(Als-Nielsen et al., 1994; Als-Nielsen & Kjær, 1990). Bragg peaks are intensity resolved
in the Qxy-direction and integrated over channels along the z-direction in the position
sensitive detector. The position of the maxima of the Bragg peaks, Qxymax, was used to
calculate the repeat distances d = 2π/Qxy of the 2D lattice. The widths of the peaks,
corrected for the instrument resolution, were used to determine the 2D crystalline
in-plane coherence length, Lxy (the average distance in the direction of the reciprocal lattice
vector Qxy over which there is “near-perfect” crystallinity).

3.5.5 Neutron reflectivity measurements
Neutron reflectometry (NR) experiments were performed on mutant or K18 tau
construct associated with supported lipid bilayers using the Surface ProfilE Analysis
Reflectometer, or SPEAR, at Los Alamos National Lab (Dubey et al., 2011). Methods and
measurement of NR using SPEAR have been previously described (Dubey et al., 2010). In
general, lipid bilayers were created using a Langmuir–Blodgett/Langmuir–Schaefer
deposition method. 1 mg/mL DMPG in 9:1 CHCl3:MeOH and DPPC in CHCl3 were used
as spreading solutions. Lipids were spread at the air–water interface in a Langmuir trough
and compressed to a target pressure of 25 or 40 mN/m. A quartz substrate was drawn
131

through the air–water interface to deposit the first layer, then rotated, and driven back
through the interface to deposit the second layer. A solid–liquid interface cell (Figure
3.19B) was then assembled and purged with D2O. After collecting NR data of the pure
lipid bilayer, which takes about an hour and half, an aliquot of 5 μM protein in deuterated
PBS was injected into the flow cell, allowed to equilibrate for 20 min, and NR data were
collected again.
Neutrons entered the lateral face of the substrate and were scattered from the
substrate–subphase interface. D2O provided scattering contrast between the substrate,
hydrogen-rich bilayer, and subphase. Similar contrast conditions can also be obtained by
using deuterated lipids in a subphase of H2O, but no additional information relevant to this
publication can be obtained by performing NR measurements in both the contrast
conditions. Therefore, NR measurements were performed on hydrogenated lipid bilayers
in a D2O subphase. During the experiments, the ratio of elastically scattered to incident
neutrons, or reflectivity (R), was measured as a function of the momentum-transfer vector
Qz. Analysis of the NR data provided information about coherent scattering-length density
(SLD) distribution normal to the sample.
SLD is a value unique to a particular chemical composition and is the sum of
coherent scattering lengths of constituent elements divided by the volume that they occupy.
The continuous function SLD often can be well approximated by a number of layers, or
boxes, each with a constant and distinct SLD. Interlayer roughness can be taken into
account using an error function centered at each interface (Chi et al., 2008). The incident
neutron beam is refracted at each interface and a theoretical NR curve can be calculated
using the Parratt recursion formula (Parratt, 1954). The measured and theoretical NR
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curves are compared, and using genetic optimization and the Levenberg–Marquardt
nonlinear least-squares method, the best least-squares fit, corresponding to the lowest χ2
value, is obtained (Nelson, 2006). The simplest SLD model that gave good fits of physical
relevance was used to interpret the NR data.
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3.6 Supplemental materials
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Figure 3.19 Supplementary: Schematics of (A) a Langmuir trough insertion assay, (B) a
solid-liquid interface cell, and (C) the lipids used in the monolayer and bilayer
experiments.
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CHAPTER 4 GREATER DISRUPTION OF LIPID MONOLAYERS WITH
PRESENCE OF MODEL OSMOLYTE SUCROSE AFTER AΒ PROTEIN
INSERTION

4.1 Osmolytes
Interaction between IDPs such as tau and lipid interfaces may be modulated by a
variety of factors beyond the charge of the lipids contained in the membrane. One such
factor that could influence protein folding and interaction with membranes is the presence
of osmolytes, small co-solutes that influence and counterbalance the osmotic pressure of
the cell and the cellular environment (Yancey et al., 1982). Living organisms utilize
osmolytes to respond to the stresses of their environment, whether it be the harsh conditions
such as high salt concentrations that extremophiles deal with or the human renal
environment. The most common naturally occurring osmolytes include polyols (glucose
and sucrose), urea and methylamines (Lee, 1981). Although osmolytes do not directly bind
to proteins, they do influence the thermodynamics of protein folding by nonspecific
interactions (Arakawa & Timasheff, 1985; Bolen, 2001; Harries & Rosgen, 2008).
Osmolytes such as sucrose are frequently used in solution chemistry to stabilize or
denature proteins. Although it had been known for many years that the osmolyte urea
denatures proteins (Limbourg, 1887; Spiro, 1900; Tanford, 1964), it was not until the early
1980s that the idea of small, non-organic osmolytes having the opposite, protective effect
began to gain support (Arakawa & Timasheff, 1985; Hochachka et al., 2002; Yancey et al.,
1982).
Sucrose is preferentially excluded over water from the protein surface, which exerts
non-specific interfacial effects on proteins. This increases the surface tension of the
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protein/solvent interface, driving the stabilization of protein structure as the protein
conformation equilibrium is shifted to a more folded state (Figure 4.1). More specific
discussion of the energetics involved has been described previously (Anaya, 2013).

Figure 4.1 Schematic of the effect of preferential exclusion on protein conformation.
Sucrose shifts the protein conformation equilibrium towards a minimal exposed
surface area (red). In the presence of interfaces, the protein will adsorb (air/subphase
interface) or insert into a leaflet of a lipid membrane interface to further minimize solvent
exposed surface area (Anaya, 2013).
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4.2 Amyloid beta protein
The amyloid beta (Aβ) protein is one of two proteins known to misfold and
aggregate in Alzheimer’s disease (AD). Aβ is a fragment cleaved from the amyloid
precursor protein (APP), an integral membrane protein (Figure 4.2). In the normal,
physiological state Aβ takes on an α-helical conformation, while in the diseased state, Aβ
takes on a β-sheet conformation. The misfolded proteins then aggregate and form
extracellular plaques (Figure 4.2).
Previous studies conducted in our lab have shown that the osmolyte sucrose greatly
enhances the interfacial activity of Aβ at an ideal air/subphase interface and in a model
membrane system. Our studies here seek to reveal more about the interactions between Aβ
protein, lipid monolayers and sucrose on a molecular level.

Figure 4.2 Enzyme action on APP crucial to formation of Aβ plaque.

Enzymes act on the APP (Amyloid precursor protein) and cut it into fragments of
protein, one of which is called Aβ and is crucial in the formation of senile plaques in AD
(Garrondo, 2008).
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4.3 Materials and methods
Anionic 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG) lipids
were purchased from Avanti Polar lipids and used as received. DMPG was dissolved in 10
vol % methanol (MeOH) in chloroform. Lipid stock solutions ranging from 2 to 10 mg/mL
were prepared and then diluted to 0.2 or 0.5 mg/mL for spreading solutions. All lipid
solutions were stored at −20 °C in glass vials.
For our subphases of varying sucrose concentrations, we used sucrose purchased
from VWR and purified water (Milli-Q system, Millipore, Bedford, MA). The Aβ used for
all experiments was the 40 amino acid long version (Aβ40) and was synthesized using 9fluorenylmethoxycarbonyl chemistry on an Applied Biosystems 433A Peptide Synthesizer
(Foster City, CA) at the University of Chicago. Our Aβ protein samples were purified as
previously described (Anaya, 2013) using high performance liquid chromatography
(HPLC).
Langmuir trough experiments were carried out at room temperature (23º C). The
troughs were filled with the desired subphase, and then lipids were spread on the top of the
subphase. During the insertion experiments, protein was injected underneath the subphase
surface.
X-ray scattering experiments were carried out at the BW1 beamline at HASYLAB,
DESY (Hamburg, Germany) and at APS/Argonne U. Chicago/CARS. XR data gives
information about the out-of-plane (perpendicular to the lipid film) electron density profile
of the film averaged over the LE and LC phases. GIXD measurements give structural
information on the in-plane (i.e., in the plane of the monolayer) ordered (hence diffracting)
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portion of the film. The presence of Bragg peaks in GIXD data indicates 2D ordered
structures. The theory of XR and GIXD has been presented in detail elsewhere (Jens AlsNielsen et al., 1994; J. Als-Nielsen & Kjaer, 1989).

4.4 Results
4.4.1 GIXD measurements of DMPG monolayers on varying concentrations of sucrose
subphase
We spread DMPG to 14.5 mN/m, compressed to 25 mN/m, and then compressed
the same monolayer again to 35 mN/m for all three subphases: 0, 0.1 and 1 M sucrose
(Figure 4.3 and 4.4). These π’s of 25 mN/m and 35 mN/m were chosen for their relevance
to physiological conditions as the lipid packing density of a bilayer is reported to roughly
correspond to that of a monolayer at ∼30 mN/m (Ege & Lee, 2004; Seelig, 1987). The
initial measurements taken at 25 mN/m only showed a Bragg peak for 1 M sucrose
subphase (Figure 4.3).
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Initial GIXD Measurements at 25 mN/m
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Figure 4.3 Initial GIXD measurements at 25 mN/m.
As illustrated in Figure 4.3, background subtracted intensity of DMPG monolayer
at initial 25 mN/m pressure for 0 M (black), 0.1 M (red) and 1 M (blue) sucrose in subphase.
A Lorentzian curve (blue line) can be fitted to the 1 M case.
Measurements taken at 35 mN/m (Figure 4.4) displayed Bragg peaks for both the
1 M and 0.1 M cases. There was also a weak signal at a smaller 2θ of ~16.5 which could
indicate folded protein. The monolayer on the pure water (0 M sucrose) subphase caused a
weak signal in the same angular location of the Bragg peak.
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GIXD Measurements at 35 mN/m
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Figure 4.4 Background subtracted intensity of DMPG monolayer at 35 mN/m pressure
for 0 M (black), 0.1 M (red) and 1 M (blue) sucrose in subphase.

4.4.2 X-ray scattering measurements of Aβ insertion experiments into 0 M or 1 M
sucrose subphases
We also conducted insertion experiments injecting 500 nM Aβ underneath a DMPG
monolayer spread onto a 0 M or 1 M sucrose subphase. For pure water subphase, we had
to decrease the pressure, step-wise in increments of 1 mN/m, all the way from
25 mN/m to 14 mN/m before any area expansion was observed. X-ray reflectivity
measurements were taken when the pressure of the DMPG monolayer stabilized to
25 mN/m (Figure 4.5) and following insertion of the Aβ protein (Figure 4.6) after
decreasing the pressure to 14 mN/m. The distinctive double hump indicates the presence
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of an ordered monolayer, while its disappearance indicates disruption of the ordered
monolayer occurred after injection of protein.

Normalized Reflectivity (R/RF)
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Figure 4.5 R/RF of DMPG monolayer on water at 25 mN/m and 23 °C.

In Figure 4.5, a model independent fit (solid line) of the XR data was obtained from
StochFit which corresponds to the water normalized electron density distribution shown in
Figure 4.7.
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Figure 4.6 Fresnel normalized X- ray reflectivity data of the DMPG monolayer after
insertion (at ~14 mN/m rather than 25 mN/m) of 500 nM Aβ on pure water at 23 °C.

In Figure 4.6, a model independent fit (solid line) of the XR data was obtained from
StochFit which corresponds to the water normalized electron density distribution shown in
Figure 4.7.
Analysis of the XR data before and after injection of protein, performed using the
StochFit model (Danauskas et al., 2008), yielded ρ/ρH2O distribution perpendicular to the
air/water interface (Figure 4.7). They indicate the presence of the Aβ protein inside the
monolayer after insertion. The black line contains two boxes, one for the headgroups (far
left) and one for the tailgroups (far right) of the DMPG lipid. After Aβ insertion, the box
on the left increases both in width and electron density, indicating the presence of more
material in that location, such as the protein. The headgroup box decreases in electron
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density as the lower density protein is included. There is also a slim amount of electron
density to the right of the lipid, indicating a buildup of protein at the water-lipid interface.
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Figure 4.7 Electron densities and box fits of both DMPG on water (black) and DMPG +
Aβ on water (red). Box model fits of the electron density profiles are also shown.

For the following experiments using a 1 M sucrose subphase, after injection of the
protein we saw an immediate increase in area. The area increased so rapidly, in fact, that
the feedback loop used on the trough to maintain a constant pressure was overloaded, and
we initially saw a sharp spike in pressure before the trough corrected itself. The area then
continually increased until the barrier was completely expanded.
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Figure 4.8 Fresnel normalized X-ray reflectivity of DMPG monolayer at 23 °C on a 1 M
sucrose subphase.

In Figure 4.8, a model independent fit (solid line) of the XR data was obtained from
StochFit which corresponds to the water normalized electron density distribution shown in
Figure 4.10.
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Figure 4.9 Fresnel normalized X- ray reflectivity data of the DMPG monolayer on 1 M
sucrose subphase after insertion (at 25 mN/m) of 500 nM Aβ at 23 °C.

In Figure 4.9, a model independent fit (solid line) of the XR data was obtained from
StochFit which corresponds to the water normalized electron density distribution shown in
Figure 4.10.
The X-ray reflectivity data taken from the 1 M sucrose subphase case once again
shows complete disruption of the monolayer on a molecular level, and in this instance did
not require any lowering of the pressure for the protein to insert (Figure 4.8 and 4.9). The
shifts in the boxfit model of ED again indicate the presence of the Aβ protein inside the
monolayer after insertion, but in this case while maintaining a pressure of 25 mN/m. After
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Aβ insertion, the box on the left increases both in width and electron density, indicating
the presence of more material in that location, such as the protein. The headgroup box
decreases significantly in electron density as the lower density protein is included. There
is also, again, a small amount of electron density to the right of the lipid, indicating a
buildup of protein at the water-lipid interface.
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Figure 4.10 Electron densities and box fits of both DMPG on 1 M sucrose subphase
(black) and DMPG + 500 nM Aβ on 1 M sucrose subphase (red).
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4.5 Discussion
We observed that the DMPG lipid monolayer was more rigid when a higher level
of sucrose was present in the subphase. At a higher concentration of sucrose, we observed
a Bragg peak which indicated a greater degree of order in the lipid monolayer even at a
low surface pressure of 25 mN/m. This same peak was not observed at 25 mN/m in the
case of subphases which had 0 or 0.1 M sucrose (Figure 4.3). This data reinforces our lab’s
previous inference that the presence of sucrose increases the rigidity of lipid membranes
(Anaya, 2013). The next experiment, compressing the monolayer to a pressure of 35 mN/m,
demonstrated that at this higher pressure, Bragg peaks (and, thus, a greater degree of order)
were observed in the subphases containing sucrose (Figure 4.4).
Subsequent experiments utilizing 0 and 1 M sucrose subphases with a DMPG
monolayer demonstrated that while surface pressure had to be decreased for a DMPG
monolayer on pure water before insertion was observed, insertion was instantaneous for
the case where the subphase contained 1 M sucrose. This data is consistent with previous
data from our lab which observed that sucrose enhanced the adsorption of Aβ to the
air/subphase interface. Simultaneous X-ray scattering experiments revealed that the order
of the monolayers was disturbed on a molecular level upon insertion of the Aβ protein. We
also observed that even though the order of the DMPG monolayer increased with high
sucrose concentration, the protein insertion increased as well.

4.6 Conclusions
The results of this study shed new light on interactions between the Aβ protein,
lipid membranes, and protective osmolytes, but can also be more widely applicable. In the
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presence of a protective osmolyte such as sucrose, anionic lipid monolayers are much more
rigid. However, amyloid proteins such as Aβ insert even at higher monolayer pressures.
This contradicts earlier findings with tau that protein insertion is less likely to occur at high
pressures when a lipid monolayer is more ordered. We believe that because of the
preferential exclusion of sucrose from the protein surface, the Aβ inserts into the membrane
interface more readily in order to decrease the surface area exposed to a subphase with a
high sucrose concentration.
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CHAPTER 5 EFFECT OF POLYMER CHAIN LENGTH ON MEMBRANE
PERTURBATION ACTIVITY OF CATIONIC PHENYLENE ETHYNYLENE
OLIGOMERS AND POLYMERS
(Parts of this chapter have been published in Langmuir and appear as Ying Wang, Emmalee
M. Jones, Yanli Tang, Eunkyung Ji, Gabriel P. Lopez, Eva Y. Chi, Kirk S. Schanze, and
David G. Whitten. 2011. Effect of Polymer Chain Length on Membrane Perturbation
Activity of Cationic Phenylene Ethynylene Oligomers and Polymers, Langmuir, 21:
10770-10775)

Abstract
The biocidal compounds (OPEs and PPEs) examined in this study are cationic only,
not amphoteric, but the investigation of their interaction with model membranes was
conducted to learn more about possible changes in structure of the inserted compound as
well as membrane perturbation ability. We examined changes in OPE and PPE
characteristics and also lipid integrity, just as we previously studied the interaction of tau
and lipid membranes by looking at changes in the structure of both the protein and the
membrane. Studying the biocidal compounds serves as a parallel to the interaction which
takes place between tau protein and lipid membranes. Whereas with tau we examined
structural changes that manifested in β-sheet formation and general compaction of protein
to form aggregate-competent intermediates, when examining the polymers we observed a
change in structure that was exhibited in changes in photophysical properties from assays
that I performed. We also examined methods of cytotoxicity by observing dye leakage from
vesicles composed of various lipids when exposed to the polymers.
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5.1 Introduction
Developing efficient and low-cost antimicrobial agents has been the focus of
significant research efforts during the past decade.(Bryers, 2008; Zasloff, 2002) Significant
progress has been made toward understanding the toxicity mechanism of naturally
occurring antimicrobial peptides and preparing their synthetic mimics.(Gabriel et al., 2007)
The main target of these compounds is believed to be the cell membrane, and importantly,
these compounds can differentiate between mammalian and bacterial cell membranes
(Brogden, 2005; Gabriel et al., 2007).
Our group has developed a series of poly(phenylene ethynylene)- (PPE-) based
cationic conjugated polyelectrolyte (CPE) and oligo(phenylene ethynylene) (OPE)
compounds that exhibit remarkable light-activated biocidal activity and moderate killing
efficiency in the dark (Tang et al., 2009; Zhao et al., 2006). The light-activated biocidal
activity of these compounds has been attributed to their ability to generate singlet O2 after
exposure to UV-visible light, and the dark killing activity is linked to their ability to disrupt
bacterial cell wells and membranes and subsequently cause the death of the bacteria
(Chemburu et al., 2008; Corbitt et al., 2009). As part of our investigation of the structurefunction relationship of CPEs and OPEs, a series of CPEs and OPEs with the same
backbone but a range of different chain lengths, in terms of numbers of repeat units (n)
with n varying from 1 to 49, were synthesized (Figure 5.1). It has been proposed that CPEs
and OPEs exert their toxicity by disrupting the bacterial membrane in the dark (Wang et
al., 2010), so it is important to gain a fundamental understanding of the interactions of these
compounds with lipid membranes. Because significant differences in lipid composition
exist between prokaryotic and eukaryotic cell membranes (Graham, 1997), we also
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examined the interactions of the CPEs and OPEs with lipid membranes of different
compositions. Specifically, the principal phospholipids in mammalian plasma membranes
are phosphatidylcholine (PC) and sphingomyelin (SM). High levels of cholesterol are also
present in mammalian plasma membranes. In addition, the dominant phospholipids in
bacterial

cytoplasmic

membrane

are

phosphatidylglycerol

(PG),

phosphatidylethanolamine (PE), and cardiolipin (Graham & Higgins, 1997). The CPEs and
OPEs used in this study were cationic amphiphilic compounds with hydrophilic, positively
charged side chains positioned along the rodlike hydrophobic PPE backbone (Figure 5.1).
We employed several photophysical techniques to examine the interaction of the CPEs and
OPEs with model membrane systems, including fluorescent dye-leakage assays and
monolayer insertion assays. Our findings provide insights into the structural basis of the
CPEs/OPEs’ membrane perturbation ability and will enable the design of more effective
antimicrobial agents.
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Figure 5.1 Structures of the OPEs [S-OPE-n(COOEt)] and CPEs (PPE-NMe3-n-CooEt)
used in this study where n denotes the number of repeat units.

5.2 Experimental methods
5.2.1 Materials
The antimicrobial compounds (Figure 5.1) used in this work were synthesized as
reported elsewhere.(Ji et al., 2011; Tang et al., 2011) The concentrations of CPEs used in
this study are based on repeat units, and the concentrations of OPEs used in this study are
molar concentrations. 1,2-Dipalmitoyl-sn-glycero-3-phospho-(10-rac-glycerol) (sodium
salt) (DPPG), 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DPPE),
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), E. coli total lipid extract, (Phase
transition temperatures of the lipids used in this article:DPPG, 41 ºC; DPPE, 63 ºC; DOPC,
-20 ºC; E. coli total lipid extract, N/A.) cholesterol, and lipid vesicle extrusion supplies
were purchased from Avanti Polar Lipids (Alabaster, AL) and used as received. 5(6)carboxyfluorescein (hereafter referred to as fluorescein) was purchased from Sigma157

Aldrich (St. Louis, MO). Superfine Sephadex G-25 was obtained from GE Healthcare BioScience (Piscataway, NJ). All other chemicals were purchased from Sigma-Aldrich.
Ultrapure water was used throughout the study (Milli-Q, 18.2 MΩ cm-1 resistivity).

5.2.2 Photophysical measurements
The large unilamellar vesicles (LUVs) were made in pure water by an extrusion
procedure (Wang et al., 2010). Briefly, lipids dissolved in organic solvent were dried to
form a lipid film. The dry lipid film was hydrated with pure water, subjected to four freezethaw cycles, and finally extruded with a 100-nm pore-size polycarbonate membrane. The
hydrodynamic radii (Rh) of the vesicles were determined by dynamic light scattering
(DLS,DAWNHELEOS II, Wyatt Technology Corporation, Santa Barbara, CA) (Ding et
al., 2009). The vesicle and CPE/OPE mixtures were prepared in pure water and kept at a
lipid-to-CPE/-OPE molar ratio of 50:1. The final lipid concentration was
0.2 mM. To assess changes in the compounds’ conjugation lengths, absorbance spectra
were measured using a microplate reader (SpectroMax M-5 microplate reader, Molecular
Devices, Sunnyvale, CA). To assess changes in the hydrophobicity of the compounds’
microenvironments, emission spectra were recorded with a spectrofluorometer
(QuantaMaster 50 spectrofluorometer, Photon Technology International, Birmingham,
NJ).

5.2.3 Preparation of fluorescein-loaded vesicles and vesicle leakage assays
Fluorescein-loaded LUVs were prepared by extrusion as previously described
(Wang et al., 2010). A dry lipid thin film was first hydrated with 100 mM fluorescein in
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water at pH 7 adjusted with NaOH) and then subjected to four freeze-thaw cycles and
extrusion. Free fluorescein was removed from the dye-loaded vesicles by column filtration
(Sephadex G-25 superfine). The mobile phase used was 200 mM NaCl containing 10 mM
2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) at pH 7 (buffer A).
After separation, the phospholipid concentrations of the dye-loaded vesicle solutions were
determined by the modified microprocedure of Bartlett (Bartlett, 1959). The hydrodynamic
radii of the vesicles were determined as described above. Stability of the vesicle in the
presence of a CPE or an OPE was evaluated by the dye-leakage assay at room temperature.
As the vesicle membrane was perturbed by the CPE or OPE, dye was released, and the
fluorescence emission intensity of the released dye was recorded at 520 nm (excitation at
485 nm) (SpectroMax M-5 microplate reader, Molecular Devices, Sunnyvale, CA). The
CPEs and OPEs are not excited at this wavelength. Fluorescein leakage fractions were
calculated as reported previously (Wang et al., 2010). The maximum fluorescence intensity
was determined by adding 1 μL of 0.5 M Triton-X100 solution to a 100-μL sample to cause
complete lysis of the vesicles, and this intensity was set as 1 in Figure 5.2 and 5.3 (below).
All experiments were repeated at least twice, and the trends were highly reproducible.

5.2.4 Lipid monolayer insertion assays
Insertion of a CPE or an OPE into a lipid monolayer held at a constant surface
pressure (Ding et al., 2009) was measured using a Teflon Langmuir trough equipped with
a Wilhelmy plate and two identical mobile Delrin barriers (MicroMini Trough System,
KSV Instruments Ltd., Espoo, Finland) (Ding et al., 2009). The water subphase volume
was 50 mL, and the maximum working surface area was 100 cm2.
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Phospholipids dissolved in a 7:3 chloroform/methanol mixture were first spread at
the air-water interface. The deposited lipids were left undisturbed for 15 minutes to allow
the complete evaporation of the organic solvent. The lipids were then compressed to a
target surface pressure (π) of 30 mN/m, a bilayer equivalent pressure (Seelig, 1987) and
the surface pressure was kept constant through a feedback loop. An aliquot of CPE or OPE
was then injected into the water subphase using a microsyringe without disturbing the
monolayer. The final concentration of CPE or OPE in the subphase was 0.1μM. All
experiments were carried out at room temperature. Favorable interactions between the
CPEs/OPEs and phospholipids that led to the insertion of the compound into the lipid
monolayer caused an expansion of the lipid monolayer surface area at constant pressure.
The percentage surface area increase was calculated using the equation

where A0 is the trough area before the injection of CPE/OPE and A is the trough area at
time t after the addition of the CPE or OPE.

5.3 Results and discussion
Over the past decade, new synthetic amphiphilic antimicrobial agents with tunable
structures have been reported (Rennie et al., 2005; Som & Tew, 2008)
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Figure 5.2 (A,C) Absorbance and (B,D) fluorescence emission spectra
Figure 5.2 shows spectra from oligomeric S-OPE-3(COOEt) and polymeric PPENMe3-7-COOEt and their mixtures with different lipid vesicles in water at room
temperature. The excitation wavelengths for S-OPE-3(COOEt) and PPE-NMe3-7-COOEt
are 383 and 401 nm, respectively.

One of the most remarkable features of these synthetic compounds is their high
toxicity to bacterial cells and low hemolytic activity against human red blood cells. In
addition, the antimicrobial ability of these molecules is related to their insertion or
perturbation ability against bacterial cell walls and membranes. Herein, photophysical
investigations, dye-leakage assays, and monolayer insertion assays were used to explore
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the membrane perturbation abilities of a series of CPEs and OPEs that differ in their
numbers of repeat units.

5.3.1 Photophysical investigation
Because the photophysical properties of CPEs and OPEs are highly dependent on
their solution microenvironment (Tang et al., 2009; Zhao et al., 2006) a set of
photophysical measurements was obtained to elucidate the changes of the
microenvironments of the CPEs and OPEs upon coming into contact with lipid vesicles
composed of either DOPC lipids (a mammalian cell membrane mimic) or E. coli total lipid
extract (a bacterial cell membrane mimic). We previously showed that, in aqueous
solutions, the OPEs are monomeric in the μM range (Ji et al., 2011). In contrast, the CPEs
readily aggregate in aqueous solutions through intra- or interchain stacking of the
conjugated backbone, and this type of aggregation dramatically decreases the fluorescence
emission intensity of the CPEs compared to that of the OPEs (Zhao et al., 2006). Thus, the
fluorescence emission intensities of the compounds were measured to probe changes in the
aggregation state of the compounds in the presence of different lipid vesicles. Absorbance
measurements were made to probe changes in conjugation length, or segment
chromophores (Tang et al., 2011) of the compounds, whereby red shifts indicate increases
of the conjugation length in the molecular backbone.
All investigated CPEs and OPEs were found to exhibit similar spectral changes,
including absorbance spectral shifts and increases in emission intensity, upon incubation
with the two types of vesicles; Figure 5.2 shows a set of representative absorbance and
emission spectra for oligomeric S-OPE-3 and polymeric PPENMe3-7-COOEt alone or
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incubated with the two different vesicles. As shown, the absorbance maxima of both OPEs
and CPEs underwent red shifts to different extents, with the E. coli total lipids inducing the
largest changes (Figure 5.2A,C). The emission intensity of the OPEs and CPEs increased
significantly in the presence of lipid vesicles, and the E. coli total lipids again induced the
largest increases.
Parameters obtained from the photophysical characterizations of the CPE and OPE
compounds are summarized in Table 5.1. Our data show that the maximum absorbance
wavelengths of the OPEs in water increased with chain length, whereas the maximum
absorbance wavelengths of the CPEs did not exhibit such a trend (Table 5.1). This is
probably due to the ability of the long chains of the CPEs, which are longer than the average
conjugation length of the segment chromophores (Tang et al., 2011) within the backbone,
to form intra- and/or interchain aggregates (Amrutha & Jayakannan, 2008; Okuyama et al.,
1984; Traiphol et al., 2010).
As shown in Table 5.1 and Figure 5.2, when the CPEs and OPEs were mixed with
different model membranes, their photophysical properties changed dramatically.
Specifically, E. coli total lipid extract vesicles induced significant red shifts in the
absorbance maxima for all of the investigated CPE and OPE compounds, whereas DOPC
vesicles induced little or no change. The red shifts could be partly due to segment
planarization of the CPEs or OPEs from their interactions with the E. coli lipid membrane,
thus extending the conjugation length of the CPEs and OPEs along their backbones.(Chen
et al., 2000; James et al., 2006; Miteva et al., 2000). Moreover, the addition of lipid vesicles
greatly increased the fluorescence emission intensity of both the CPEs and OPEs (Figure
5.2) suggesting that, when exposed to lipid membranes, the microenvironment of CPEs
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and OPEs changed from an aqueous to a hydrophobic environment and, consequently,
nonradiative processes were significantly reduced (Tang et al., 2009; Zhao et al., 2006).
Meanwhile, the lipid vesicles induced blue shifts in the CPEs’ emission spectra (Figure
5.2D and Table 5.1), implying that the conformation of the CPEs might have changed from
an aggregated state to a more extended state and that this conformational change was
facilitated by the lipid membranes (Kaur et al., 2007; Liu et al., 2008; Ngo et al., 2008;
Tan et al., 2004). Overall, changes in spectral characteristics induced by the E. coli lipid
vesicles were significantly larger than those induced by the mammalian-mimicking
vesicles, indicating that the interactions of the CPE and OPE compounds with E. coli lipid
vesicles were stronger and more extensive than those with the mammalian membrane
mimic.

Table 5.1 Photophysical Characterization of the CPEs and OPEs in Different Solutions at
Room Temperature
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Table 5.2 Vesicle Abbreviations and Their Corresponding Compositions, Sizes, and
Overall Charges

Figure 5.3 Fluorescein leakage profiles
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In Figure 5.3 fluorescein leakage profiles from DOPC/cholesterol (67:33)
vesicles (V-1) with the addition of a CPE or an OPE in buffer A at room temperature
(excitation/emission wavelengths: 485/520 nm). Fluorescence from vesicles incubated
alone was subtracted.

Figure 5.4 Fluorescein leakage profiles
In Figure 5.4 fluorescein leakage profiles from E. coli total lipid vesicles
(V-2) with the addition of a CPE or an OPE in buffer A at room temperature
(excitation/emission wavelengths: 485/520 nm). Fluorescence from vesicles incubated
alone was subtracted.
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Our results indicate that the amphiphilic CPEs and OPEs bind to lipid vesicles
readily and that, upon binding, properties such as the conjugation length and aggregation
state of the compounds change. The binding of the CPEs and OPEs to the lipid vesicles
was further confirmed by increases in Rh values of the vesicles after the addition of a CPE
or an OPE to the vesicles; for example, Rh of E. coli vesicles increased from
67 ± 3 nm to 75 ± 2 and 91 ± 3 nm upon the addition of S-OPE-2(COOEt) and PPENME320-COOEt, respectively. The binding of the antimicrobial agents to vesicles has been
shown to be driven in part by electrostatic interactions. Favorable entropy increases by the
release of interfacial water through the binding of CPE or OPE to membranes might also
contribute to their high affinity toward membranes (Chen et al., 2000).

5.3.2 Disruption of mammalian- and bacterial-membrane-mimicking vesicles.
Vesicles of two different lipid compositions were prepared to mimic mammalian
and bacterial cell membranes (Graham, 1997) (Table 5.2). V-1, composed of PC lipids and
cholesterol, was used as a model for mammalian cell membranes. Figure 5.3 shows the
fluorescein leakage profiles from V-1 vesicles incubated with the different CPEs and OPEs.
In all cases, no dye release in excess of that of vesicles incubated alone was observed during
the incubation period. Clearly, the antimicrobial molecules in the concentration range
tested are inactive at disrupting the mammalian membrane mimic.
The binding of the antimicrobial agents to vesicles has been shown to be driven in
part by electrostatic interactions. Favorable entropy increases by the release of interfacial
water through the binding of CPE or OPE to membranes might also contribute to their high
affinity toward membranes (Chen et al., 2000). Vesicles V-2, made from E. coli total lipid
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extract, were used as a model for the bacterial membrane. As shown in Figure 5.4, all CPEs
and OPEs tested induced dye leakage, indicative of membrane disruption against V-2
vesicles. Moreover, the extent of dye leakage was highly dependent on the molecular size
and concentration of OPEs and CPEs (Figure 5.4). Increasing the chain length of the
oligomers enhanced their membrane perturbation activity (Figure 5.4A, B). In contrast, the
polymers showed the opposite trend: increasing the number of repeat units decreased the
polymers’ membrane perturbation ability (Figure 5.4C, D). The results from dye-leakage
assays show that the CPEs and OPEs selectively perturb the bacterial membranes and that
the membrane disruption ability is highly dependent on chain length. For the oligomers
tested, increasing the chain length enhanced their ability to incorporate or perturb lipid
membranes, which led to the leakage of dye molecules from inside the vesicles to the bulk
phase. In contrast, increasing the chain length of polymers reduced their membrane
perturbation ability, probably by enhancing their tendency to form aggregates through
intra- and/or interchain stacking. As a result, the effective concentration of the polymers
that could interact with the lipid vesicles was reduced. Additionally, formation of
aggregates can also reduce the polymer’s cooperativity in inducing membrane surface
defects, which might proceed by a highly synergistic mechanism (Bechinger & Lohner,
2006; Orioni et al., 2009).

5.3.3 Lipid monolayer insertion assays
Monolayer insertion assays are often used to evaluate the interactions and
membrane insertion abilities of naturally occurring antimicrobial peptides and synthetic
biocidal agents (Ding et al., 2010; Ege & Lee, 2004). In the current study, insertion assays
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of CPEs and OPEs into lipid monolayers at the air/water interface composed of DPPG and
DPPE were carried out at constant surface pressure to evaluate the effect of chain length
on membrane insertion ability. DPPE is zwitterionic and was used instead of DOPC for
insertion assays because DPPE forms a more stable monolayer. Moreover, because DPPE
and DPPG monolayers are both in the lipid-condensed phase under the experimental
conditions, whereas DOPC would be in a liquid expanded phase, the effect of membrane
fluidity or lipid packing will have minimal influence on the insertion results.
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Figure 5.5 Insertion profiles of CPEs (0.1 μM) or OPEs (0.1 μM) into DPPG monolayers
held at 30 mN/m on water at room temperature.

Figure 5.5 shows insertion isotherms of the CPEs and OPEs into DPPG monolayers
held at 30 mN/m on water at room temperature. Note that CPEs and OPEs alone did not
give rise to any surface pressure at the air/water interface (data not shown). The insertion
results shown in Figure 5.5 are thus due to favorable interactions between DPPG
monolayer and the CPEs or OPEs. Consistent with the results obtained from dye-leakage
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assays, the CPEs and OPEs show repeat-unit-dependent monolayer insertion abilities.
Specifically, increasing chain length increased the extent of insertion of OPE oligomers,
whereas the opposite trend was observed for CPEs. The longest CPE, PPE-NMe3-49COOEt, did not insert into the DPPG monolayer at 0.1μM. However, increasing the
concentration to 0.5 μM resulted in extensive insertion (data not shown). In contrast, none
of the CPEs or OPEs tested inserted into the lipid monolayers composed of the zwitterionic
DPPE lipids (data not shown). Taken together, the results obtained from lipid monolayer
insertion assays provide additional evidence for the size-dependent membrane perturbation
ability of CPEs and OPEs and their selectivity toward negatively charged membranes.

5.4 Conclusions
Our study clearly demonstrates that cationic CPEs and OPEs exhibit affinity toward
both mammalian- and bacterial-mimicking lipid membranes and that they selectively
perturb bacterial model membranes. The dye-leakage assays reveal that all of the CPEs and
OPEs investigated are inactive against model mammalian membranes in the concentration
ranges tested. However, they show significant membrane perturbation activity against
model bacterial membranes, and they readily insert into negatively charged lipid
monolayers at the air/water interface. Moreover, the compounds exhibit chain-lengthdependent membrane perturbation abilities, whereby increasing chain length increases the
ability of the oligomers to incorporate into and perturb membranes, and the reverse trend
was observed for the polymers. Taken together, these results indicate that there might be
an optimum chain length for these PPE-based antimicrobial compounds that corresponds
to the highest membrane perturbation efficiency. The results of the current study will serve
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as a guide to design more efficient and nontoxic materials resistant to bacteria growth and
biofilm formation.
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CHAPTER 6 X-RAY REFLECTIVITY AND DIFFRACTION STUDIES OF
INTERACTION BETWEEN ADHESION/GROWTH-REGULATORY
GALECTIN-1 AND DPPE:GM1 LIPID MONOLAYER AT THE AIR/WATER
INTERFACE

Abstract
Another protein and membrane interaction which we examined was between
galectin and a lipid membrane containing the ganglioside GM1. We looked at the changes
to both the protein and the membrane on a molecular scale using X-ray scattering
techniques as a parallel to the experiments we performed using tau protein and lipid
membrane. I modeled the X-ray reflectivity data from the insertion experiments to observe
where the Gal-1 protein inserted in a 8:2 DPPE:GM1 lipid monolayer. The galectin protein
Gal-1 and the lipid membrane itself also undergo structural changes upon the protein’s
insertion.

6.1: Introduction
Cell surface gangliosides are receiving increasing attention as constituents of
microdomains within the plasma membrane and as contact sites for carbohydrate receptors
(lectins), especially bacterial toxins such as the pentameric lectin part of the cholera toxin
(Ctx) (Kopitz, 2009; Ledeen & Wu, 2009; Pontier & Schweisguth, 2012; Wennekes et al.,
2009). Recently, the ganglioside GM1, the Ctx binder, has also been identified as
physiological counter receptor for members of the family of human galectins, tissue lectins
sharing the b-sandwich fold and a sequence signature with a central tryptophan residue
(Kaltner & Gabius, 2012; Solis et al., 2014). Functionally, proto-type (homodimeric)
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galectin-1 (Gal-1) exerts growth control via GM1 binding on human neuroblastoma (SKN-MC) cells in vitro and on activated T effector cells (Fajka-Boja et al., 2008; Kopitz et
al., 2012; Kopitz et al., 2010; Ledeen et al., 2012; Lencer & Saslowsky, 2005; Wang et al.,
2009; Wu et al., 2011). As reported for bacterial Ab5 toxins, the ganglioside is involved in
rapidly internalizing Gal-1 measured in T leukemic (Jurkat) cells (Fajka-Boja et al., 2008;
Lencer & Saslowsky, 2005). However, membrane reactivity between the cholera toxin and
the human lectin will not necessarily cause the same post-binding mechanisms: only the
human lectin is a growth regulator for the neuroblastoma cells (Kopitz et al., 2012).
Obviously, topological aspects of association are different, prompting us to initiate the
analysis of galectin binding to a GM1-containing model surface.
In addition to cellular uptake and routing as well as impact on growth, the study of
association to the surface of trypsinized erythrocytes has revealed an effect on membrane
properties such as fluidity and osmofragility that may depend on a change in quaternary
structure of Gal-1 upon entering the hydrophobic environment (Gupta et al., 2006). Of
note, in an aprotic solvent the lectin has been demonstrated to form a dimer of the
homodimer with a cylindrical shape (He et al., 2003). This evidence directed us to start our
study with examining the possibility of an insertion of this potent effector into the lipid
monolayer.
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6.2 Materials and methods
6.2.1: Materials
1,2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DPPE) and ganglioside
GM1 (brain, ovine-ammonium salt, powder) were purchased from Avanti Polar Lipids
(Alabaster, AL) and used without further purification (Figure 6.1). Stock solutions of each
sphingo(glycol)lipid (~5 mg/ml) were first prepared by dissolving the lipid in chloroform
containing 9 vol% methanol and 1 vol% water to a concentration of ~ 5 mg/ml. Lipid
monolayer spreading solutions (0.3 mg/ml) containing 80 mol% DPPE and 20 mol% GM1
(8:2 DPPE:GM1) were then prepared and stored at -20 °C in glass vials until use. Human
Gal-1 was obtained by recombinant production, purified by affinity chromatography as a
crucial step and rigorously controlled for purity (by two-dimensional gel electrophoresis
and mass-spectrometric fingerprinting) and for bioactivity (by haemagglutination and
assays for growth inhibition) (Amano et al., 2012; Andre et al., 2007; Ledeen et al., 2012).
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Figure 6.1 Molecular structures of the sphingolipids DPPE (A) and GM1 (B) used.

6.2.2: Constant pressure lipid monolayer insertion assay
To examine the galectin’s interaction with lipid membranes, the insertion of the
protein into a mixed DPPG and GM1 lipid monolayer at the air/buffer interface under
constant surface pressure was carried out in a Langmuir trough (Chi et al., 2007) at the
BW1 (undulator) beam line at the HASYLAB synchrotron source (Hamburg, Germany)
( Majewski et al., 1995). A schematic of the experimental set-up of the constant pressure
protein insertion assay carried out in a Langmuir trough is shown in the Supplementary
Material, Figure 6.7. The temperature-controlled trough at the dedicated liquid surface
diffractometer was equipped with a Wilhelmy plate balance that measures surface pressure
at the air/buffer interface and a movable hydrophobic Teflon barrier that controls the trough
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surface area. The trough was first filled with approximately 240 mL of subphase buffer
(20 mM PBS at pH 7.2 containing 16.2 mM Na2HPO4, 4 mM KH2PO4, 154 mM NaCl, and
1% NaN3) at 20 °C. A solution of mixed lipids (8:2 DPPE:GM1 90:9:1
chloroform:methanol:water) was then spread at the air/buffer interface. The system was
allowed to equilibrate for 15 minutes to ensure the complete evaporation of the organic
solvent, after which the lipid monolayer was compressed to a target surface pressure of 20
mN/m and this pressure was kept constant for the remainder of the experiment via a
feedback loop (Figure 6.7A). X-ray scattering data (described in more detail below) was
then collected on the lipid film at 20 mN/m and 20 °C. Then, an aliquot of Gal-1 (5 mg
dissolved in 1 ml PBS buffer) was injected into the buffer subphase of the trough and
allowed to equilibrate with the lipid monolayer (Figure 6.7B). The galectin concentration
in the trough subphase was approximately 21 μg/ml. Since the lipid monolayer surface
pressure was kept constant, insertion of Gal-1 into the lipid monolayer resulted in an
expansion of the lipid monolayer surface area (Figure 6.7C). Thus monolayer surface area
expansion is taken as a measure of productive protein-membrane interactions. X-ray
scattering data were taken 5 (t1) and 13 (t2) hours after injection of Gal-1-containing
solution.

6.2.3: X-ray scattering measurements
To elucidate the molecular-scale structure of the Gal-1 – lipid monolayer film,
complementary grazing-incidence X-ray diffraction (GIXD) and X-ray reflectivity (XR)
data were collected before (e.g., lipid membrane alone) and two time points after
(t1 and t2) placing Gal-1 underneath the 80:20 DPPE:GM1 lipid monolayer. The X-ray
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beam that illuminates the sample has a wavelength (λ) of 1.30± 0.02 Å (9510 eV) and a
power of ca. 0.3 mW. To reduce scattering background and to minimize oxidative X-ray
beam damage to the protein-lipid film, the trough container was purged for 30-40 minutes
with helium. As an additional precaution against damage by radiation, the trough was
translated by 0.025 mm in the horizontal direction after every step during GIXD scans and
by 2 mm during XR scans.
GIXD measurements provide in-plane (i.e., in the plane of the monolayer) structural
information on the crystalline diffracting portion of the film. In general, the lipidcondensed (LC) phase in Langmuir monolayers can be described as 2D powers with 2Dcrystallites that are azimuthally and randomly oriented on the subphase surface. The
reciprocal space of GIXD patterns from the crystalline portion of the monolayer arise from
a 2D array of Bragg rods, which extend parallel to the vertical component, qz , of the
scattering vector, q (Als-Nielsen & Kjær, 1990; Kjær, 1994). To maximize surface
sensitivity for the GIXD measurements, the monochromatic X-ray beam was adjusted to
strike the surface at an incident grazing angle of 0.11°, which is 85% of the critical angle
for total external reflection (Eisenberger & Marra, 1981). The dimensions of the footprint
2

of the incoming X-ray beam on the liquid surface were approximately 2x50 mm .
Diffracted intensities were collected using a one-dimensional position-sensitive detector
(PSD, OEM-100-M, Braun; Garching, Germany), as a function of the vertical scattering
angle and has a measuring window of ∆qz ≈ 0.9 Å-1. A Soller collimator was mounted in
front of the PSD, which gave the horizontal resolution of the detector of
∆qxy = 0.0084 Å-1. The scattered intensity was measured by scanning over a range of the
horizontal scattering vector component, q xy 
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2 xy 
, where 2θxy is the angle
sin
 2 


4

between the incident and diffracted beam projected onto the horizontal plane, and  is the
wavelength of the X-ray beam. Such a scan, integrated over the whole window of the
position sensitive detector (PSD), yields the Bragg peaks. Simultaneously, the scattered
intensity recorded in channels along the PSD, but integrated over the scattering vector in
the horizontal plane across a Bragg peak, produces qz -resolved scans called Bragg rod
profiles. The intensity distribution along a Bragg rod can be analyzed in terms of a model
of the molecular conformation, packing and orientation, to yield, e. g., information on the
direction and magnitude of the molecular tilt in the crystalline part of the amphiphilic film.
In this work, lipid tails were modeled by a cylinder of constant electron distribution.
Adjustable parameters, then, were the tilt angle of the cylinder from vertical, the lateral tilt
direction, the length, Lc , of the cylinder (i.e., the length of the part of the molecule which
scatters coherently), and the vertical root-mean-square displacement, σz (Debye-Waller
factor), in the crystallites. Analysis of the Bragg peaks yields d-spacing and coherence
length (i.e., average size) of the 2D crystallites in the film at the air/buffer interface.
While GIXD measurements afford structural information on the in-plane crystalline
portion of the film, XR measurements yield information about the out-of-plane (vertical)
monolayer structure, laterally averaged over both crystalline and amorphous portions (AlsNielsen et al., 1994; Jensen & Kjaer, 2001). For XR measurements, an additional slit is
used to exclude diffuse scattered background around the reflected beam. This slit, together
with a scintillation detector having a thin vertical measuring window
-1

(∆qz ≈ 0.02 Å ), is mounted on an elevator situated on a diffractometer arm which is
pivoted around a vertical axis through the sample center. Detailed information on the
electron density variation in the vertical direction, laterally averaged over both the ordered
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and disordered parts of the film, can be obtained from the deviation of the measured
specular XR from Fresnel's law (Als-Nielsen & Kjær, 1990; Kjær, 1994).

6.3 Results
6.3.1 Gal-1 insertion into DPPE:GM1 monolayer
During the lipid monolayer insertion assay, monolayer surface area was recorded and
the

percent

area

expansion

( %DA / A )

was

calculated

using

the

equation

æ A - Ai ö
%DA / A =100 ç
÷ , where Ai is the trough area of the monolayer at 20 mN/m and
è Ai ø
20 °C before the injection of Gal-1-containing solution and A is the trough area at time t
after applying the protein. The isotherm and insertion data are summarized in Figure 6.2,
revealing a productive interaction.
As shown in Figure 6.2B, Gal-1 inserted into the monolayer immediately after starting
the experiment by injection into the buffer subphase and steadily continued to do so during
the seven hours. The area per molecule shown here reflects the average area per lipid
molecule, accounting for both ordered (LC) and disordered (liquid-expanded) phases. Note
that the “bilayer-equivalent surface pressure”, i.e., the pressure at which monolayer lipid
packing density mimics those in a lipid bilayer, has been reported to be in the range of
30-33 mN/m (Seelig, 1987). An insertion assay at a constant surface pressure of 30 mN/m
had first been carried out. However, because no lectin insertion into the lipid monolayer
was observed at this pressure, the surface pressure was lowered to 20 mN/m for the
subsequent experiment, during which protein insertion occurred as reported here.
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Figure 6.2 Isotherm (A) and insertion (B) of Gal-1 into a 8:2 DPPE:GM1 monolayer
held at 20 mN/m at 20 °C.

6.3.2 Structure of the Gal-1 – lipid monolayer film at the air/buffer interface
By combining the methods of GIXD and XR, the in-plane and out-of-plane structures
of the lipid film and location of the lectin at the lipid film interface were elucidated. Figure
6.3 shows a contour plot of the GIXD data for the mixed 8:2 DPPE:GM1 monolayer with
both qxy and qz resolved. Very similarly shaped contour plots for the monolayer after lectin
insertion were observed, although absolute intensities of the plots differed (data not
shown). Figure 6.4 shows GIXD data projected on the qxy and on qz axis, yielding Bragg
peaks and Bragg rods, respectively. The time points five (t1) and 13 (t2) hours corresponded
to approximately 14% and 20% area expansion of the lipid monolayer. The rate of area
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expansion due to lectin insertion was approximately 2%/hr. Note that Gal-1 insertion did
not reach equilibrium after 13 hours – a plateau in area/molecule versus time was not
observed.

Figure 6.3 Reciprocal space contour plot, , of DPPE:GM1 monolayer at 20 mN/m and 20
°C.
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Figure 6.4 The integrated GIXD (Bragg peaks) data of the lipid film.

Figure 6.4 illustrates the integrated GIXD (Bragg peaks) data of the lipid film before
(A), five hours (B) and 13 hours (C) after applying Gal-1. The two time points
corresponded to approximately 14% and 20% area expansion of the lipid monolayer. The
diffraction pattern was fitted using the sum of three Voigt profiles (solid line) and deconvoluted into separate peaks (dashed lines) corresponding to each of {1,0}, {0,1} and {1,1} Bragg peaks. Bragg peaks were obtained by integrating over the (-0.05 Å-1 ≤ qz ≤ 0.8
Å-1). (A’, B’, C’) Sum of the three {1,0}, {0,1}, {1,-1} Bragg rods corresponding to
DPPE:GM1, t = 5hrs and t = 13hrs after injection of Gal-1. By integrating over the
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(1.35 Å-1 ≤ qxy ≤ 1.55 Å-1) region, the Bragg rods were fitted (solid line) by approximating
the coherently scattering part of the alkyl tail by a cylinder of constant electron density.
Each of the separate Bragg rods are shown as dashed lines in the figure.
The diffraction patterns obtained for a DPPE:GM1 monolayer at 20 mN/m and 20 °C
before and after applying Gal-1 are shown in Figure 6.3 and Figure 6.4, the resulting
structural parameters are summarized in Table 6.1 and Table 6.2. The diffraction obtained
for the mixed DPPE-GM1 before Gal-1 injection is similar to previously published data
(Miller et al., 2008; Watkins et al., 2011).
For each of the systems measured, three Bragg peaks were observed at qxy ~ 1.42, 1.45,
and 1.48 Å-1. The presence of three Bragg peaks is indicative of an oblique 2D cell. For
each of the system the integrated intensities of the three Bragg peaks
(-0.05 Å-1 ≤ qz ≤ 0.8 Å-1) were approximately the same (see dashed lines in Figure 6.4) in
agreement with the multiplicity rule. The three peaks can be indexed as {1,0}, {0,1} and
{1,-1}. The calculated d-spacing values (d-spacing = 2π/qxy), d10, d01, and d1-1, give rise to
the dimensions and of the unit vectors |a| , |b| and the angle between them γ for the primitive
2D unit cell, with as well the area per two alkyl chains, are summarized in
Table 6.1.
Assuming that the monolayer consists of perfect 2D crystallites of an average
dimension Lxy (the lateral coherence length) in the crystallographic direction {h, k} with
no preferred azimuthal orientation, the Scherrer formula (Guinier, 1963) can be used to
calculate the coherence length in the three crystallographic directions using the equation
Lxy ≈ 0.9[2π/ FWHMintrinsic (qxy)] {h, k}. As the corresponding full width at half maximum
(FWHM) of the three peaks exceeds the instrumental resolution of
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FWHMresol (qxy) = 0.0084Å-1, the intrinsic FWHM can be obtained using the equation
FWHMintrinsic (qxy) = [FWHMmeas (qxy) 2 - FWHMresol (qxy) 2]1/2. From this analysis, the lateral
coherence lengths for the three peaks, L10 , L01, and L1-1, were calculated and summarized
in Table 6.2. As a reference, a distance of 500 Å encompasses approximately 100 alkyl
chains or a crystalline domain 50 lipids across.
The combined Bragg rod profile of the {0,1}, {1,0} and {1,-1} reflections, shown in
Figure 6.4 A’, B’, C’, was produced by integrating the scattering data through the
1.35 Å-1 ≤ qxy ≤ 1.55 Å-1 region of the three peaks. Analysis of the Bragg rod profiles was
done by approximating the lipid alkyl tails as tilted cylinders with constant electron density
and length Lc (Als-Nielsen et al., 1994). Results are summarized in Table 6.1. As shown in
Figure 6.4, the diffraction patterns from the DPPE:GM1 and DPPE:GM1 + Gal-1
(t2 = 13 hrs) monolayers are similar, indicating that in the ordered phase, they have similar
area per lipid molecule (43.5Å2), alkyl tails tilt (~21.45 0.15° from the surface normal),
and azimuthal angle (10.8  0.3° from the nearest neighbor defined by the vector a+b).
However, the length of the cylinder with constant electron density used to model the
intensity distribution along the Bragg rods, Lc, was 18.9 for pure DPPE:GM1 vs. 17.3 Å at
t2. This suggests that Gal-1 interaction with DPPE:GM1 caused a small (1.5 Å) vertical
displacement in the lipid packing. Additionally, at t2 the L1-1 coherence length increased
from 500 to 760 Å, suggesting improvement in packing of the lipid tails along this
crystallographic direction (Table 6.2).
The diffraction from DPPE:GM1 + Gal-1 at t1 = 5 hours is different from the so far
presented cases of pure lipids (no protein) or 13 hours after lectin application. Although
the length of the cylinder, Lc, was the same as in the case of the DPPE:GM1 monolayer
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before Gal-1 insertion (18.9 Å), which suggested no out-of-plane lipid displacements, the
area per molecule decreased to 43.1 Å2, and alkyl tails tilt and azimuthal angle decreased
to 19.4° and 2.6°, respectively. The L1-1 coherence length also decreased from 500 to 380
Å, suggesting a reduction in the positional registry between the lipid tails along this
crystallographic direction (Table 6.2).
With the insertion of Gal-1, the intensity of the diffraction peaks decreased to about
35% at t1 compared to that of lipids alone, indicating that crystalline order in lipids has
been partially disrupted. As indicated, this appeared as transient phenomenon, partial
recovery of the amount of ordered phase as the integrated intensities increased to 70% at t2
= 13 hours. Of note, such a result has not been previously observed for the number of
protein-membrane systems we have studied to date. Although the cause of this recovery of
ordered phase is unclear, it is evident that the initial association of Gal-1 with the LC phase
of the lipid membrane was followed by reorganization and/or relaxation of the system such
that liquid-condensed phase reformed, e.g., clustering and oligomerization of membraneassociated Gal-1. The increased LC phase with incubation time could also be caused by
large-scale heterogeneities, e.g., lipid phases and protein may not have been uniformly
distributed in the film. This is rather unlikely since we have never observed such
phenomena.
Interestingly, no diffraction signal was observed in the low qxy region (0.05 - 1.0 Å-1,
120 Å > d-spacing >6 Å) corresponding with higher d-spacings of the measured spectra
(data not shown). Therefore, we can conclude that neither Gal-1 nor pentasaccharide
headgroups of GM1 form regular arrays of sufficient size to be detectable by GIXD.
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Table 6.1 Summary of Parameters Obtained from Analysis of GIXD data
DPPE:GM1
20 mN/m, 20ºC
Distorted a (Å)
4.91  0.01
Hexagonal
b (Å)
5.01  0.01
Unit Cell
γ (degrees) 117.1  0.4

DPPE:GM1
Gal-1
t1 = 5hrs

DPPE:GM1
Gal-1
t2 = 13hrs

4.89  0.01

4.90  0.01

5.00  0.01

5.01  0.01

118.0  0.4

117.7  0.4

Area per
molecule
(Å2)

43.5  0.1

43.1  0.1

43.5  0.1

Integrated
Intensity
(%)

100

35

70

Coherence
Length, Lc
(Å)

18.9  0.5

18.9  0.5

17.3  0.5

Tilt Angle
t (°)

21.6  1.0

19.4  1.0

21.3  1.0

11.1  1.0

2.6  2.0

10.5  1.0

0.9  0.2

0.94  0.2

0.84  0.2

Tilt dir.
from NN,
non-symmetry
(°)


(Å)

Lc is the length of the coherently scattering part of the alkyl tail measured along its
backbone. Tilt angle is measured from the surface normal. The tilt angle is measured
between direction of nearest neighbor and the projection of the alkyl tail on the subphase
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surface. Nearest neighbor (NN) is along a + b, where a and b are the 2D unit cell vectors.

 is the vertical Debye-Waller factor or root mean-square molecular displacement normal
to the surface.

Table 6.2 In-plane Coherence Lengths Obtained from GIXD Data
In-Plane Bragg Peaks

20 mN/m, 20ºC

Coherence
Lxy

Length,

(Å)  10 Å
L01

L10

L1-1

160

190

500

DPPE:GM1 + Gal-1, 180
t1 = 5hrs

180

380

DPPE:GM1 + Gal-1, 160
t2 = 13hrs

200

760

DPPE:GM1

Length, Lxy, is the in-plane coherence length; an average size of the 2-D “crystalline”
islands.

Whereas GIXD measurements probe only the crystalline portion of the hydrocarbon
chains in the footprint of the X-ray beam, XR provides averaged structural information
from both the 2D-crystalline and amorphous parts of the monolayer along the direction
perpendicular to the lipid film. The reflectivity data was analyzed using an optical matrix
method (StochFit) (Danauskas et al., 2008), assuming that the mixed monolayers formed
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homogeneous thin films. This is justified since previous Brewster angle and fluorescent
microscopy studies show that the components mix, rather than phase separate (Miller et
al., 2008; Watkins et al., 2011). Following the StochFit procedure (Danauskas et al., 2008)
the electron density distribution, normalized to that of water, along the subphase surface
normal was approximated by a large number slabs, each with a constant electron density,
interconnected by error functions. In this model-independent fitting procedure, the electron
density of each slab was varied to optimize a mathematical construct to obtain the smooth
functional form of the electron density distribution which results in the best fit (lowest χ2
values) to the measured XR data. Twelve slabs were sufficient to adequately model XR
profiles obtained from this study. The top row of Figure 6.5 shows XR data (red circles)
along with the best fits (solid and dashed black lines) based on electron density
distributions presented in the bottom row by color solid lines.
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Figure 6.5 Fresnel normalized X-ray reflectivity (top row) and normalized electron
density distribution (bottom row) of the DPPE:GM1 lipid films.
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Figure 6.5 illustrates Fresnel normalized X-ray reflectivity (top row) and
normalized electron density distribution (bottom row) of the DPPE:GM1 lipid films before
(A and A’) and at t1 = 5 hours after Gal-1 injection (B, B’), and t1 = 13 hours after Gal-1
injection (C, C’). Measured data is represented as symbols, and lines (solid and dashed)
represent fits corresponding to the electron density profiles shown in A’, B’ and C’. The
electron densities (z) are normalized to the electron density of buffer subphase
(subphase 0.335 e-/Å-3). Error bars for the reflectivity data represent statistical errors in these
measurements.
As shown in Figure 6.5, insertion of the lectin induced substantial changes in the
reflectivity profiles of the lipid monolayer (Figure 6.5A-C). Not surprisingly, electron
density profiles from the model independent fitting of XR data also appeared to undergo
significant changes with insertion (solid profiles in Figure 6.5A’, 6.5B’, and 6.5C’). In
order to gain a better physical understanding of structural changes of the DPPE:GM1
monolayer upon interactions with Gal-1, the electron density profiles obtained from the
model independent StochFit procedure were de-convoluted into three boxes (or slabs) of
constant electron densities (dashed, step-like electron density distributions shown in
bottom row of Figure 6.5). This the model-dependent fitting of the XR data. Applying
roughness (or smearing) to the step-like model-dependent profiles resulted in the electron
density distributions (solid black lines in the bottom row) almost indistinguishable from
the original distribution from the model independent fits (solid color lines). The new
electron density profiles can be used to calculate the XR (dashed lines, top row). These
new fits, based on only three slabs, differ from model independent fits only at high
momentum transfer vectors, qz. Such a simple, but physically reasonable model allows for
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better understanding of the evolution of the system and provides a mean to approximate
the location of Gal-1 at the interface. As shown in Figure 6.5A’, and in agreement with
previously published studies (Majewski et al., 2001; Miller et al., 2008; Watkins et al.,
2011), the mixed DPPE:GM1 monolayer can be adequately modeled by three slabs - one
for the GM1 headgroups and water, one for the mixed DPPE and GM1 headgroup region,
and another for the acyl tails of both lipids. The same scheme of slabs were found to
adequately model the XR data at both time points after the injection of Gal-1 into the
subphase (Figure 6.5B’, 6.5C’).
A few qualitative observations can be made directly from the reflectivity profiles in
Figure 6.5. When the lectin was present in the subphase, the XR interference fringes
became less distinguished. This is indicative of an increased disorder (along surface
normal) imposed on perfectly aligned DPPE:GM1 monolayer by lectin presence. Electron
density profiles of the membrane before and after lectin insertion are overlaid and presented
in Figure 6.6A for direct comparison. It is immediately visible that interaction with Gal-1
molecules results in pronounced changes in the electron density distribution across the airliquid interface. The initial three distinct slabs composed of tails/DPPE:GM1-heads/GM1heads structure becomes less stratified and more electrons are present towards the air
interface, i.e. in the alkyl chain region with the addition of Gal-1. Increasing incubation
time, and thereby the extent of Gal-1 insertion, resulted in a monotonic increase of the
electron density in the lipid tail region (0 to 20 Å from the air interface) and decease in the
headgroup regions (approximately 20 to 40 Å towards the liquid subphase). These changes
are more apparent when the differences between t1 and t2 electron density profiles and that
of the lipids alone are calculated and plotted (Figure 6.6B).
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Figure 6.6 Comparison of normalized electron density distribution for

Figure 6.6 illustrates in A: Comparison of normalized electron density
distribution for DPPE-GM1 monolayer (red) and at t1 = 5 hours (blue) and t2 = 13
hours (green) after Gal-1 injection. Dashed and solid lines represent the electron
densities from the three slab model that is un-smeared and smeared, respectively.
The electron densities (z) are normalized to the electron density of liquid subphase
(subphase 0.335 e-/Å-3). B: Differences between the electron density profiles of
DPPE:GM1 monolayer and Gal-1 associated lipid monolayer at t1 = 5 hours
(dashed line) and t2 = 13 hours (solid line) after Gal-1 injection.

The integration of the area under the step-like profiles (dashed lines in Figure 6.5A’,
B’, and C’) provides information on the total number of electrons per Å2 in the footprint of
the X-ray beam. Despite the increase of the area per molecule (Figure 6.2B) and therefore
decrease in the number of DPPE:GM1 lipids in the footprint of the X-ray beam, the number
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of electrons increased from 14.0 e-/Å2 for DPPE:GM1, to 14.5 and 17.2 e-/Å2 at t1 = 5 hrs
and t2 =13 hrs, respectively. These changes correspond to 4% and 23% increases in the
number of electrons. Such enhancement can only be explained by the presence of lectin in
the lipid monolayer. When corrected by the 14% and 20% increase in area per molecule
due to lectin insertion, the rises in electron density were increased to 19% and 48% at t1
and t2, respectively. Therefore, at the final stage of the measurement (t = 13 hours), 50%
electron density increase can be attributed to the presence of Gal-1 in the monolayer.

6.4 Conclusions
X-ray scattering data of DPPE–GM1 mixed monolayers at the air–buffer interface
before and after injection of lectin have been presented. We studied a 80:20 mol%
DPPE:GM1 monolayer before and after injection of solution of 21 μg/ml into the subphase
at the constant surface pressure of 20 mN/m and temperature of 20 ºC. Similar to previously
published data (Majewski et al., 2001), no phase separation of DPPE and GM1 components
or lateral domain formation in these mixtures was detected. The GIXD results indicate that
insertion of lectin into the lipid monolayer affects the lipid-ordered (LC) phase of the
monolayer, but in a very peculiar way. Upon interaction with Gal-1, the packing
arrangement of alkyl chains was only slightly changing (Table 6.1). However, the amount
of the LC phase after five hours of incubation first decreased to 35% of the original value,
then subsequently increased to 70% after 13 hours of incubation. The oblique 2D unit cell
dimensions and size of the crystallite domains of the pure DPPE:GM1 monolayer and at t
= 13 hours after Gal-1 injection remained similar. However, for the intermediate time of t
= 5 hours, the changes in the packing of the alkyl tails (and overall intensity of the
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scattering) were very pronounced and suggest that there might be an initial stage of strong
interaction after which the Gal-1 molecules oligomerize, become more soluble and leave
the gel phase or, alternatively, assume different conformation vis-à-vis the ordered lipids
which lead to decreased interactions. The changes in the GIXD pattern indicate that Gal-1
molecules have a tendency to interact with ordered monolayer phase. The average distance
between the lipid head groups in the LC phase is approximately 10 Å (twice the value of
the 2D cell dimensions, Table 6.1) and the average distance between GM1 headgroups for
the 80:20 DPPE:GM1 mixture is ~30 Å. Therefore, it is expected that protein residues
separated by such distances will predominantly influence these interactions.
The XR measurements show very pronounced changes in the electron density
distribution along the line perpendicular to the monolayer. Prior to injection of Gal-1containing solution, the electron density distribution obtained from XR measurements
shows that the DPPE headgroups and the proximal headgroups of ganglioside GM1 line
up in the 2D monolayer plane. The bulkier, branched portion of the pentasaccharide
headgroup extends further into the water subphase, minimizing lateral interactions. The
ganglioside’s sugar headgroup is easily detectable in the reflectivity profiles for t = 0 and
t = 5hours.
Based on the measured electron density distributions (Figure 6.6), there is clear
evidence of Gal-1 penetration into the hydrophobic tail region of the lipid monolayer and/or
staggering of the headgroups. XR results indicate a significant increase in the number of
electrons in the monolayer despite of the increase in area per lipid molecule due to
monolayer expansion. The excess of electrons can only be attributed to presence of Gal-1
molecules at the interface. The resulting electron density distributions (Figure 6.6 A, B)
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indicate that, along the direction of surface normal, the length scale of ~ 40 Å is affected
by the protein. There is also clear evidence that insertion of the Gal-1 is also influencing
the hydrophobic portion (alkyl tail region) of the monolayer. Despite a strong impact on
electron density distribution of the DPPE:GM1 monolayer by interactions with Gal-1, no
clear evidence of location of the molecules in a regular strata below the monolayer was
observed. The low qxy GIXD studies did not detect any in-plane ordered structures of dspacings shorter than 120 Å. That indicates no in-plane ordering of Gal-1 into regular 2D
arrays. The interaction of Gal-1 and DPPE:GM1 monolayer is very surface pressure
dependent. At the pressure of 30 mN/m, we observed no protein insertion into the
monolayer.
Contrary to the XR results, the GIXD obtained after 13 hours of Gal-1 incubation
showed only small changes in the gel phase of the monolayer. Thus we can deduce that the
protein molecules are predominantly interacting with the liquid-expanded phase. This is
also supported by the fact that at higher surface pressures (when the amount of the ordered
phase is increasing) no evidence of interaction has been observed.
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6.5 Supplementary materials

Surface Pressure

= air-water-lipid

(A)
PBS

(B)
0.021mg/mL Gal-1

(C)

Figure 6.7 Schematics of compression, injection and expansion in trough
Figure 6.7(A): Compression of lipid monolayer to 20 mN/m.
A Wilhelmy plate surface pressure sensor was used to measure the surface
pressure (π) of the lipid monolayer, which is related to the surface tension of the film
(γ) at the air/water interface.
Figure 6.7(B): Injection of Gal-1 into the subphase.

198

The protein was injected into the subphase underneath the barriers using an Lshaped syringe needle to minimize disturbances to the lipid monolayer.
Figure 6.7(C). Expansion of the lipid monolayer due to the insertion of Gal-1.
Monolayer surface area was recorded and the area expansion was calculated
as ΔA/A = (A-Ai)/Ai, where A is the surface area at time t and Ai is the surface area
of the monolayer when first compressed to 20 mN/m.
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CHAPTER 7 CONCLUSIONS AND FUTURE DIRECTIONS
We have gained numerous insights from our studies into the interactions of tau protein
and other ampholytic molecules with lipid membranes. We have observed the possible
toxicity mechanism of disruption of membranes as well as the templating and misfolding
of the agents. These observed mechanisms are consistent with the known toxicity of the
ampholytic tau protein’s interaction with the lipid membrane. We have learned about the
interactions of tau with a variety of interfaces, including the hydrophobic air/water
interface and anionic lipid membranes. Significantly, the interaction with the anionic lipid
membrane affects both the structure of the tau protein, inducing compaction and
misfolding, and the lipid membrane, causing instability and possible permeability.
Examination of hyperphosphorylation and domain composition of tau has also yielded
promising results, suggesting which domains of the protein are responsible for its abnormal
functions.

In the future, further physiologic components such as osmolytes will continue to be
added to these models. More complex models that are directly analogous to the in vivo cell
membrane could, in turn, lead to not only possible treatments and testing for pathologic
conditions caused by tau protein aggregation, but also to a better understanding of the
physiology of the normal interaction of other intrinsically disordered proteins with the cell
membrane. The data which has been collected is also being applied to the creation and
validation of computer models of ampholyte/lipid membrane interaction which are
currently underway in our laboratory. These computerized models may allow us to gain
further understanding of complex interactions that cannot be easily or practically replicated
using a physical model.
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